
<html lang="en"     class="pb-page"  data-request-id="2d29ba27-9f56-4d29-b14c-759282928437"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-8;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b01811;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach" /></meta><meta name="dc.Creator" content="Paolo  Innocenti" /></meta><meta name="dc.Creator" content="Hannah L.  Woodward" /></meta><meta name="dc.Creator" content="Savade  Solanki" /></meta><meta name="dc.Creator" content="Sébastien  Naud" /></meta><meta name="dc.Creator" content="Isaac M.  Westwood" /></meta><meta name="dc.Creator" content="Nora  Cronin" /></meta><meta name="dc.Creator" content="Angela  Hayes" /></meta><meta name="dc.Creator" content="Jennie  Roberts" /></meta><meta name="dc.Creator" content="Alan T.  Henley" /></meta><meta name="dc.Creator" content="Ross  Baker" /></meta><meta name="dc.Creator" content="Amir  Faisal" /></meta><meta name="dc.Creator" content="Grace Wing-Yan  Mak" /></meta><meta name="dc.Creator" content="Gary  Box" /></meta><meta name="dc.Creator" content="Melanie  Valenti" /></meta><meta name="dc.Creator" content="Alexis  De Haven Brandon" /></meta><meta name="dc.Creator" content="Lisa  O’Fee" /></meta><meta name="dc.Creator" content="Harry  Saville" /></meta><meta name="dc.Creator" content="Jessica  Schmitt" /></meta><meta name="dc.Creator" content="Berry  Matijssen" /></meta><meta name="dc.Creator" content="Rosemary  Burke" /></meta><meta name="dc.Creator" content="Rob L. M.  van Montfort" /></meta><meta name="dc.Creator" content="Florence I.  Raynaud" /></meta><meta name="dc.Creator" content="Suzanne A.  Eccles" /></meta><meta name="dc.Creator" content="Spiros  Linardopoulos" /></meta><meta name="dc.Creator" content="Julian  Blagg" /></meta><meta name="dc.Creator" content="Swen  Hoelder" /></meta><meta name="dc.Description" content="Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint. Chromosomally unstable ca..." /></meta><meta name="Description" content="Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint. Chromosomally unstable ca..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 7, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01811" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01811" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01811" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01811" /></link>
        
    
    

<title>Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01811" /></meta><meta property="og:title" content="Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0017.jpeg" /></meta><meta property="og:description" content="Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint. Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal numbers of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells. We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit. Compounds in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01811"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01811">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01811&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01811&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01811&amp;href=/doi/10.1021/acs.jmedchem.5b01811" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3671-3688</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01807" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01827" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rapid Discovery of Pyrido[3,4-<i>d</i>]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Innocenti">Paolo Innocenti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hannah+L.++Woodward">Hannah L. Woodward</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Savade++Solanki">Savade Solanki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A9bastien++Naud">Sébastien Naud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+M.++Westwood">Isaac M. Westwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nora++Cronin">Nora Cronin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Hayes">Angela Hayes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennie++Roberts">Jennie Roberts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+T.++Henley">Alan T. Henley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ross++Baker">Ross Baker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amir++Faisal">Amir Faisal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grace+Wing-Yan++Mak">Grace Wing-Yan Mak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Box">Gary Box</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melanie++Valenti">Melanie Valenti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexis++De+Haven+Brandon">Alexis De Haven Brandon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++O%E2%80%99Fee">Lisa O’Fee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harry++Saville">Harry Saville</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Schmitt">Jessica Schmitt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Berry++Matijssen">Berry Matijssen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosemary++Burke">Rosemary Burke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rob+L.+M.++van+Montfort">Rob L. M. van Montfort</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence+I.++Raynaud">Florence I. Raynaud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+A.++Eccles">Suzanne A. Eccles</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Spiros++Linardopoulos">Spiros Linardopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julian++Blagg">Julian Blagg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swen++Hoelder">Swen Hoelder</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Division of Structural Biology and <sup>§</sup>Breast Cancer Now, Division of Breast Cancer Research, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e99a9e8c87c781868c858d8c9ba9808a9bc7888ac79c82"><span class="__cf_email__" data-cfemail="e695918388c88e89838a828394a68f8594c88785c8938d">[email protected]</span></a>. Phone: +44 (0)2087224353.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01811&amp;href=/doi/10.1021%2Facs.jmedchem.5b01811" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3671–3688</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 7, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 November 2015</li><li><span class="item_label"><b>Published</b> online</span>7 April 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01811" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01811</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01811"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3160</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01811" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Innocenti&quot;},{&quot;first_name&quot;:&quot;Hannah&quot;,&quot;last_name&quot;:&quot;L. Woodward&quot;},{&quot;first_name&quot;:&quot;Savade&quot;,&quot;last_name&quot;:&quot;Solanki&quot;},{&quot;first_name&quot;:&quot;Sébastien&quot;,&quot;last_name&quot;:&quot;Naud&quot;},{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;M. Westwood&quot;},{&quot;first_name&quot;:&quot;Nora&quot;,&quot;last_name&quot;:&quot;Cronin&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Hayes&quot;},{&quot;first_name&quot;:&quot;Jennie&quot;,&quot;last_name&quot;:&quot;Roberts&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;T. Henley&quot;},{&quot;first_name&quot;:&quot;Ross&quot;,&quot;last_name&quot;:&quot;Baker&quot;},{&quot;first_name&quot;:&quot;Amir&quot;,&quot;last_name&quot;:&quot;Faisal&quot;},{&quot;first_name&quot;:&quot;Grace&quot;,&quot;last_name&quot;:&quot;Wing-Yan Mak&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Box&quot;},{&quot;first_name&quot;:&quot;Melanie&quot;,&quot;last_name&quot;:&quot;Valenti&quot;},{&quot;first_name&quot;:&quot;Alexis&quot;,&quot;last_name&quot;:&quot;De Haven Brandon&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;O’Fee&quot;},{&quot;first_name&quot;:&quot;Harry&quot;,&quot;last_name&quot;:&quot;Saville&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Schmitt&quot;},{&quot;first_name&quot;:&quot;Berry&quot;,&quot;last_name&quot;:&quot;Matijssen&quot;},{&quot;first_name&quot;:&quot;Rosemary&quot;,&quot;last_name&quot;:&quot;Burke&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;L. M. van Montfort&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;I. Raynaud&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;A. Eccles&quot;},{&quot;first_name&quot;:&quot;Spiros&quot;,&quot;last_name&quot;:&quot;Linardopoulos&quot;},{&quot;first_name&quot;:&quot;Julian&quot;,&quot;last_name&quot;:&quot;Blagg&quot;},{&quot;first_name&quot;:&quot;Swen&quot;,&quot;last_name&quot;:&quot;Hoelder&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3671-3688&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01811&quot;},&quot;abstract&quot;:&quot;Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint. Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal numbers of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells. We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit. Compounds in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01811&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01811" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01811&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01811" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01811&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01811" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01811&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01811&amp;href=/doi/10.1021/acs.jmedchem.5b01811" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01811" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01811" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01811%26sid%3Dliteratum%253Aachs%26pmid%3D27055065%26genre%3Darticle%26aulast%3DInnocenti%26date%3D2016%26atitle%3DRapid%2BDiscovery%2Bof%2BPyrido%255B3%252C4-d%255Dpyrimidine%2BInhibitors%2Bof%2BMonopolar%2BSpindle%2BKinase%2B1%2B%2528MPS1%2529%2BUsing%2Ba%2BStructure-Based%2BHybridization%2BApproach%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D8%26spage%3D3671%26epage%3D3688%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/jmcmar.2016.59.issue-8/20160428/jmcmar.2016.59.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint. Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal numbers of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells. We report the discovery and optimization of a series of new pyrido[3,4-<i>d</i>]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit. Compounds in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Interfering with mitotic processes has been a successful therapeutic approach to fight cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One example of a mitotic target is monopolar spindle 1 (MPS1, also known as TTK), a dual-specificity kinase that occupies a central role in the transition from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint (SAC).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This kinase prevents cells from progressing through mitosis until the kinetochores are properly attached to the microtubules and are under the appropriate tension. While this mechanism is important to ensure error-free segregation of chromosomes in normal tissues, aneuploid and chromosomally unstable cancer cells often overexpress, and are particularly dependent on, MPS1 to cope with the stress arising from abnormal numbers of chromosomes and centrosomes.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Due to these findings, it is not surprising that MPS1 is upregulated in a number of tumor types<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and that higher levels correlate with higher histological grade, aggressiveness, and poorer patient survival in breast cancer, glioblastoma, and pancreatic ductal adenocarcinoma.<a onclick="showRef(event, 'cit4a ref5'); return false;" href="javascript:void(0);" class="ref cit4a ref5">(4a, 5)</a> Furthermore, phosphatase and tensin homologue (PTEN)-deficient breast cancer cell lines have been reported to be more sensitive to MPS1 depletion or kinase inhibition.<a onclick="showRef(event, 'cit3b ref6'); return false;" href="javascript:void(0);" class="ref cit3b ref6">(3b, 6)</a></div><div class="NLM_p">Using advanced inhibitors, including our own <b>1</b> (CCT251455, vide infra),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> effective dosing schedules have been investigated in vivo. Importantly, it has recently been shown that MPS1 inhibitors have a relatively narrow therapeutic window<a onclick="showRef(event, 'cit5a ref8'); return false;" href="javascript:void(0);" class="ref cit5a ref8">(5a, 8)</a> and that they are particularly effective when used in combination with, for example, tubulin-targeting agents such as paclitaxel or CDK4/6 inhibitors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Several MPS1 inhibitors have been disclosed,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> these include AstraZeneca’s AZ3146 (<b>2</b>),<a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">(10b)</a> the Myrexis compound MPI-0479605 (<b>3</b>),<a onclick="showRef(event, 'cit8c'); return false;" href="javascript:void(0);" class="ref cit8c">(8c)</a> and the Nerviano compound NMS-P715 (<b>4</b>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Also described in the literature are MPS-IN-3 (<b>5</b>),<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a> CFI-401870 (<b>6</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and the Shionogi compounds (<b>7</b>, <b>8</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'cit8a ref13'); return false;" href="javascript:void(0);" class="ref cit8a ref13">(8a, 13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0019.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published MPS1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently disclosed a series of 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridines exemplified by the potent and selective chemical probe <b>1</b>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, while this compound showed excellent potency in biochemical and cellular assays, other properties hampered further development. In particular, <b>1</b> has a relatively high molecular weight (504) and AlogP (5.7) and also featured a <i>tert</i>-butoxycarbonyl (Boc) moiety that appeared critical for potent inhibition but unsurprisingly proved to be unstable under strongly acidic conditions.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In addition, <b>1</b> was a potent cytochrome P450 (CYP) inhibitor (IC<sub>50</sub> < 1 μM observed for CYP 1A2, 3A4, 2C9, 2C19, 2D6) which represented a significant issue not least because MPS1 inhibitors are reported to be particularly effective in combination with other chemotherapeutic agents, e.g., paclitaxel. To mitigate the risk that these undesirable features were inherent to the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series, we set out to discover a second structurally unrelated chemotype featuring a clean CYP profile, no acid labile groups, and significantly lower molecular weight and lipophilicity. We thus set out to discover an additional lead series that (a) showed potent inhibition of MPS1 in cellular assays (IC<sub>50</sub> < 100 nM), (b) showed good ligand efficiency (L.E. ∼ 0.35),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (c) displayed excellent selectivity, in particular against other cell cycle kinases such as cyclin-dependent kinase 2 (CDK2), Aurora A and B, and more generally against the wider kinome (<i>K</i><sub>i</sub> ratio >100), (d) robustly modulated MPS1 kinase activity in a human tumor xenograft PK/PD model, and (e) showed significant scope for further modification.</div><div class="NLM_p last">Herein we describe the rapid discovery of such a series by structure-based hybridization of the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series and a modestly potent hit from a focused kinase library screen. This completely new MPS1 series featured an unexploited kinase chemotype (the pyrido[3,4-<i>d</i>]pyrimidines) and advanced examples displayed subnanomolar <i>K</i><sub>i</sub>s and excellent overall selectivity. The favorable in vitro properties translated into biomarker modulation in an in vivo human tumor xenograft model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of isoquinolines <b>14</b>, <b>15a</b> and <b>15b</b> was carried out from the commercially available 5-bromo-3-chloroisoquinoline <b>9</b> through sequential Suzuki couplings and Buchwald reactions using suitable boronic acids or esters and the required anilines (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Isoquinoline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Furan-2-ylboronic acid or 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, DME/water, μW, 105 °C; (b) 4-methoxyaniline <b>12</b> or 2,4-dimethoxyaniline <b>13</b>, <sup><i>t</i></sup>BuXPhos, Pd<sub>2</sub>dba<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, <sup><i>t</i></sup>BuOH/water, μW, 80–100 °C. Reaction yields are in parentheses.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrido[3,4-<i>d</i>]pyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, THF/water, 65 °C (<b>17</b>); (b) cyclopropyl boronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(OAc)<sub>2</sub>, PCy<sub>3</sub>, toluene/water, 95 °C (<b>18</b>); (c) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) <i>N</i>-(4-methoxyphenyl)formamide <b>21</b> or <i>N</i>-(2,4-dimethoxyphenyl)formamide <b>22</b>, DMSO, Cs<sub>2</sub>CO<sub>3</sub>, 100 °C (<b>24a</b>,<b>b</b>); (e) 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>23</b>, TFA, 1,2,3-trifluoroethanol, μW, 130 °C (<b>24c</b>,<b>d</b>); (f) ArNHCHO (<b>26a</b>–<b>e</b>), NaH, THF, rt; (g) 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole or phenyl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane/water, 100 °C. Reaction yields are in parentheses.</p></p></figure><div class="NLM_p">Compounds <b>24a</b>–<b>d</b> and <b>28a</b>–<b>e</b> in the pyrido[3,4-<i>d</i>]pyrimidine series were prepared according to a previously described strategy which makes use of the novel 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine building block <b>16</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Thus, reaction with 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole or cyclopropylboronic acid under Suzuki conditions yielded intermediates <b>17</b> and <b>18</b>. These thiomethyl derivatives were in turn oxidized to the corresponding sulfones using <i>m</i>-CPBA and subsequently coupled with the required anilines or formamides to afford compounds <b>24a</b>–<b>d</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). In the majority of cases though, the order of events was reversed. Oxidation of 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>16</b> yielded the corresponding sulfone <b>25</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which was coupled with a series of formamides furnishing chloro-intermediates <b>27a</b>–<b>e</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Final compounds <b>28a</b>–<b>e</b> were obtained by means of palladium-catalyzed Suzuki couplings with commercially available boronic acids or esters. Pyrido[3,4-<i>d</i>]pyrimidines <b>33a</b> and <b>33b</b> were prepared by direct substitution of amines on the 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine building block <b>16</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The resulting thiomethyl derivatives <b>29</b> and <b>30</b> were oxidized to the corresponding sulfones <b>31</b> and <b>32</b> and subsequently coupled with the required formamides to afford final compounds <b>33a</b> and <b>33b</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Functionalization of Pyrido[3,4-<i>d</i>]pyrimidine Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Amine, NMP, 80–135 °C; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>23</b>, TFA, 1,2,3-trifluoroethanol, μW, 130 °C. Reaction yields are in parentheses.</p></p></figure><div class="NLM_p">Pyrido[3,4-<i>d</i>]pyrimidines <b>34a</b>–<b>h</b> were prepared from intermediate <b>27a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> by displacement using the appropriate nucleophiles (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). In one instance the synthetic strategy involved the use of known pyridone <b>35</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> as a starting material: O-alkylation in the presence of base and bromomethyl cyclopropane gave intermediate <b>36</b>. Oxidation using <i>m</i>-CPBA and subsequent coupling with formamide <b>26a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> afforded pyrido[3,4-<i>d</i>]pyrimidine <b>38</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Derivatives Containing 8-Position N, O, and S Substituents<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Amine, NMP, 80–135 °C (<b>34a</b>–<b>e</b>, <b>g</b>, <b>h</b>); (b) cyclohexyl thiol, K<sub>2</sub>CO<sub>3</sub>, DMF, rt (<b>34f</b>); (c) Ag<sub>2</sub>CO<sub>3</sub>, bromomethyl cyclopropane, CHCl<sub>3</sub>, rt to 60 °C; (d) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) <i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide <b>26a</b>, NaH, THF, rt. Reaction yields are in parentheses.</p></p></figure><div class="NLM_p last">In all cases, formamides and anilines were commercially available (<b>12</b>, <b>13</b>, <b>21</b>) or could be synthesized by means of standard transformations (<b>22</b>, <b>23</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and <b>26a</b>–<b>e</b>, see <a class="ref internalNav" href="#sec5" aria-label="Experimental">Experimental</a> section and <a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">Supporting Information</a> for details). In every case, formylation was carried out by refluxing in formic acid.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">At the start of this work, relatively few inhibitors of MPS1 had been disclosed. In addition to our 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> we had identified and crystallized 1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine <b>39</b>, a modestly potent hit, during an initial screening campaign. This compound showed low molecular weight (MW = 261) and acceptable ligand efficiency (L.E. = 0.43). The crystal structure of MPS1 in complex with <b>39</b> revealed that it binds in a complementary way to <b>4</b>, whereby the pyrazole moiety binds to the hinge region of the protein. The furan moiety occupies the same region as the carbamate in the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series. The phenyl ring and aniline moiety also occupy similar parts of the binding pocket (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Based on these results, we anticipated that <b>39</b> would represent a viable starting point for a second series but that extensive optimization of potency and selectivity would be required. In order to rapidly discover a new series, while utilizing previously gained SAR data, we merged the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine scaffold with the screening hit <b>39</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Docking suggested that both the isoquinoline and pyrido[3,4-<i>d</i>]pyrimidine scaffolds could serve as hinge-binder elements for such a hybrid series (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The isoquinoline scaffold had the advantage that proof-of-concept molecules could be rapidly prepared using precedented chemistry and commercially available building blocks. The pyrido[3,4-<i>d</i>]pyrimidine scaffold, on the other hand, was attractive from the point of view of novelty, the significantly lower lipophilicity, and the fact that it incorporated an additional pyridine nitrogen from screening hit <b>39</b>. This scaffold, however, required significant investigation into its synthesis.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Our plan was thus to prepare a select number of proof-of-concept molecules based on the isoquinoline core and to expand into the less explored and more polar pyrido[3,4-<i>d</i>]pyrimidine series if the initial isoquinolines showed promising activity and ligand efficiency.</div><div class="NLM_p">We used our biochemical MPS1 assay at 10 μM ATP concentration and an in-house electrochemiluminescence Meso Scale Discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition, we routinely determined selectivity against CDK2 and Aurora A and B. We did not detect significant activity against either Aurora A or B throughout the series (see <a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">Supporting Information</a>). Furthermore, as the IC<sub>50</sub> values of our inhibitors approached the assay enzyme concentrations, and thus the limit of the dynamic range of our biochemical assay, we also determined the biochemical potency at a higher (1 mM) ATP concentration (vide infra). As stated above, our overall goal for this lead-finding effort was to show that potent (cellular IC<sub>50</sub> < 100 nM) and selective compounds (CDK2/MPS1 <i>K</i><sub>i</sub> ratio >100) could be obtained which exhibit lower molecular weight (around 450 Da) and improved ligand efficiency (L.E. in region of 0.35) compared with the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series. Moreover, our goal was to show robust activity in our PK/PD human tumor xenograft model.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0020.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Superimposed crystal structure of MPS1 (pale green) bound to <b>1</b> (carbon atoms colored pink), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, onto the structure of MPS1 (not shown) bound to <b>39</b> (carbon atoms colored yellow), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHY">5EHY</a>, showing the complementary binding of the modestly potent hit <b>39</b> and MPS1 inhibitor <b>1</b> to the hinge region of MPS1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0021.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hybridization strategy for the development of a novel chemical series of inhibitors of MPS1, from previously reported inhibitor <b>1</b> and screening hit <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The data for the initial set of compounds are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. The MPS1 inhibition for <b>14</b> was modest (IC<sub>50</sub> = 3.66 μM, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), but replacing the furan with a pyrazole (<b>15a)</b> not only lowered lipophilicity but also gave a 5-fold increase in potency (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Moreover, incorporating an additional methoxy group led to a significant gain in potency, and the IC<sub>50</sub> of <b>15b</b> reached our goal for an initial proof-of-concept compound. As seen with the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridines,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the latter greatly improved selectivity toward CDK2. The significant gain in potency can be ascribed to the interaction of the aniline’s 2-methoxy substituent with a small hydrophobic pocket formed by Lys529, Ile531, Gln541, and Cys604.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This pocket is not present in most other kinases including CDK2, explaining the beneficial effect on kinase selectivity.</div><div class="NLM_p">Having achieved satisfactory potency and ligand efficiency (L.E. for <b>15b</b> = 0.36) by merging the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series and screening hit <b>39</b>, we investigated the less lipophilic pyrido[3,4-<i>d</i>]pyrimidine scaffold. Gratifyingly, 8-substituted 2-anilinopyrido[3,4-<i>d</i>]pyrimidines proved to be more potent than their isoquinoline counterparts, reaching the double digit nanomolar range despite significantly lower calculated logP (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Isoquinoline <b>15b</b> along with pyrido[3,4-<i>d</i>]pyrimidines <b>24a</b> and <b>24b</b> were next tested in an MSD-based cellular assay. Both <b>15b</b> and <b>24b</b> showed only modest inhibition of the autophosphorylation of ectopically expressed MPS1 in HCT116 cells, most likely due to suboptimal biochemical potency. In the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series, introduction of a pyrazole substituent at the 4-position of the aniline caused a significant increase in biochemical and cellular potency.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Gratifyingly, this structural modification also resulted in a further improvement in biochemical potency for the pyrido[3,4-<i>d</i>]pyrimidine series, with compound <b>24c</b> achieving a MPS1 IC<sub>50</sub> = 0.008 μM and a cellular P-MPS1 IC<sub>50</sub> = 0.604 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Data for Initial Proof-of-Concept Isoquinolines (<b>14</b>, <b>15a</b>, <b>15b</b>) and Pyrido[3,4-<i>d</i>]pyrimidines (<b>24a</b>–<b>c</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Results are mean (±SD) for <i>n</i> ≥ 3 or mean values of two independent determinations with individual determinations in parentheses or samples run <i>n</i> = 1. “P-MPS1″ indicates an electrochemiluminescence MSD-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Potency at the lower limit of the dynamic range of the Caliper assay run at 10 μM ATP concentration. IC<sub>50</sub> value is likely to be lower than that quoted.</p></div></div><div></div></div><div class="NLM_p">We solved the crystal structure of MPS1 in complex with isoquinoline <b>15b</b> and pyrido[3,4-<i>d</i>]pyrimidine <b>24b</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The two structures overlaid very well with the crystal structure of <b>1</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and B), binding to the hinge region through the same motif as seen with the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridines. This reinforced our initial hypothesis that merging the 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine series and <b>39</b> would give a suitable starting point for an additional series of inhibitors. The aniline portion of all compounds overlaps as well as the 5-position and 8-position substituents of the isoquinolines and pyrido[3,4-<i>d</i>]pyrimidines, respectively, occupying the same region as the carbamate group of <b>1</b>. Of note is the difference in conformation for <b>15b</b> and <b>24b</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and D). The introduction of two extra nitrogen atoms into the aromatic ring, and thus removal of two hydrogen atoms, results in a much more planar structure for the pyrido[3,4-<i>d</i>]pyrimidine <b>24b</b>. We measured the dihedral angles for both of these compounds: isoquinoline <b>15b</b> exhibits a dihedral angle of 98° and pyrido[3,4-<i>d</i>]pyrimidine <b>24b</b> exhibits a dihedral angle of −20° (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D). The more coplanar conformation of pyrido[3,4-<i>d</i>]pyrimidines mirrors the coplanar conformation of the carbamate function of <b>1</b> and is likely to be at least partially responsible for the improved activity seen with the much less lipophilic pyrido[3,4-<i>d</i>]pyrimidines. Based on these crystal structures, we had confidence that with further optimization we would achieve potent and selective pyrido[3,4-<i>d</i>]pyrimidine based inhibitors of MPS1.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0022.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Superimposed crystal structure of MPS1 (pale green) bound to <b>1</b> (carbon atoms colored pink), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, onto the structure of MPS1 (not shown) bound to <b>15b</b> (carbon atoms colored cyan), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6">5EI6</a>. (B) Superimposed crystal structure of MPS1 (pale green) bound to <b>1</b> (carbon atoms colored pink), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, onto the structure of MPS1 (not shown) bound to <b>24b</b> (carbons atoms colored green), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2">5EI2</a>. (C) Superimposed crystal structure of MPS1 (pale green) bound to <b>15b</b> (carbon atoms colored cyan), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6">5EI6</a>, onto the structure of MPS1 (not shown) bound to <b>24b</b> (carbon atoms colored green), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2">5EI2</a>, showing the extent of the conformational difference between the isoquinoline and pyrido[3,4-<i>d</i>]pyrimidine scaffolds. (D) Side-by-side view of compound <b>15b</b> (carbon atoms colored cyan) and <b>24b</b> (carbon atoms colored green) showing the difference in angle of the <i>N</i>-methylpyrazole group. 2Fo – Fc density contoured at 1σ is overlaid and displayed in the same color as the respective compound carbon atom color. A water molecule interacting with compound <b>24b</b> is also displayed as a red sphere. <b>15b</b> exhibits a dihedral angle of 98°, and <b>24b</b> exhibits a dihedral angle of −20°.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Through our hybridization strategy and exploration of the pyrido[3,4-<i>d</i>]pyrimidine scaffold, we had achieved a potent inhibitor (<b>24c</b>, MPS1 IC<sub>50</sub> = 0.008 μM) and for the first time reached significant levels of cellular inhibition with IC<sub>50</sub> values below 1 μM. Compound <b>24c</b> represented a promising starting point for further optimization of this compound into a novel series of MPS1 inhibitors.</div><div class="NLM_p">Since our initial goal was to show target modulation in a human tumor xenograft model in mice, we investigated the stability of <b>24c</b> in mouse liver microsomes. Unfortunately, <b>24c</b> showed high turnover (MLM = 73% following 30 min incubation) and was not suitable for in vivo experiments. Metabolite ID studies suggested loss of a methyl group, and we suspected that the methoxy aniline substituent was the most likely site of demethylation. This methoxy group was important for both potency and selectivity. After consideration of the X-ray crystal structures we had in hand, suggesting that larger substituents at this position would be tolerated, we prepared and tested a series of compounds in which this putative metabolic soft spot was replaced with similar moieties (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The majority of these compounds showed higher IC<sub>50</sub> values than <b>24c</b> with the exception of the ethoxy derivative <b>28c</b>, which achieved comparable potency, while exhibiting significantly improved CDK2 selectivity (>28 fold improvement over <b>24c</b>) and MLM stability (MLM = 45%). This increase in selectivity is likely due to the fact that the aniline 2-position substituent occupies a small lipophilic pocket present in MPS1, mentioned previously, consisting of Lys529, Ile531, Gln541 and the gatekeeper+2 residue Cys604. This pocket is not available in CDK2 due to the presence of the bulkier gatekeeper residue Phe82. The larger 2-position ethoxy substituent (<b>28c</b>) clashes with the CDK2 gatekeeper+2 residue, resulting in a better selectivity window than is seen for the methoxy derivative <b>24c</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical, Cellular, And Mouse Microsomal Turnover Data for Compounds Bearing Alternative Aniline Substituents<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0009.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0010.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Results are mean (±SD) for <i>n</i> ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run <i>n</i> = 1. “P-MPS1″ indicates an electrochemiluminescence MSD-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Potency at the lower limit of the dynamic range of the Caliper assay run at 10 μM ATP concentration. IC<sub>50</sub> value is likely to be lower than that quoted.</p></div></div><div></div></div><div class="NLM_p">Unfortunately, <b>28c</b> was 5-fold less active in the cellular assay, which given the similar biochemical potency and physicochemical properties was difficult to rationalize. While we regarded the ethoxy as a valuable alternative for the methoxy group, with significantly improved selectivity and reduced risk of reactive intermediate formation through metabolic dealkylation, we decided to maintain the methoxy in place due to the improved cellular activity. Instead, we looked to improve the metabolic stability through modification at the 8-position of the pyrido[3,4-<i>d</i>]pyrimidine scaffold. We hypothesized that by introducing diverse substituents at this position of the scaffold, the molecular recognition of the compounds by metabolic enzymes would be affected leading to increased stability.</div><div class="NLM_p">In order to address these aspects we used the structural information gathered on pyrido[3,4-<i>d</i>]pyrimidine <b>24c</b>. The crystal structure of this inhibitor showed that the 8-position pyrazole group binds to a hydrophobic pocket formed by Ile531, Val539, Met671, and Pro673 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). This is the same pocket that is occupied by the carbamate group of <b>1</b> and is sufficiently large to accommodate a variety of hydrophobic groups (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). It is also of note that the crystal structure of MPS1 in complex with <b>24c</b> shows ordering of the activation loop of MPS1, as is seen with <b>1</b>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We thus prepared and tested a small set of compounds with different pyrazole replacements including a saturated pyrrolidine ring.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Crystal structure of MPS1 (pale green) bound to <b>24c</b> (carbon atoms colored orange), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, showing residues (Ile531, Val539, Met671, and Pro673) present in the hydrophobic pocket occupied by 8-position pyrazole. (B) Superimposed crystal structure of MPS1 (pale green) bound to <b>24c</b> (carbon atoms colored orange), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, onto the structure of MPS1 (not shown) bound to <b>1</b> (carbon atoms colored pink), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, showing that this is the same pocket occupied by the carbamate group of <b>1</b> (carbon atoms colored pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The data for these compounds are summarized in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. The phenyl-substituted derivative (<b>28a</b>) showed comparable potency in the biochemical and cellular assay and, despite higher lipophilicity, improved microsomal stability. The cyclopropyl derivative <b>24d</b> lost considerable activity, possibly due to the fact that this group is too small to engage in significant hydrophobic interactions. Interestingly, replacement of the pyrazole with a saturated pyrrolidine (<b>33a</b>) led to an equipotent compound in the biochemical assay. All compounds showed selectivity against CDK2 (CDK2/MPS1 ratio >80).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical, Cellular, And Mouse Microsomal Turnover Data for Compounds Bearing Alternative 8-Position Substituents<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0011.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0012.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Results are mean (±SD) for <i>n</i> ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run <i>n</i> = 1. “P-MPS1″ indicates an electrochemiluminescence MSD-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Potency at the lower limit of the dynamic range of the Caliper assay run at 10 μM ATP concentration. IC<sub>50</sub> value is likely to be lower than that quoted.</p></div></div><div></div></div><div class="NLM_p">Of the compounds presented in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, we considered the pyrrolidine derivative (<b>33a</b>) as the most promising for further optimization. A saturated moiety offered more possibilities to optimize the three-dimensional hydrophobic interactions in this subpocket compared with an aromatic ring where substituents can only be placed in the plane of the ring. Furthermore, increasing the number of sp<sup>3</sup> centers has been suggested as a general approach to improve solubility and drug-like properties.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We thus prepared a series of compounds with a saturated substituent in this position.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biochemical, Cellular, And Mouse Microsomal Turnover Data for Compounds Bearing a Saturated Substituent at the 8-Position<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0013.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0014.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Results are mean (±SD) for <i>n</i> ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run <i>n</i> = 1. “P-MPS1″ indicates an electrochemiluminescence MSD-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. “HCT116 GI<sub>50</sub>” indicates a cell proliferation assay carried out by colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in HCT116 cells.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Potency at the lower limit of the dynamic range of the Caliper assay run at 10 μM ATP concentration. IC<sub>50</sub> value is likely to be lower than that quoted.</p></div></div><div></div></div><div class="NLM_p">Importantly, since the IC<sub>50</sub> values of many compounds were now approaching the enzyme concentration and thus the limit of the dynamic range of the biochemical assay, we complemented the MPS1 kinase assay at 10 μM ATP with testing at 1 mM ATP. It has been demonstrated that increasing the ATP concentration shifts the IC<sub>50</sub> values of ATP competitive inhibitors to higher values, therefore increasing the dynamic range of the assay.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Due to the differing ATP concentrations in the high ATP Caliper assay and the CDK2 assay (1 mM MPS1 vs 10 μM CDK2), the assays were no longer directly comparable. For this reason, we used the Cheng–Prusoff equation to calculate the <i>K</i><sub>i</sub> values<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and, in turn, used these values to determine the selectivity window.</div><div class="NLM_p">Compound <b>33b</b>, incorporating a diethylamine substituent, was significantly (6-fold) less potent in the 1 mM ATP Caliper assay than the pyrrolidine <b>33a</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). This is likely due to a higher free energy penalty when binding to the target for this less constrained compound. Gratifyingly, several amine substituents (<b>34b</b>, <b>d</b>, and <b>e</b>) not only showed comparable biochemical potency but also improved microsomal stability, now in an acceptable range of 30% turnover.</div><div class="NLM_p">Since saturated amines were well tolerated in this position, we next prepared and tested derivatives in which the alkyl groups were linked through a sulfur or oxygen atom (<b>34f</b> and <b>38</b>). Remarkably, both lost significant activity (at least 10-fold) compared to the corresponding amine derivatives <b>34b</b> and <b>34d</b>. It is difficult to reconcile the pronounced loss of activity of compounds <b>34f</b> and <b>38</b> with the wide range of both primary and secondary amines that are tolerated. Computational conformational analysis did not suggest a significant difference in the conformational preference of the oxygen and sulfur-linked substituents compared to the amine substituents. Furthermore, analysis of the available crystal structure did not support the hypothesis that this difference may be driven by different hydrogen-bond pattern, e.g., to water molecules.</div><div class="NLM_p">Several amino-substituted compounds did however show potent IC<sub>50</sub> values suggesting significant scope for further modifications. The neopentyl derivative <b>34e</b> was particularly promising due to its cellular potency combined with selectivity and improved mouse microsomal stability. As is apparent from the MPS1 IC<sub>50</sub> at 1 mM ATP, it was also the most potent derivative in this series.</div><div class="NLM_p">We solved the structure of neopentyl <b>34e</b> bound into MPS1 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> shows that the bulkier, more hydrophobic neopentyl substituent of <b>34e</b> addresses the hydrophobic pocket first mentioned in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A to a greater extent than the pyrazole substituent of <b>24c</b>. We hypothesized that an additional increase in potency could be achieved by further increasing the bulk of the hydrophobic substituent.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Superimposed crystal structure of MPS1 (pale green) bound to <b>24c</b> (carbon atoms colored orange), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, onto the structure of MPS1 (not shown) bound to <b>34e</b> (carbon atoms colored blue), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0">5EH0</a>, showing the hydrophobic pocket formed by Ile531, Val539, Met671, and Pro673. The bulkier neopentyl substituent of <b>34e</b> addresses the pocket to a greater extent than the pyrazole substituent of <b>24c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We thus followed up by synthesizing the two enantiomers <b>34g</b> and <b>34h</b> which differ from the neopentyl <b>34e</b> by an additional methyl group (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The (<i>S</i>)-enantiomer (<b>34h</b>) particularly, translated into an additional gain in biochemical and cellular potency compared with neopentyl derivative <b>34e</b>, achieving cellular modulation of MPS1 in the sub-100 nM range (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). <b>34h</b> showed sufficient selectivity over CDK2 and very good microsomal stability (MLM = 27%).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biochemical, Cellular, And Mouse Microsomal Turnover Data for Enantiomers <b>34g</b> and <b>34h</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0015.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0016.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Results are mean (±SD) for <i>n</i> ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run <i>n</i> = 1. “P-MPS1″ indicates an electrochemiluminescence MSD-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. “HCT116 GI<sub>50</sub>” indicates a cell proliferation assay carried out by colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in HCT116 cells.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Potency at the lower limit of the dynamic range of the Caliper assay run at 10 μM ATP concentration. IC<sub>50</sub> value is likely to be lower than that quoted.</p></div></div><div></div></div><div class="NLM_p">With <b>34h</b> we had achieved our initial potency goal in the biochemical and cellular assay. Especially considering its moderate molecular weight of 432 Da, <b>34h</b> represented an extremely potent MPS1 inhibitor with an IC<sub>50</sub> = 0.020 μM at 1 mM ATP (corresponding to a <i>K</i><sub>i</sub> of 0.0002 μM)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and a GI<sub>50</sub> value in HCT116 cells of 0.16 μM. Furthermore, the combined SAR suggested significant scope for additional modifications to further optimize the series. This pyrido[3,4-<i>d</i>]pyrimidine (<b>34h</b>) was selective over CDK2 (CDK2/MPS1 <i>K</i><sub>i</sub> ratio > 1000),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Aurora A and B (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">Table S1</a> ), and PLK1 (IC<sub>50</sub> > 100 μM) as well as against a wide panel of kinases (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">Tables S2–S4</a> ). Pyrido[3,4-<i>d</i>]pyrimidine <b>34h</b> inhibited a small number of kinases, namely TNK2, JNK1, JNK2, and LRRK at >80% at 1 μM. JNK1 and JNK2 are considered to be structurally related to MPS1, so follow up IC<sub>50</sub> values were obtained (JNK1 IC<sub>50</sub> = 0.11 μM, JNK2 IC<sub>50</sub> = 0.22 μM), showing that <b>34h</b> was selective for MPS1 over JNK1 and JNK2 by 100- and 200-fold, respectively.</div><div class="NLM_p">Next we profiled <b>34h</b> against a panel of cell lines (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). As expected for an MPS1 inhibitor, <b>34h</b> showed potent growth inhibition for all cancer cell lines but importantly a significantly higher GI<sub>50</sub> for the nontransformed line PNT2.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. GI<sub>50</sub> Values for <b>34h</b> in 3 Day MTT Assay Carried out on Panel of Cell Lines<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">origin</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="left">SW620</td><td class="colsep0 rowsep0" align="char" char=".">0.065</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">head and neck</td><td class="colsep0 rowsep0" align="left">CAL27</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">CAL51</td><td class="colsep0 rowsep0" align="char" char=".">0.068</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pancreatic</td><td class="colsep0 rowsep0" align="left">Miapaca-2</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">RMG1</td><td class="colsep0 rowsep0" align="char" char=".">0.110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">PNT2</td><td class="colsep0 rowsep0" align="char" char=".">3.95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">“GI<sub>50</sub>” indicates a cell proliferation assay carried out by colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in a panel of cell lines.</p></div></div></div><div class="NLM_p"><b>34h</b> did not inhibit CYP or hERG (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">Tables S5 and S6</a>). Importantly, pyrido[3,4-<i>d</i>]pyrimidine <b>34h</b>, showed low turnover in mouse and rat liver microsomes (27 and 24%, after 30 min incubation, respectively), and we progressed the compound to mouse and rat PK experiments, despite a 70% turnover in human liver microsomes, in order to evaluate its suitability for proof of mechanism in vivo experiments. <b>34h</b> showed moderate clearance (28 and 24 mL/min/kg in mouse and rat, respectively) and high oral bioavailability (68 and 100% in mouse and rat, respectively) with moderate to high volumes of distribution (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mouse and Rat Blood Pharmacokinetics of <b>34h</b> at 5 mg/kg iv and po</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Cmax<sub>po</sub> (nmol/L)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>po</sub> (nmol·h/L)</th><th class="colsep0 rowsep0" align="center" char=".">PPB (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">770</td><td class="colsep0 rowsep0" align="char" char=".">4800</td><td class="colsep0 rowsep0" align="char" char=".">99.98</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2.5<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">560</td><td class="colsep0 rowsep0" align="char" char=".">9300</td><td class="colsep0 rowsep0" align="char" char=".">99.97</td><td class="colsep0 rowsep0" align="char" char=".">4.64</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Only detected to 4 h.</p></div></div></div><div class="NLM_p">We thus performed a 3 day pharmacokinetic/pharmacodynamic (PK/PD) study to determine whether biomarker modulation could be achieved in vivo. MPS1 inhibition results in premature exit of cells from mitosis,<a onclick="showRef(event, 'cit10e'); return false;" href="javascript:void(0);" class="ref cit10e">(10e)</a> and we therefore chose the mitotic marker phospho-histone H3 as a readout. Histone H3 is specifically phosphorylated at Ser 10 during mitosis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Gratifyingly, oral administration of 100 mg/kg of <b>34h</b> b.i.d. for 3 days to mice bearing HCT116 human colon carcinoma xenografts caused a reduction of the phospho-histone H3 levels compared with vehicle control treated animals at 2 and 6 h, consistent with MPS1 inhibition (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A,B) Representative immunoblots of phospho-histone H3 showing dose-dependent PD modulation in HCT116 human tumor xenografts, following 100 mg/kg b.i.d. dosing of <b>34h</b> for 3 consecutive days. Total histone H3, cleaved poly ADP ribose polymerase (PARP, a measure of apoptosis) and glyceraldehyde 3-phosphate dehydrogenase (GADPH, for protein loading) are also shown. (C) Phospho-histone H3 versus total histone H3 ratio for control and treated samples at 2 and 6 h after last dose. Asterisks show statistically significant differences from control groups as determined by one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>34h</b> fulfilled all of the criteria we had initially set and compared favorably with our best-in-class 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine (<b>1</b>). Particularly, <b>34h</b> was devoid of CYP inhibition, did not require an acid labile Boc group for biochemical and cellular potency, and showed excellent overall selectivity. Its physicochemical properties (ALogP = 4.65 and MW = 432) made <b>34h</b> a better starting point for further optimization especially given that we had already achieved the targeted potency. Surprisingly, given that it represented a pyrimidine-based kinase scaffold, the 2-amino pyrido[3,4-<i>d</i>]pyrimidine chemotype was relatively unexplored when we initiated this work, with only one published kinase patent application in the public domain.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Our previously published chemical route<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> facilitated the synthesis of a large range of derivatives as well as upscaling of advanced derivatives. We thus nominated <b>34h</b> as an advanced lead compound.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By merging two distinct chemical series, namely 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridines and 1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridines, we successfully fulfilled our aim to discover a new class of MPS1 inhibitors that did not require an acid labile Boc group for potent inhibition. The pyrido[3,4-<i>d</i>]pyrimidine core was unprecedented for kinases,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and our structure guided optimization resulted in potent MPS1 inhibitors of substantially reduced size and lipophilicity compared with the parent 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridines. Moreover, our optimized compound <b>34h</b> was devoid of CYP inhibition and proved to be extremely potent in the MPS1 biochemical assay with the ability to target this kinase in cells and to induce significant growth inhibition at nanomolar concentrations. A screen against a large sample of the human kinome revealed a high level of selectivity, especially with regard to mitotic kinases. Most importantly, pyrido[3,4-<i>d</i>]pyrimidine <b>34h</b> showed a satisfactory pharmacokinetic profile in rodents and effectively inhibited MPS1 activity in vivo.</div><div class="NLM_p last">Optimization of the remaining issues associated with <b>34h</b>, in particular HLM instability and plasma protein binding, as well as the investigation of advanced compounds in combination efficacy models, is ongoing and the results will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Chemistry Information</h3><div class="NLM_p">Starting materials, reagents, and solvents for reactions were reagent grade and used as purchased. Chromatography solvents were HPLC grade and were used without further purification. Thin-layer chromatography analysis was performed using silica gel 60 F-254 thin-layer plates. Flash column chromatography was carried out using columns prepacked with 40–63 μm silica. Microwave-assisted reactions were carried out using a Biotage Initiator microwave system. LCMS and HRMS analyses were performed on a HPLC system with diode array detector operating at 254 nm, fitted with a reverse-phase 50 × 4.6 mm column at a temperature of 22 °C, connected to a time of flight mass spectrometer (ESI). The following solvent system, at a flow rate of 2 mL/min, was used: Solvent A: methanol; solvent B: 0.1% formic acid in water. Gradient elution was as follows: 1:9 (A:B) to 9:1 (A:B) over 2.5 min, 9:1 (A:B) for 1 min then reversion back to 1:9 (A:B) over 0.3 min, 1:9 (A:B) for 0.2 min. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance 500 MHz spectrometer using an internal deuterium lock. NMR data is given as follows: chemical shift (δ) in ppm, multiplicity, coupling constants (<i>J</i>) given in Hz and integration. The purity of final compounds was determined by HPLC as described above and is ≥95% unless specified otherwise.</div><div class="NLM_p">Compounds 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline (<b>23</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> 8-chloro-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine (<b>25</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide (<b>26a</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> 8-chloro-<i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine (<b>27a</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and 2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidin-8(7<i>H</i>)-one (<b>35</b>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> were synthesized using previously published procedures.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 3-Chloro-5-(furan-2-yl)isoquinoline <b>10</b></h4><div class="NLM_p last">A suspension of 5-bromo-3-chloroisoquinoline <b>9</b> (58 mg, 0.24 mmol), furan-2-ylboronic acid (32 mg, 0.29 mmol), and Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (20 mg, 0.024 mmol) in DME (0.5 mL) and sodium carbonate (2 M, 0.24 mL) was heated to 105 °C under microwave irradiation for 1 h. The mixture was concentrated onto silica gel and purified by flash column chromatography (0–50% EtOAc in cyclohexane) to give the title compound (41 mg, 75%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>9</sub>ClNO (M + H) 230.0367, found 230.0343. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.09 (s, 1H), 8.33 (s, 1H), 7.99–7.90 (m, 2H), 7.71–7.55 (m, 2H), 6.79 (dd, <i>J</i> = 3.4, 0.6 Hz, 1H), 6.62 (dd, <i>J</i> = 3.4, 1.8 Hz, 1H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-Chloro-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinoline <b>11</b></h4><div class="NLM_p last">A suspension of 5-bromo-3-chloroisoquinoline <b>9</b> (300 mg, 1.24 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (309 mg, 1.49 mmol), and Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (105 mg, 0.124 mmol) in DME (2.5 mL) and sodium carbonate (2 M, 1.24 mL) was heated to 105 °C under microwave irradiation for 1.5 h. The mixture was concentrated onto silica gel and purified by flash column chromatography (0–100% EtOAc in cyclohexane) to give the title compound (324 mg, quant.). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>ClN<sub>3</sub> (M + H) 244.0636, found 244.0639. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.08 (s, 1H), 7.96 (s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 1H), 7.73 (s, 1H), 7.67–7.55 (m, 3H), 4.05 (s, 3H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 5-(Furan-2-yl)-<i>N</i>-(4-methoxyphenyl)isoquinolin-3-amine <b>14</b></h4><div class="NLM_p last">A suspension of 3-chloro-5-(furan-2-yl)isoquinoline <b>10</b> (41 mg, 0.18 mmol), 4-methoxyaniline <b>12</b> (29 mg, 0.23 mmol), cesium carbonate (204 mg, 0.626 mmol), <sup><i>t</i></sup>BuXPhos (30 mg, 0.071 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (16 mg, 0.018 mmol), and <sup><i>t</i></sup>BuOH (3% H<sub>2</sub>O) (1 mL) was heated to 80 °C under microwave irradiation for 3 h. The mixture was concentrated onto silica gel and purified by flash column chromatography (0–100% EtOAc in cyclohexane) to give the title compound (10 mg, 18%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub> (M + H) 317.1285, found 317.1282. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.95 (s, 1H), 7.84–7.75 (m, 2H), 7.61 (s, 1H), 7.57 (s, 1H), 7.58–7.25 (m, 3H), 7.17–6.90 (m, 2H), 6.77–6.60 (m, 2H), 6.54 (dd, <i>J</i> = 3.3, 1.8 Hz, 1H), 3.85 (s, 3H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(4-Methoxyphenyl)-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinolin-3-amine <b>15a</b></h4><div class="NLM_p last">A suspension of 3-chloro-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinoline <b>11</b> (55 mg, 0.23 mmol), 4-methoxyaniline <b>12</b> (36 mg, 0.29 mmol), cesium carbonate (257 mg, 0.789 mmol), <sup><i>t</i></sup>BuXPhos (38 mg, 0.090 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (21 mg, 0.023 mmol), and <sup><i>t</i></sup>BuOH (3% H<sub>2</sub>O) (1 mL) was heated to 80 °C under microwave irradiation for 1.5 h. The mixture was concentrated onto silica gel and purified by flash column chromatography (0–100% EtOAc in cyclohexane) to give the title compound (6 mg, 8%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O (M + H) 331.1553, found 331.1546. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.95 (s, 1H), 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 7.68 (s, 1H), 7.52 (s, 1H), 7.50–7.46 (m, 2H), 7.31–7.21 (m, 3H), 7.03–6.89 (m, 2H), 6.48 (s, 1H), 3.98 (s, 3H), 3.83 (s, 3H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-(2,4-Dimethoxyphenyl)-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinolin-3-amine <b>15b</b></h4><div class="NLM_p last">A suspension of 3-chloro-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinoline <b>11</b> (55 mg, 0.23 mmol), 2,4-dimethoxyaniline <b>13</b> (45 mg, 0.29 mmol), cesium carbonate (257 mg, 0.789 mmol), <sup><i>t</i></sup>BuXPhos (38 mg, 0.090 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (21 mg, 0.023 mmol), and <sup><i>t</i></sup>BuOH (3% H<sub>2</sub>O) (1 mL) was heated to 80 °C under microwave irradiation for 1.5 h and then to 100 °C for 1.5 h. The mixture was concentrated onto silica gel and purified by flash column chromatography (0–100% EtOAc in cyclohexane) to give the title compound (22 mg, 27%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> (M + H) 361.1659, found 361.1661. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.96 (s, 1H), 7.78–7.69 (m, 2H), 7.61 (d, <i>J</i> = 8.6 Hz, 1H), 7.54 (s, 1H), 7.47 (dd, <i>J</i> = 7.0, 1.0 Hz, 1H), 7.33–7.23 (m, 2H), 6.73 (s, 1H), 6.58–6.49 (m, 2H), 3.99 (s, 3H), 3.85 (s, 3H), 3.83 (s, 3H).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Preparation of Compounds in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (Exemplified by the Preparation of Compounds <b>24a</b>, <b>24d</b>, <b>28a</b>, and <b>28b</b>)</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 8-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>17</b></h4><div class="NLM_p last">A solution of 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>16</b> (480 mg, 2.27 mmol), (1-methyl-1<i>H</i>-pyrazol-4-yl)boronic acid pinacol ester (940 mg, 4.52 mmol), and Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (100 mg, 0.122 mmol) in THF (15 mL) and sodium carbonate (2 M, 5 mL) was heated to 65 °C for 18 h. The mixture was diluted with EtOAc and quenched with brine. The aqueous layer was extracted with EtOAc three times. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–4% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give the title compound (658 mg, quant). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>12</sub>N<sub>5</sub>S (M + H) 258.0813, found 258.0817. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.22 (s, 1H), 8.67 (s, 1H), 8.63–8.56 (m, 2H), 7.47 (d, <i>J</i> = 5.3 Hz, 1H), 4.05 (s, 3H), 2.78 (s, 3H).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 8-Cyclopropyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>18</b></h4><div class="NLM_p last">A solution of 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>16</b> (20 mg, 0.094 mmol), cyclopropyl boronic acid (11 mg, 0.13 mmol), PCy<sub>3</sub> (3 mg, 11 μmol), K<sub>3</sub>PO<sub>4</sub> (70 mg, 0.32 mmol), and Pd(OAc)<sub>2</sub> (1.0 mg, 4.5 μmol) was dissolved in toluene/water (6:1, 1 mL) and heated to 95 °C for 18 h. The mixture was diluted with EtOAc and quenched with brine. The aqueous layer was extracted with EtOAc three times. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–20% EtOAc in cyclohexane) to give the title compound (13 mg, 62%). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>12</sub>N<sub>3</sub>S (M + H) 218.0746, found 218.0751. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1H), 8.46 (d, <i>J</i> = 5.4 Hz, 1H), 7.37 (d, <i>J</i> = 5.5 Hz, 1H), 3.46 (tt, <i>J</i> = 8.2, 4.8 Hz, 1H), 2.74 (s, 3H), 1.34–1.27 (m, 2H), 1.25–1.17 (m, 2H).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 8-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>19</b></h4><div class="NLM_p last">A suspension of 8-(1-methyl-1<i>H</i>-pyrazol-4-yl)-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>17</b> (584 mg, 2.27 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (22 mL) was treated with <i>m</i>-CPBA (77% w/w, 1.12 g, 4.98 mmol) at 0 °C and then allowed to reach rt over 18 h. The mixture was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were washed with water, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–100% EtOAc in cyclohexane) to give the title compound (408 mg, 62%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>12</sub>N<sub>5</sub>O<sub>2</sub>S (M + H) 290.0706, found 290.0722. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 10.00 (s, 1H), 8.91 (d, <i>J</i> = 5.4 Hz, 1H), 8.81 (s, 1H), 8.53 (s, 1H), 7.99 (d, <i>J</i> = 5.4 Hz, 1H), 3.99 (s, 3H), 3.59 (s, 3H).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 8-Cyclopropyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>20</b></h4><div class="NLM_p last">A suspension of 8-cyclopropyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>18</b> (127 mg, 0.584 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was treated with <i>m</i>-CPBA (77% w/w, 290 mg, 1.29 mmol) at 0 °C and then allowed to reach rt over 18 h. The mixture was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were washed with water, dried, and concentrated onto silica. The residue was purified by flash column chromatography (0–70% EtOAc in cyclohexane) to give the title compound (128 mg, 88%). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>11</sub>H<sub>12</sub>N<sub>3</sub>O<sub>2</sub>S (M + H) 250.0645, found 250.0648. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.99 (s, 1H), 8.79 (d, <i>J</i> = 5.5 Hz, 1H), 7.94 (d, <i>J</i> = 5.5 Hz, 1H), 3.56 (s, 3H), 3.44 (m, 1H), 1.30–1.25 (m, 2H), 1.24–1.20 (m, 2H).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(4-Methoxyphenyl)-8-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>24a</b></h4><div class="NLM_p last">To a solution of 8-(1-methyl-1<i>H</i>-pyrazol-4-yl)-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>19</b> (29 mg, 0.10 mmol) in DMSO (4 mL) was added cesium carbonate (59 mg, 0.18 mmol) and <i>N</i>-(4-methoxyphenyl)formamide (15 mg, 0.10 mmol). The mixture was heated to 100 °C for 18 h. The mixture was diluted with EtOAc and water. The aqueous layer was re-extracted with EtOAc. The combined organics were washed with brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), followed by SCX-2 cartridge (MeOH - 1 M NH<sub>3</sub> in MeOH) to give the title compound (8 mg, 24%). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>16</sub>N<sub>6</sub>O (M + H) 333.1464, found 333.1450. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.24 (s, 1H), 8.38 (s, 1H), 8.29 (d, <i>J</i> = 5.4 Hz, 1H), 7.63–7.59 (m, 3H), 7.54 (d, <i>J</i> = 5.4 Hz, 1H), 7.05 (d, <i>J</i> = 8.9 Hz, 2H), 3.91 (s, 3H), 3.87 (s, 3H).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 8-Cyclopropyl-<i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>24d</b></h4><div class="NLM_p last">A solution of 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>23</b> (50 mg, 0.25 mmol), TFA (45 μL, 0.60 mmol), and 8-cyclopropyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>20</b> (31 mg, 0.12 mmol) in 2,2,2-trifluoroethanol (0.7 mL) was heated to 130 °C under microwave irradiation for 1.5 h. The reaction was diluted with EtOAc and quenched with aqueous sat. sodium bicarbonate. The aqueous layer was extracted with EtOAc, and the combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–60% EtOAc in cyclohexane) to give the title compound (20 mg, 43%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>6</sub>O (M + H) 373.1771, found 373.1773. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.40 (s, 1H), 8.54 (s, 1H), 8.41 (d, <i>J</i> = 8.3 Hz, 1H), 8.28 (d, <i>J</i> = 5.3 Hz, 1H), 8.17 (d, <i>J</i> = 0.9 Hz, 1H), 7.90 (d, <i>J</i> = 0.8 Hz, 1H), 7.56 (d, <i>J</i> = 5.3 Hz, 1H), 7.30 (d, <i>J</i> = 1.8 Hz, 1H), 7.25 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 3.96 (s, 3H), 3.88 (s, 3H), 3.24 (m, 1H), 1.16–1.08 (m, 4H).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Preparation of Formamides <b>26b</b>–<b>e</b> (Exemplified by Preparation of Compound <b>26b</b>)</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(2-Methyl-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide <b>26b</b></h4><div class="NLM_p last">A solution of 2-methyl-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>S1</b> (100 mg, 0.534 mmol) in formic acid (3 mL) was heated to 100 °C for 3 h. The mixture was concentrated in vacuo. The residue was partitioned between aqueous sat. sodium bicarbonate and EtOAc. The aqueous layer was re-extracted with EtOAc. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–10% MeOH in EtOAc) to give the title compound (160 mg, 34%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>14</sub>N<sub>3</sub>O (M + H) 216.1131, found 216.1141. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.31 (s, 1H), 7.93 (s, 1H), 7.80 (s, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.44 (d, <i>J</i> = 2.0 Hz, 1H), 7.38 (dd, <i>J</i> = 8.0, 2.0, Hz, 1H), 3.92 (s, 3H), 2.31 (s, 3H).</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 8-Chloro-<i>N</i>-(2-methyl-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>27b</b></h4><div class="NLM_p last">To a cooled (0 °C) suspension of <i>N</i>-(2-methyl-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide <b>26b</b> (40 mg, 0.19 mmol) in THF (4 mL) was added sodium hydride (60% w/w dispersion in oil, 12 mg, 0.30 mmol). The reaction mixture was stirred at rt for 10 min. The mixture was cooled to 0 °C, and 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>25</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (60 mg, 0.24 mmol) was added. The mixture was stirred for 18 h while slowly warming to rt and then concentrated in vacuo, and the residue was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc and CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–5% MeOH in EtOAc) to give the title compound (79 mg, 97%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>16</sub>ClN<sub>6</sub> (M + H) 351.1119, found 351.1111. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 1H), 8.26 (d, <i>J</i> = 5.0 Hz, 1H), 7.79 (s, 1H), 7.63 (s, 1H), 7.52 (d, <i>J</i> = 5.0 Hz, 1H), 7.47 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.42 (m, 1H), 7.39 (d, <i>J</i> = 2.0 Hz, 1H), 3.98 (s, 3H), 2.44 (s, 3H).</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(2-Methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)-8-phenylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>28a</b></h4><div class="NLM_p last">To a solution of 8-chloro-<i>N-</i>(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>27a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (25 mg, 0.068 mmol) in 1,4-dioxane/water (2:1, 3 mL) was added phenyl boronic acid (17 mg, 0.14 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (16 mg, 0.014 mmol), and cesium carbonate (33 mg, 0.10 mmol). The reaction was heated to 100 °C under microwave irradiation for 30 min. The reaction was diluted with EtOAc and water, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–100% EtOAc in cyclohexane) followed by SCX-2 cartridge (MeOH - 1 M NH<sub>3</sub> in MeOH) to give the title compound (8 mg, 29%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>21</sub>N<sub>6</sub>O (M + H) 409.1777, found 409.1771. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.37 (s, 1H), 8.56 (d, <i>J</i> = 8.5 Hz, 1H), 8.50 (d, <i>J</i> = 5.5 Hz, 1H), 8.11–8.09 (m, 2H), 7.97 (s, 1H), 7.82 (s, 1H), 7.79 (d, <i>J</i> = 5.5 Hz, 1H), 7.61–7.59 (m, 3H), 7.19 (d, <i>J</i> = 2.0 Hz, 1H), 6.99 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 4.02 (s, 3H), 3.95 (s, 3H).</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 8-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-<i>N</i>-(2-methyl-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>28b</b></h4><div class="NLM_p last">To a solution of 8-chloro-<i>N</i>-(2-methyl-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>27b</b> (12 mg, 0.034 mmol) in 1,4-dioxane/water (2:1, 3 mL) were added 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (14 mg, 0.068 mmol), cesium carbonate (17 mg, 0.051 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (2 mg, 1.7 μmol). The reaction mixture was heated to 100 °C under microwave conditions for 30 min. The reaction mixture was diluted with EtOAc and water. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–15% MeOH in EtOAc) to give the title compound (7 mg, 52%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>8</sub> (M + H) 397.1884, found 397.1878. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.16 (s, 1H), 8.43 (d, <i>J</i> = 5.5 Hz, 1H), 8.40 (d, <i>J</i> = 5.5 Hz, 2H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (s, 1H), 7.67 (s, 1H), 7.50–7.45 (m, 2H), 7.36 (d, <i>J</i> = 5.5 Hz, 1H), 7.05 (br s, 1H), 4.00 (s, 3H), 3.77 (s, 3H), 2.39 (s, 3H).</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Preparation of Compounds in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> (Exemplified by the Preparation of <b>33a</b>)</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(Methylsulfonyl)-8-(pyrrolidin-1-yl)pyrido[3,4-<i>d</i>]pyrimidine <b>31</b></h4><div class="NLM_p">A mixture of 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>16</b> (105 mg, 0.496 mmol) and pyrrolidine (425 μL, 5.10 mmol) in NMP (2.5 mL) was stirred at 135 °C for 3 h. The mixture was quenched with aqueous sat. sodium bicarbonate and extracted with EtOAc. The combined organics were washed with water and brine, dried, and concentrated in vacuo to afford the crude sulfide.</div><div class="NLM_p last">A suspension of crude sulfide <b>29</b> (ca. 0.496 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was treated with <i>m</i>-CPBA (77% w/w, 250 mg, 1.11 mmol) at 0 °C and then allowed to reach rt for 18 h. An additional portion of <i>m</i>-CPBA (77% w/w, 60 mg, 0.27 mmol) was added at rt, and the mixture stirred for 2 h. The mixture was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were washed with aqueous sat. sodium bicarbonate and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–70% EtOAc in cyclohexane) to give the title compound (62 mg, 45% over two steps). LCMS (ESI) <i>m</i>/<i>z</i> 279 (M + H). <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.62 (s, 1H), 8.30 (d, <i>J</i> = 5.4 Hz, 1H), 7.11 (d, <i>J</i> = 5.5 Hz, 1H), 3.97 (br s, 4H), 3.45 (s, 3H), 1.98 (s, 4H).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(2-Methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)-8-(pyrrolidin-1-yl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>33a</b></h4><div class="NLM_p last">A solution of 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>23</b> (52 mg, 0.26 mmol), TFA (50 μL, 0.65 mmol) and 2-(methylsulfonyl)-8-(pyrrolidin-1-yl)pyrido[3,4-<i>d</i>]pyrimidine <b>31</b> (35 mg, 0.13 mmol) in 2,2,2-trifluoroethanol (0.6 mL) was heated to 130 °C under microwave irradiation for 2 h. An additional portion of TFA (50 μL, 0.65 mmol) was added, and the mixture was heated to 180 °C under microwave irradiation for 2 h. The reaction mixture was diluted with EtOAc, quenched with aqueous sat. sodium bicarbonate, and the aqueous layer extracted with EtOAc. The combined organics were washed with water and brine, dried, concentrated in vacuo, and purified by flash column chromatography (0–100% EtOAc in cyclohexane) to give the title compound (10 mg, 20%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>24</sub>N<sub>7</sub>O (M + H) 402.2037, found 402.2040. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.12 (s, 1H), 8.37 (s, 1H), 8.14 (s, 1H), 7.88 (d, <i>J</i> = 0.9 Hz, 1H), 7.87–7.79 (m, 2H), 7.24 (d, <i>J</i> = 1.9 Hz, 1H), 7.17 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 6.86 (d, <i>J</i> = 5.4 Hz, 1H), 3.89 (s, 3H), 3.87 (s, 3H), 3.84–3.76 (m, 4H), 1.91–1.81 (m, 4H).</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Preparation of Compounds in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> (Exemplified by the Preparation of Compounds <b>34a</b>, <b>34f</b>, and <b>38</b>)</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i><sup>8</sup>-Isobutyl-<i>N</i><sup>2</sup>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>34a</b></h4><div class="NLM_p last">A mixture of 8-chloro-<i>N-</i>(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>27a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (27 mg, 0.074 mmol) and 2-methylpropan-1-amine (100 μL, 1.0 mmol) in NMP (0.7 mL) was stirred at 130 °C in a closed cap vial for 5 h. The reaction mixture was quenched with aqueous sat. sodium bicarbonate and extracted with EtOAc. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–80% EtOAc in cyclohexane) to give the title compound (19 mg, 63%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>O (M + H) 404.2193, found 404.2177. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.16 (s, 1H), 8.43 (s, 1H), 8.19 (d, <i>J</i> = 8.3 Hz, 1H), 8.15 (d, <i>J</i> = 0.8 Hz, 1H), 7.88 (d, <i>J</i> = 0.8 Hz, 1H), 7.77 (d, <i>J</i> = 5.7 Hz, 1H), 7.27 (d, <i>J</i> = 1.9 Hz, 1H), 7.18 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 6.88–6.85 (m, 2H), 3.93 (s, 3H), 3.87 (s, 3H), 3.39–3.28 (m, 2H), 2.00 (hept, <i>J</i> = 6.8 Hz, 1H), 0.95 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 8-(Cyclohexylthio)-<i>N-</i>(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>34f</b></h4><div class="NLM_p last">A mixture of 8-chloro-<i>N-</i>(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>27a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (26 mg, 0.071 mmol) and potassium carbonate (15 mg, 0.11 mmol) in DMF (0.35 mL) was treated with cyclohexanethiol (12 μL, 0.098 mmol) and stirred at rt for 4 d. An additional batch of potassium carbonate (10 mg, 0.070 mmol) and cyclohexanethiol (12 μL, 0.098 mmol) was added, and the mixture stirred at 50 °C for 18 h. The reaction was quenched with brine and extracted with EtOAc. The combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–80% EtOAc in cyclohexane) to give the title compound (30 mg, 94%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>27</sub>N<sub>6</sub>OS (M + H) 447.1962, found 447.1948. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.35 (s, 1H), 8.55 (br s, 1H), 8.29 (d, <i>J</i> = 5.4 Hz, 1H), 8.20 (d, <i>J</i> = 0.9 Hz, 1H), 7.93 (d, <i>J</i> = 0.8 Hz, 1H), 7.48 (d, <i>J</i> = 5.4 Hz, 1H), 7.29 (d, <i>J</i> = 1.9 Hz, 1H), 7.26 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 3.96 (br s, 4H), 3.87 (s, 3H), 2.17–2.05 (m, 2H), 1.82–1.72 (m, 2H), 1.65 (m, 1H), 1.59–1.40 (m, 4H), 1.35 (m, 1H).</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 8-(Cyclopropylmethoxy)-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>36</b></h4><div class="NLM_p last">A suspension of 2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidin-8(7<i>H</i>)-one <b>35</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (502 mg, 2.60 mmol) and silver carbonate (988 mg, 3.58 mmol) in CHCl<sub>3</sub> (25 mL) was treated with bromomethyl cyclopropane (310 μL, 3.19 mmol) and stirred at rt for 18 h. The mixture was heated to 60 °C for 4 h, and an additional batch of bromomethyl cyclopropane (310 μL, 3.19 mmol) was added. The reaction was heated to 60 °C for 18 h. An additional batch of bromomethyl cyclopropane (310 μL, 3.19 mmol) was added and heated for a further 2 h. Et<sub>3</sub>N was added (6 mL), the mixture filtered through Celite (CH<sub>2</sub>Cl<sub>2</sub>), and concentrated in vacuo. The residue was purified by flash column chromatography (0–80% EtOAc in cyclohexane) to give the title compound (112 mg, 17%). LCMS (ESI) <i>m</i>/<i>z</i> 248 (M + H). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.14 (s, 1H), 8.07 (d, <i>J</i> = 5.6 Hz, 1H), 7.18 (d, <i>J</i> = 5.6 Hz, 1H), 4.43 (d, <i>J</i> = 7.0 Hz, 2H), 2.74 (s, 3H), 1.48 (m, 1H), 0.73–0.61 (m, 2H), 0.54–0.43 (m, 2H).</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 8-(Cyclopropylmethoxy)-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>37</b></h4><div class="NLM_p last">A suspension of 8-(cyclopropylmethoxy)-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>31</b> (110 mg, 0.445 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was treated with <i>m</i>-CPBA (77% w/w, 325 mg, 1.35 mmol) at 0 °C and then allowed to reach rt for 18 h. The mixture was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were washed with aqueous sat. sodium bicarbonate, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–55% EtOAc in cyclohexane) to give the title compound (95 mg, 77%). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>14</sub>N<sub>3</sub>O<sub>3</sub>S (M + H) 280.0750, found 280.0748. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.92 (s, 1H), 8.44 (d, <i>J</i> = 5.7 Hz, 1H), 7.72 (d, <i>J</i> = 5.7 Hz, 1H), 4.43 (d, <i>J</i> = 7.2 Hz, 2H), 3.50 (s, 3H), 1.41(m, 1H), 0.69–0.57 (m, 2H), 0.49–0.40 (m, 2H).</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 8-(Cyclopropylmethoxy)-<i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>38</b></h4><div class="NLM_p last">A solution of <i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide <b>26a</b> (30 mg, 0.13 mmol) in THF (1 mL) was treated with sodium hydride (60% w/w dispersion in oil, 8 mg, 0.20 mmol) at 0 °C. After stirring for 40 min at rt, the mixture was cooled to 0 °C, and 8-(cyclopropylmethoxy)-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>37</b> (46 mg, 0.17 mmol) was added. The reaction was allowed to reach rt and stirred for 18 h. Sodium hydroxide (2 M, 1 mL) and MeOH (1 mL) were added, and the resulting mixture stirred at rt for 3 h. The mixture was concentrated in vacuo. The residue was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc, and the combined organics were washed with water and brine, dried, and concentrated in vacuo. The residue was purified by flash column chromatography (0–75% EtOAc in cyclohexane) to give the title compound (27 mg, 52%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>6</sub>O<sub>2</sub> (M + H) 403.1877, found 403.1871. <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.31 (s, 1H), 8.61 (s, 1H), 8.39 (s, 1H), 8.17 (d, <i>J</i> = 0.8 Hz, 1H), 7.94–7.84 (m, 2H), 7.35 (d, <i>J</i> = 5.6 Hz, 1H), 7.28 (d, <i>J</i> = 1.8 Hz, 1H), 7.19 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 4.33 (d, <i>J</i> = 6.9 Hz, 2H), 3.94 (s, 3H), 3.88 (s, 3H), 1.40 (m, 1H), 0.68–0.59 (m, 2H), 0.49–0.39 (m, 2H).</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Biochemical Assays</h3><div class="NLM_p last">MPS1, CDK2, and Aurora A and B counterscreen assays were performed as reported previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> MSD Assay</h3><div class="NLM_p last">IC<sub>50</sub> of MPS1 autophosphorylation inhibition at pTpS<sup>33/37</sup> sites in HCT116 cells was determined by an electrochemiluminescence assay (Meso Scale Discovery, MSD) as described previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Cell Viability Assay</h3><div class="NLM_p last">Cell proliferation assays were carried out by colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma) in HCT116 cells as described previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Crystallization</h3><div class="NLM_p">The kinase domain (residues 519–808) of MPS1 was produced in <i>E. coli</i> and purified as described previously.<a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> For compound <b>39</b>, apo crystals of MPS1 were grown in PEG300 as previously described<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> prior to soaking in a fresh solution containing 35% PEG300, 1 mM inhibitor, and 1% (v/v) DMSO for 24 h. The crystal was cryo-protected in soak solution supplemented with 22.5% ethylene glycol prior to flash cooling in liquid nitrogen.</div><div class="NLM_p">Co-crystals of MPS1 with compound <b>S11</b> were grown at 18 °C using the sitting-drop vapor-diffusion method. The crystallization drops were composed of 2 μL of protein/ligand solution (8.9 mg/mL protein and 5 mM <b>S11</b>) and 2 μL of reservoir solution placed over 200 μL of reservoir solution of 18–26% (w/v) PEG3350, 0.1 M bis-Tris propane pH 7.5, 0.1 M MgCl<sub>2</sub>, and 0.1 M sodium formate in 48-well plates. Co-crystals typically grew in 12–16 h. Crystals of MPS1 with <b>S11</b> were transferred to backsoaking solutions containing reservoir solution also containing 200 mM of inhibitor and up to 20% (v/v) DMSO and incubated at 18 °C for 24–48 h. Crystals were cryo-protected with paratone-N oil prior to flash cooling in liquid nitrogen.</div><div class="NLM_p last">Co-crystals of MPS1 with compound <b>34e</b> were grown at 18 °C using the sitting-drop vapor-diffusion method. The crystallization drops were composed of 2 μL of protein/ligand solution (11.4 mg/mL protein and 2 mM <b>34e</b>) with 20% (w/v) PEG3350, 0.1 M bis-Tris propane pH 7.5, and 0.2 M sodium formate. Crystals were cryo-protected with paratone-N oil prior to flash cooling in liquid nitrogen.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Data Collection, Structure Solution, and Refinement</h3><div class="NLM_p last">X-ray diffraction data were collected at 100 K at Diamond Light Source (Oxfordshire, U.K.) or in-house on a Rigaku FRX with Pilatus 300 K detector. Data were integrated with XDS<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> or MOSFLM (<b>S11</b> data set only).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> All data were imported to MTZ format with POINTLESS,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> then scaled and merged with AIMLESS<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in the CCP4 suite.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The structures were solved by molecular replacement with PHASER,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with the PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> as the search model after removal of all nonprotein atoms. Structures were refined in iterative cycles of model building with COOT<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and refinement with BUSTER.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> TLS groups were selected with PHENIX phenix.find_tls_groups.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Ligand restraints were generated with GRADE<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and MOGUL.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The final structure quality was checked with MOLPROBITY.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The data collection and refinement statistics are presented in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">Table S7</a>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Microsomal Metabolism</h3><div class="NLM_p last">Microsomal turnover was carried out in male CD1 mice, female Sprague–Dawley rats, and pooled human liver microsomes obtained from Tebu-Bio (Peterborough, U.K.) following 30 min incubation of 10 μM compound in 1 mg/mL microsomal protein, 3 mmol/L MgCl<sub>2</sub>, 1 mmol/L NADPH, 2.5 mmol/L, UDP-glucuronic acid, and 10 mmol/L phosphate buffer (pH 7.4) (all purchased from Sigma-Aldrich, Gillingham, U.K). Reactions, at 37 °C, were started by addition of the test compound and were terminated at 0 and 30 min by the addition of 3 volumes of ice-cold methanol containing internal standard. Samples were centrifuged at 2800<i>g</i> for 30 min at 4 °C and the supernatants analyzed. Control incubations were prepared as above with omission of cofactors. Compound measurements were performed by LCMS on an Agilent quadrupole time-of-flight instrument (Agilent 6510) following separation with a 6 min gradient of 10 mM ammonium acetate in methanol on a 50 × 2.1 mm 2.6μm particles C18 column (Kinetex Phenomenex). For metabolite identification, the gradient was extended to 20 min, and MS/MS carried out with fragment elucidation for ions of interest.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Pharmacokinetic Studies</h3><div class="NLM_p">All in vivo studies were performed in accordance with U.K. Home Office regulations, ICR ethical review processes, and U.K. National Cancer Research Institute guidelines.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Female Balb/C mice and Sprague–Dawley rats were obtained from Charles River (Margate, U.K.). Animals were adapted to laboratory conditions for at least 1 week prior to dosing and were allowed food and water ad libitum. Compounds were administered iv or po (mouse: 0.1 mL/10g in 10% DMSO, 5% tween 20 in saline, rat: 0.05 mL/10g in 10% DMSO, 5% tween 20 in saline). Blood samples were collected from the tail vein (20 μL) at 8 time points over the 24 h post dose and spotted on Whatman B cards together with a standard curve and quality controls spiked in control blood. Cards were allowed to dry at rt for at least 6 h. Cards were punched, and 6 mm discs were extracted with 200 μL methanol containing 500 nM olomoucine as an internal standard. Following centrifugation, extracts were analyzed by multiple reaction monitoring of precursor and product ions by ESI-LCMS/MS on a QTRAP 4000 (ABSciex) following separation as above. Quantitation was carried out with an external calibration (8 points ranging from 1 nM to 25 μM). Quality controls were included (3 concentrations) at the beginning and the end of the analytical run and were within 20% of nominal concentrations.</div><div class="NLM_p last">Pharmacokinetic parameters were derived from noncompartmental analysis WiniNONlin (model 200 and 201) Pharsight version.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> In Vivo Proof-of-Concept Studies</h3><div class="NLM_p last">Animals (6–8 week old female NCr athymic mice) were supplied by a commercial breeder and fed sterilized food and water ad libitum.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> PK/PD Study</h3><div class="NLM_p last">Three million HCT116 human colorectal carcinoma cells were injected s.c. bilaterally into the flanks. Dosing commenced when tumors reached a mean diameter of 8–10 mm (day 14). Animals (<i>n</i> = 6 per group) were dosed twice daily with compound <b>34h</b> (100 mg/kg po) or vehicle (10% DMSO, 5% Tween 20, 85% saline) over 3 days (6 doses), and groups of three were culled at 2 or 6 h after the final dose. Heparinized plasma and tumor samples were collected and snap frozen for pharmacokinetic (PK) and pharmacodynamic (PD) biomarker analysis.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> PD Assays</h3><div class="NLM_p last">For PD analysis, frozen tumor samples were homogenized in RIPA lysis buffer (150 mM NaCl, 50 mM Tris pH 7.5, 1 mM EDTA pH 8.0, 1% NP40, 1% sodium deoxycholate, 1% sodium dodecyl sulfate, and supplemented with protease and phosphatase inhibitors), sonicated, and centrifuged to clear the debris. Protein concentrations of the supernatants were measured, and 5 μg protein for each sample was loaded onto LDS-PAGE (Life technologies). Proteins were separated, transferred to nitrocellulose membrane, and probed with phospho-histone H3 (Millipore), total-histone H3 (Abcam), cleaved-PARP (Cell Signaling), and GAPDH (Millipore) antibodies. Blots were quantified using ImageJ and analyzed with Graphpad Prism.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01811">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01811" class="ext-link">10.1021/acs.jmedchem.5b01811</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental procedures and analytical data for final compounds <b>24b</b>, <b>24c</b>, <b>28c</b>, <b>28d</b>, <b>28e</b>, <b>33b</b>, <b>34b</b>–<b>e</b>, <b>34g</b>, <b>34h</b>, intermediates and formamides. Aurora A and B inhibition data available for all compounds. CYP and hERG activity as well as kinase selectivity profiling of <b>34h</b>. Crystallographic analysis of compounds <b>15b</b>, <b>24b</b>, <b>24c</b>, <b>34e</b>, <b>39</b> bound to MPS1 (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_001.csv">jm5b01811_si_001.csv (3.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf">jm5b01811_si_002.pdf (281.34 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for compounds <b>1</b>, <b>15b</b>, <b>24b</b>, <b>24c</b>, <b>34e</b> and <b>39</b> can be accessed using PBD codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6">5EI6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2">5EI2</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0">5EH0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHY">5EHY</a>, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b01811" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swen Hoelder</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#aeddd9cbc080c6c1cbc2cacbdceec7cddc80cfcd80dbc5"><span class="__cf_email__" data-cfemail="bdcecad8d393d5d2d8d1d9d8cffdd4decf93dcde93c8d6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Innocenti</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannah L. Woodward</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Savade Solanki</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sébastien Naud</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac M. Westwood</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nora Cronin</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Division of Structural Biology and §Breast Cancer Now,
Division of Breast Cancer
Research, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Hayes</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennie Roberts</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan T. Henley</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ross Baker</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amir Faisal</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grace Wing-Yan Mak</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Box</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melanie Valenti</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexis De Haven Brandon</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa O’Fee</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harry Saville</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Schmitt</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Berry Matijssen</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosemary Burke</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob L. M. van Montfort</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence I. Raynaud</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne A. Eccles</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spiros Linardopoulos</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julian Blagg</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, United
Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d360e4163-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Cancer Research U.K. [grant number C309/A11566]. We also acknowledge the Cancer Research Technology Pioneer Fund and Sixth Element Capital for funding (to P.I.) and NHS funding to the NIHR Biomedical Research Centre. S.L. is also supported by Breakthrough Breast Cancer (recently merged with Breast Cancer Campaign forming Breast Cancer Now). We thank the staff of DIAMOND Light Source for their support during data collection. We thank Dr. Amin Mirza, Dr. Maggie Liu, and Mr. Meirion Richards for their help with LC, NMR, and mass spectrometry.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> Abbreviations Used</h2><tr><td class="NLM_term">CDK2</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 2</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">JNK1</td><td class="NLM_def"><p class="first last"><i>c</i>-Jun N-terminal kinase 1</p></td></tr><tr><td class="NLM_term">JNK2</td><td class="NLM_def"><p class="first last"><i>c</i>-Jun N-terminal kinase 2</p></td></tr><tr><td class="NLM_term">L.E.</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">L.L.E</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LRRK</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">MPS1</td><td class="NLM_def"><p class="first last">monopolar spindle kinase 1</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">Meso Scale Discovery</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP ribose polymerase</p></td></tr><tr><td class="NLM_term">PLK1</td><td class="NLM_def"><p class="first last">polo-like kinase 1</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">SAC</td><td class="NLM_def"><p class="first last">spindle assembly checkpoint</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1038/nrc2049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F&doi=10.1038%2Fnrc2049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0lgueoGyP97erQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117%26doi%3D10.1038%2Fnrc2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwell, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span> </span><span class="NLM_article-title">Past and future of the mitotic spindle as an oncology target</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/S1471-4892(01)00064-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2FS1471-4892%2801%2900064-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=11710735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=370-377&author=K.+W.+Woodauthor=W.+D.+Cornwellauthor=J.+R.+Jackson&title=Past+and+future+of+the+mitotic+spindle+as+an+oncology+target&doi=10.1016%2FS1471-4892%2801%2900064-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Past and future of the mitotic spindle as an oncology target</span></div><div class="casAuthors">Wood, Kenneth W.; Cornwell, William D.; Jackson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Tubulin poisons were first discovered decades ago, but the recent clin. and com. success of Taxol has led to a renaissance in the search for novel mitotic spindle poisons to treat cancer.  Many tubulin poisons have been identified, but few have demonstrated clin. utility.  Recent studies have begun to identify the factors that differentiate the efficacy of these agents.  In addn., promising alternative approaches to targeting the mitotic spindle have been identified from detailed studies of mitotic regulation and mechanics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLTbni6UbogrVg90H21EOLACvtfcHk0lizklMXTv1Qmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D&md5=1e7120d622f29b6d89d5127eaa72f61b</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2801%2900064-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252801%252900064-9%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DCornwell%26aufirst%3DW.%2BD.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26atitle%3DPast%2520and%2520future%2520of%2520the%2520mitotic%2520spindle%2520as%2520an%2520oncology%2520target%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2001%26volume%3D1%26spage%3D370%26epage%3D377%26doi%3D10.1016%2FS1471-4892%2801%2900064-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span> </span><span class="NLM_article-title">Mitosis-targeted anti-cancer therapies: where they stand</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e411</span><span class="refDoi"> DOI: 10.1038/cddis.2012.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fcddis.2012.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=23076219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e411&author=K.+S.+Chanauthor=C.+G.+Kohauthor=H.+Y.+Li&title=Mitosis-targeted+anti-cancer+therapies%3A+where+they+stand&doi=10.1038%2Fcddis.2012.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Mitosis-targeted anti-cancer therapies: where they stand</span></div><div class="casAuthors">Chan, K.-S.; Koh, C.-G.; Li, H.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">e411, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The strategy of clin. targeting cancerous cells at their most vulnerable state during mitosis has instigated numerous studies into the mitotic cell death (MCD) pathway.  As the hallmark of cancer revolves around cell-cycle deregulation, it is not surprising that antimitotic therapies are effective against the abnormal proliferation of transformed cells.  Moreover, these antimitotic drugs are also highly selective and sensitive.  Despite the robust rate of discovery and the development of mitosis-selective inhibitors, the unpredictable complexities of the human body's response to these drugs still herald the biggest challenge towards clin. success.  Undoubtedly, the need to bridge the gap between promising preclin. trials and effective translational bedside treatment prompts further investigations towards mapping out the mechanistic pathways of MCD, understanding how these drugs work as medicine in the body and more comprehensive target validations.  In this review, current antimitotic agents are summarized with particular emphasis on the evaluation of their clin. efficacy as well as their limitations.  In addn., we discuss the basis behind the lack of activity of these inhibitors in human trials and the potential and future directions of mitotic anticancer strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJjbhSTCZ8rVg90H21EOLACvtfcHk0lizklMXTv1Qmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSjtQ%253D%253D&md5=cfab128f78a4437ae746aeb777f72320</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.148%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BS.%26aulast%3DKoh%26aufirst%3DC.%2BG.%26aulast%3DLi%26aufirst%3DH.%2BY.%26atitle%3DMitosis-targeted%2520anti-cancer%2520therapies%253A%2520where%2520they%2520stand%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De411%26doi%3D10.1038%2Fcddis.2012.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardwick, K. G.</span><span> </span><span class="NLM_article-title">The spindle checkpoint</span> <span class="citation_source-journal">Trends Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1016/S0168-9525(97)01340-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2FS0168-9525%2897%2901340-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=9448456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1998&pages=1-4&author=K.+G.+Hardwick&title=The+spindle+checkpoint&doi=10.1016%2FS0168-9525%2897%2901340-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle checkpoint</span></div><div class="casAuthors">Hardwick, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">TRGEE2</span>;
        ISSN:<span class="NLM_cas:issn">0168-9525</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 33 refs., on the spindle checkpoint, localization of checkpoint components, global signaling, and a role for the checkpoint proteins in the timing of a normal mitosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCK07I41QTXrVg90H21EOLACvtfcHk0lizklMXTv1Qmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D&md5=b7c46a342b829847a9c7ebacbbe03915</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0168-9525%2897%2901340-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-9525%252897%252901340-1%26sid%3Dliteratum%253Aachs%26aulast%3DHardwick%26aufirst%3DK.%2BG.%26atitle%3DThe%2520spindle%2520checkpoint%26jtitle%3DTrends%2520Genet.%26date%3D1998%26volume%3D14%26spage%3D1%26epage%3D4%26doi%3D10.1016%2FS0168-9525%2897%2901340-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amendola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodricks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, D.</span><span> </span><span class="NLM_article-title">Expression of TTK, a novel human protein kinase, is associated with cell proliferation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">16000</span><span class="NLM_x">–</span> <span class="NLM_lpage">16006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=16000-16006&author=G.+B.+Millsauthor=R.+Schmandtauthor=M.+McGillauthor=A.+Amendolaauthor=M.+Hillauthor=K.+Jacobsauthor=C.+Mayauthor=A.+M.+Rodricksauthor=S.+Campbellauthor=D.+Hogg&title=Expression+of+TTK%2C+a+novel+human+protein+kinase%2C+is+associated+with+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DMcGill%26aufirst%3DM.%26aulast%3DAmendola%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRodricks%26aufirst%3DA.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DExpression%2520of%2520TTK%252C%2520a%2520novel%2520human%2520protein%2520kinase%252C%2520is%2520associated%2520with%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D16000%26epage%3D16006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lauze, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoelcker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luca, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span> </span><span class="NLM_article-title">Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=1655-1663&author=E.+Lauzeauthor=B.+Stoelckerauthor=F.+C.+Lucaauthor=E.+Weissauthor=A.+R.+Schutzauthor=M.+Winey&title=Yeast+spindle+pole+body+duplication+gene+MPS1+encodes+an+essential+dual+specificity+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauze%26aufirst%3DE.%26aulast%3DStoelcker%26aufirst%3DB.%26aulast%3DLuca%26aufirst%3DF.%2BC.%26aulast%3DWeiss%26aufirst%3DE.%26aulast%3DSchutz%26aufirst%3DA.%2BR.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DYeast%2520spindle%2520pole%2520body%2520duplication%2520gene%2520MPS1%2520encodes%2520an%2520essential%2520dual%2520specificity%2520protein%2520kinase%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D1655%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, E. D.</span><span> </span><span class="NLM_article-title">The spindle-assembly checkpoint in space and time</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1038/nrm2163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnrm2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=17426725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=379-393&author=A.+Musacchioauthor=E.+D.+Salmon&title=The+spindle-assembly+checkpoint+in+space+and+time&doi=10.1038%2Fnrm2163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle-assembly checkpoint in space and time</span></div><div class="casAuthors">Musacchio, Andrea; Salmon, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-393</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, the spindle-assembly checkpoint (SAC) is a ubiquitous safety device that ensures the fidelity of chromosome segregation in mitosis.  The SAC prevents chromosome missegregation and aneuploidy, and its dysfunction is implicated in tumorigenesis.  Recent mol. analyses have begun to shed light on the complex interaction of the checkpoint proteins with kinetochores - structures that mediate the binding of spindle microtubules to chromosomes in mitosis.  These studies are finally starting to reveal the mechanisms of checkpoint activation and silencing during mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBFNiU9YS2zbVg90H21EOLACvtfcHk0ljdaqHHG_rW_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D&md5=b790220dccee5f0ad57f41aef0a3be32</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1038%2Fnrm2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2163%26sid%3Dliteratum%253Aachs%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DE.%2BD.%26atitle%3DThe%2520spindle-assembly%2520checkpoint%2520in%2520space%2520and%2520time%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D379%26epage%3D393%26doi%3D10.1038%2Fnrm2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Daniel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">5384</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span><span class="refDoi"> DOI: 10.1073/pnas.1007645108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1073%2Fpnas.1007645108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5384-5389&author=J.+Danielauthor=J.+Coulterauthor=J.-H.+Wooauthor=K.+Wilsbachauthor=E.+Gabrielson&title=High+levels+of+the+Mps1+checkpoint+protein+are+protective+of+aneuploidy+in+breast+cancer+cells&doi=10.1073%2Fpnas.1007645108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1007645108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1007645108%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DHigh%2520levels%2520of%2520the%2520Mps1%2520checkpoint%2520protein%2520are%2520protective%2520of%2520aneuploidy%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5384%26epage%3D5389%26doi%3D10.1073%2Fpnas.1007645108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes-Pereira, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Cabral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafiq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natrajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiu, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterskog, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Functional Viability Profiles of Breast Cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-11-0107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F2159-8290.CD-11-0107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=260-273&author=R.+Broughauthor=J.+R.+Frankumauthor=D.+Simsauthor=A.+MacKayauthor=A.+M.+Mendes-Pereiraauthor=I.+Bajramiauthor=S.+Costa-Cabralauthor=R.+Rafiqauthor=A.+S.+Ahmadauthor=M.+A.+Ceroneauthor=R.+Natrajanauthor=R.+Sharpeauthor=K.-K.+Shiuauthor=D.+Wetterskogauthor=K.+J.+Dedesauthor=M.+B.+Lambrosauthor=T.+Rawjeeauthor=S.+Linardopoulosauthor=J.+S.+Reis-Filhoauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=A.+Ashworth&title=Functional+Viability+Profiles+of+Breast+Cancer&doi=10.1158%2F2159-8290.CD-11-0107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-11-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-11-0107%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%2BR.%26aulast%3DSims%26aufirst%3DD.%26aulast%3DMacKay%26aufirst%3DA.%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DCerone%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DShiu%26aufirst%3DK.-K.%26aulast%3DWetterskog%26aufirst%3DD.%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DRawjee%26aufirst%3DT.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFunctional%2520Viability%2520Profiles%2520of%2520Breast%2520Cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D260%26epage%3D273%26doi%3D10.1158%2F2159-8290.CD-11-0107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gordon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span> </span><span class="NLM_article-title">Causes and consequences of aneuploidy in cancer</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1038/nrg3123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnrg3123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=22269907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=189-203&author=D.+J.+Gordonauthor=B.+Resioauthor=D.+Pellman&title=Causes+and+consequences+of+aneuploidy+in+cancer&doi=10.1038%2Fnrg3123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Causes and consequences of aneuploidy in cancer</span></div><div class="casAuthors">Gordon, David J.; Resio, Benjamin; Pellman, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-203</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer.  Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood.  Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations.  We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4uwB4F0Xu7Vg90H21EOLACvtfcHk0ljdaqHHG_rW_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D&md5=9c730e7390d7aafd54301777e2270721</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrg3123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3123%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BJ.%26aulast%3DResio%26aufirst%3DB.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DCauses%2520and%2520consequences%2520of%2520aneuploidy%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D189%26epage%3D203%26doi%3D10.1038%2Fnrg3123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yuan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersto, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tully, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F1078-0432.CCR-05-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=16428479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=405-410&author=B.+Yuanauthor=Y.+Xuauthor=J.-H.+Wooauthor=Y.+Wangauthor=Y.+K.+Baeauthor=D.-S.+Yoonauthor=R.+P.+Werstoauthor=E.+Tullyauthor=K.+Wilsbachauthor=E.+Gabrielson&title=Increased+Expression+of+Mitotic+Checkpoint+Genes+in+Breast+Cancer+Cells+with+Chromosomal+Instability&doi=10.1158%2F1078-0432.CCR-05-0903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span></div><div class="casAuthors">Yuan, Bibo; Xu, Yi; Woo, Ju-Hyung; Wang, Yunyue; Bae, Young Kyung; Yoon, Dae-Sung; Wersto, Robert P.; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints.  Because the mol. basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.  Exptl. Design: We analyzed sequences and expression levels (RNA and protein) of eight major spindle checkpoint genes (MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, and TTK) in a panel of 12 breast cancer cell lines, most with established genetic instability and defective spindle damage checkpoint response.  MRNA levels of these genes were also measured in primary tumor samples, and immunohistochem. staining was used to evaluate BUB1B protein levels in a panel of 270 addnl. cases of breast cancer.  Results: No functionally significant sequence variations were found for any of the eight genes in the breast cancer cell lines with chromosomal instability.  More surprisingly, the mRNA and protein levels for these checkpoint genes are significantly higher in the genetically unstable breast cancer cell lines and in high-grade primary breast cancer tissues than in the stable (and checkpoint proficient) MCF-10A and normal mammary epithelial cells, or in normal breast tissues.  In fact, overexpression of the BUB1B protein is a marker that recognizes nearly 80% of breast cancers in paraffin-embedded tissues.  Conclusions: Defective mitotic spindle checkpoints in breast cancer are most likely not caused by low expression or mutations of these eight checkpoint genes.  High levels of these particular transcripts could represent a cellular compensation for defects in other mol. components of the mitotic spindle damage checkpoint, and increased expression of these genes might be markers of breast cancers with chromosomal instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcNtMRC1xcrVg90H21EOLACvtfcHk0ljF4IN9ms7_ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D&md5=06a8afcd6636218ae3a7bf38fe9939b4</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0903%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DYoon%26aufirst%3DD.-S.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DTully%26aufirst%3DE.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DIncreased%2520Expression%2520of%2520Mitotic%2520Checkpoint%2520Genes%2520in%2520Breast%2520Cancer%2520Cells%2520with%2520Chromosomal%2520Instability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D405%26epage%3D410%26doi%3D10.1158%2F1078-0432.CCR-05-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mizukami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, H.</span><span> </span><span class="NLM_article-title">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1454</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.00844.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1111%2Fj.1349-7006.2008.00844.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=18452554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1448-1454&author=Y.+Mizukamiauthor=K.+Konoauthor=Y.+Daigoauthor=A.+Takanoauthor=T.+Tsunodaauthor=Y.+Kawaguchiauthor=Y.+Nakamuraauthor=H.+Fujii&title=Detection+of+novel+cancer-testis+antigen-specific+T-cell+responses+in+TIL%2C+regional+lymph+nodes%2C+and+PBL+in+patients+with+esophageal+squamous+cell+carcinoma&doi=10.1111%2Fj.1349-7006.2008.00844.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span></div><div class="casAuthors">Mizukami, Yoshiki; Kono, Koji; Daigo, Yataro; Takano, Atsushi; Tsunoda, Takuya; Kawaguchi, Yoshihiko; Nakamura, Yusuke; Fujii, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1448-1454</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">The authors recently identified three HLA-A2402-restricted epitope peptides derived from cancer-testis antigens (CTA), TTK protein kinase (TTK), lymphocyte antigen 6 complex locus K (LY6K), and insulin-like growth factor (IGF)-II mRNA binding protein 3 (IMP-3) for the development of immunotherapies against esophageal squamous cell carcinoma (ESCC).  To evaluate their immunotherapeutic potential in ESCC patients, the authors estd. by ELISPOT assay the TTK-, LY6K-, or IMP-3-specific T-cell immune responses in tumor-infiltrating lymphocytes (TIL), regional lymph node lymphocytes (RLNL), and peripheral blood lymphocytes (PBL) expanded from 20HLA-A2402 (+) ESCC patients, and correlated their immune activity with the expression levels of TTK, LY6K, and IMP-3, and MHC class I in the tumors.  Induction of TTK-antigen specific T-cell response in TIL to the peptide-pulsed target cells was detected in 14 out of 20 (70%) cases, while LY6K or IMP-3 specific T-cell activity was obsd. in 11 of 20 (55%) or in eight of 20 (40%) cases, resp.  Furthermore, T-cell activity in RLNL and PBL was detectable in the similar proportion of the 20 ESCC patients.  Interestingly, CTA-specific T-cell immune response was found in 13 of 14 (93%) TIL obtained from ESCC tumors with strong MHC class I expression, while it could be obsd. only in two of six (33%) TIL from ESCC tumors with weak MHC class I expression.  These results strongly suggest the pre-existence of specific T-cell responses to HLA-A24-restricted epitope peptides from TTK, LY6K, and IMP-3 in ESCC patients.  Monitoring antigen-specific T-cell responses, as well as the expression levels of MHC class I and epitope CTA in tumors, should be a selection index for application of cancer vaccine therapies to the patients who are likely to show good immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8reosidZGbVg90H21EOLACvtfcHk0ljF4IN9ms7_ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D&md5=dcb4be9405b2f37475bcd8785b27722a</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00844.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00844.x%26sid%3Dliteratum%253Aachs%26aulast%3DMizukami%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DH.%26atitle%3DDetection%2520of%2520novel%2520cancer-testis%2520antigen-specific%2520T-cell%2520responses%2520in%2520TIL%252C%2520regional%2520lymph%2520nodes%252C%2520and%2520PBL%2520in%2520patients%2520with%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D1448%26epage%3D1454%26doi%3D10.1111%2Fj.1349-7006.2008.00844.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Salvatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nappi, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miccoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirafici, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">10148</span><span class="NLM_x">–</span> <span class="NLM_lpage">10158</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F0008-5472.CAN-07-1887" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10148-10158&author=G.+Salvatoreauthor=T.+C.+Nappiauthor=P.+Salernoauthor=Y.+Jiangauthor=C.+Garbiauthor=C.+Ugoliniauthor=P.+Miccoliauthor=F.+Basoloauthor=M.+D.+Castelloneauthor=A.+M.+Ciraficiauthor=R.+M.+Melilloauthor=A.+Fuscoauthor=M.+L.+Bittnerauthor=M.+Santoro&title=A+Cell+Proliferation+and+Chromosomal+Instability+Signature+in+Anaplastic+Thyroid+Carcinoma&doi=10.1158%2F0008-5472.CAN-07-1887"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-1887%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DG.%26aulast%3DNappi%26aufirst%3DT.%2BC.%26aulast%3DSalerno%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGarbi%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DC.%26aulast%3DMiccoli%26aufirst%3DP.%26aulast%3DBasolo%26aufirst%3DF.%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DCirafici%26aufirst%3DA.%2BM.%26aulast%3DMelillo%26aufirst%3DR.%2BM.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BL.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DA%2520Cell%2520Proliferation%2520and%2520Chromosomal%2520Instability%2520Signature%2520in%2520Anaplastic%2520Thyroid%2520Carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10148%26epage%3D10158%26doi%3D10.1158%2F0008-5472.CAN-07-1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Thykjaer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruhoffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demtroder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orntoft, T. F.</span><span> </span><span class="NLM_article-title">Identification of gene expression patterns in superficial and invasive human bladder cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2492-2499&author=T.+Thykjaerauthor=C.+Workmanauthor=M.+Kruhofferauthor=K.+Demtroderauthor=H.+Wolfauthor=L.+D.+Andersenauthor=C.+M.+Frederiksenauthor=S.+Knudsenauthor=T.+F.+Orntoft&title=Identification+of+gene+expression+patterns+in+superficial+and+invasive+human+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThykjaer%26aufirst%3DT.%26aulast%3DWorkman%26aufirst%3DC.%26aulast%3DKruhoffer%26aufirst%3DM.%26aulast%3DDemtroder%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DH.%26aulast%3DAndersen%26aufirst%3DL.%2BD.%26aulast%3DFrederiksen%26aufirst%3DC.%2BM.%26aulast%3DKnudsen%26aufirst%3DS.%26aulast%3DOrntoft%26aufirst%3DT.%2BF.%26atitle%3DIdentification%2520of%2520gene%2520expression%2520patterns%2520in%2520superficial%2520and%2520invasive%2520human%2520bladder%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2492%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tannous, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Stoop, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandrowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiddingh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sol, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerweij, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedekind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niers, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barazas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, R. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Witt Hamer, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandertop, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Würdinger, T.</span><span> </span><span class="NLM_article-title">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span> <span class="citation_source-journal">J. Nat. Canc. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1331</span><span class="refDoi"> DOI: 10.1093/jnci/djt168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1093%2Fjnci%2Fdjt168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=23940287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=1322-1331&author=B.+A.+Tannousauthor=M.+Keramiauthor=P.+M.+Van+der+Stoopauthor=N.+Kwiatkowskiauthor=J.+Wangauthor=W.+Zhouauthor=A.+F.+Kesslerauthor=G.+Lewandrowskiauthor=L.+Hiddinghauthor=N.+Solauthor=T.+Lagerweijauthor=L.+Wedekindauthor=J.+M.+Niersauthor=M.+Barazasauthor=R.+J.+A.+Nilssonauthor=D.+Geertsauthor=P.+C.+De+Witt+Hamerauthor=C.+Hagemannauthor=W.+P.+Vandertopauthor=O.+Van+Tellingenauthor=D.+P.+Noskeauthor=N.+S.+Grayauthor=T.+W%C3%BCrdinger&title=Effects+of+the+Selective+MPS1+Inhibitor+MPS1-IN-3+on+Glioblastoma+Sensitivity+to+Antimitotic+Drugs&doi=10.1093%2Fjnci%2Fdjt168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span></div><div class="casAuthors">Tannous, Bakhos A.; Kerami, Mariam; Van der Stoop, Petra M.; Kwiatkowski, Nicholas; Wang, Jinhua; Zhou, Wenjun; Kessler, Almuth F.; Lewandrowski, Grant; Hiddingh, Lotte; Sol, Nik; Lagerweij, Tonny; Wedekind, Laurine; Niers, Johanna M.; Barazas, Marco; Nilsson, R. Jonas A.; Geerts, Dirk; De Witt Hamer, Philip C.; Hagemann, Carsten; Vandertop, W. Peter; Van Tellingen, Olaf; Noske, David P.; Gray, Nathanael S.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1322-1331</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastomas exhibit a high level of chemotherapeutic resistance, including to the antimitotic agents vincristine and taxol.  During the mitotic agent-induced arrest, glioblastoma cells are able to perform damage-control and self-repair to continue proliferation.  Monopolar spindle 1 (MPS1/TTK) is a checkpoint kinase and a gatekeeper of the mitotic arrest.  Methods We used glioblastoma cells to det. the expression of MPS1 and to det. the effects of MPS1 inhibition on mitotic errors and cell viability in combination with vincristine and taxol.  The effect of MPS1 inhibition was assessed in different orthotopic glioblastoma mouse models (n = 3-7 mice/group).  MPS1 expression levels were examd. in relation to patient survival.  Results Using publicly available gene expression data, we detd. that MPS1 overexpression corresponds pos. with tumor grade and neg. with patient survival (two-sided t test, P < .001).  Patients with high MPS1 expression (n = 203) had a median and mean survival of 487 and 913 days (95% confidence intervals [CI] = 751 to 1075), resp., and a 2-yr survival rate of 35%, whereas patients with intermediate MPS1 expression (n = 140) had a median and mean survival of 858 and 1183 days (95% CI = 1177 to 1189), resp., and a 2-yr survival rate of 56%.  We demonstrate that MPS1 inhibition by RNAi results in sensitization to antimitotic agents.  We developed a selective small-mol. inhibitor of MPS1, MPS1-IN-3, which caused mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induced mitotic checkpoint override, increased aneuploidy, and augmented cell death.  MPS1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models (two-sided log-rank test, P < .01), resulting in prolonged survival without toxicity.  Conclusions Our results collectively demonstrate that MPS1, a putative therapeutic target in glioblastoma, can be selectively inhibited by MPS1-IN-3 sensitizing glioblastoma cells to antimitotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUG67Lkc5qcbVg90H21EOLACvtfcHk0lhFNO1r0S6oqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK&md5=b7e51ef38e02d9fbf0ce0191af530b3a</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjt168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjt168%26sid%3Dliteratum%253Aachs%26aulast%3DTannous%26aufirst%3DB.%2BA.%26aulast%3DKerami%26aufirst%3DM.%26aulast%3DVan%2Bder%2BStoop%26aufirst%3DP.%2BM.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DLewandrowski%26aufirst%3DG.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DSol%26aufirst%3DN.%26aulast%3DLagerweij%26aufirst%3DT.%26aulast%3DWedekind%26aufirst%3DL.%26aulast%3DNiers%26aufirst%3DJ.%2BM.%26aulast%3DBarazas%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DVandertop%26aufirst%3DW.%2BP.%26aulast%3DVan%2BTellingen%26aufirst%3DO.%26aulast%3DNoske%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DW%25C3%25BCrdinger%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520Selective%2520MPS1%2520Inhibitor%2520MPS1-IN-3%2520on%2520Glioblastoma%2520Sensitivity%2520to%2520Antimitotic%2520Drugs%26jtitle%3DJ.%2520Nat.%2520Canc.%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D1322%26epage%3D1331%26doi%3D10.1093%2Fjnci%2Fdjt168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Slee, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasaway, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victorino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korc, M.</span><span> </span><span class="NLM_article-title">Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F1535-7163.MCT-13-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=24282275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=307-315&author=R.+B.+Sleeauthor=B.+R.+Grimesauthor=R.+Bansalauthor=J.+Goreauthor=C.+Blackburnauthor=L.+Brownauthor=R.+Gasawayauthor=J.+Jeongauthor=J.+Victorinoauthor=K.+L.+Marchauthor=R.+Colomboauthor=B.+S.+Herbertauthor=M.+Korc&title=Selective+inhibition+of+pancreatic+ductal+adenocarcinoma+cell+growth+by+the+mitotic+MPS1+kinase+inhibitor+NMS-P715&doi=10.1158%2F1535-7163.MCT-13-0324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715</span></div><div class="casAuthors">Slee, Roger B.; Grimes, Brenda R.; Bansal, Ruchi; Gore, Jesse; Blackburn, Corinne; Brown, Lyndsey; Gasaway, Rachel; Jeong, Jaesik; Victorino, Jose; March, Keith L.; Colombo, Riccardo; Herbert, Brittney-Shea; Korc, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-315</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most solid tumors, including pancreatic ductal adenocarcinoma (PDAC), exhibit structural and numerical chromosome instability (CIN).  Although often implicated as a driver of tumor progression and drug resistance, CIN also reduces cell fitness and poses a vulnerability that can be exploited therapeutically.  The spindle assembly checkpoint (SAC) ensures correct chromosome-microtubule attachment, thereby minimizing chromosome segregation errors.  Many tumors exhibit upregulation of SAC components such as MPS1, which may help contain CIN within survivable limits.  Prior studies showed that MPS1 inhibition with the small mol. NMS-P715 limits tumor growth in xenograft models.  In cancer cell lines, NMS-P715 causes cell death assocd. with impaired SAC function and increased chromosome missegregation.  Although normal cells appeared more resistant, effects on stem cells, which are the dose-limiting toxicity of most chemotherapeutics, were not examd.  Elevated expression of 70 genes (CIN70), including MPS1, provides a surrogate measure of CIN and predicts poor patient survival in multiple tumor types.  Our new findings show that the degree of CIN70 upregulation varies considerably among PDAC tumors, with higher CIN70 gene expression predictive of poor outcome.  We identified a 25 gene subset (PDAC CIN25) whose overexpression was most strongly correlated with poor survival and included MPS1.  In vitro, growth of human and murine PDAC cells is inhibited by NMS-P715 treatment, whereas adipose-derived human mesenchymal stem cells are relatively resistant and maintain chromosome stability upon exposure to NMS-P715.  These studies suggest that NMS-P715 could have a favorable therapeutic index and warrant further investigation of MPS1 inhibition as a new PDAC treatment strategy.  Mol Cancer Ther; 13(2); 307-15. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooKyK5kaMEOLVg90H21EOLACvtfcHk0lhFNO1r0S6oqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLc%253D&md5=5a7352667013f1fd2bfc11b233fbe548</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0324%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DR.%2BB.%26aulast%3DGrimes%26aufirst%3DB.%2BR.%26aulast%3DBansal%26aufirst%3DR.%26aulast%3DGore%26aufirst%3DJ.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DGasaway%26aufirst%3DR.%26aulast%3DJeong%26aufirst%3DJ.%26aulast%3DVictorino%26aufirst%3DJ.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DHerbert%26aufirst%3DB.%2BS.%26aulast%3DKorc%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%2520cell%2520growth%2520by%2520the%2520mitotic%2520MPS1%2520kinase%2520inhibitor%2520NMS-P715%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D307%26epage%3D315%26doi%3D10.1158%2F1535-7163.MCT-13-0324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Aarts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span> </span><span class="NLM_article-title">Tumour selective targeting of cell cycle kinases for cancer treatment</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/j.coph.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.coph.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=23597425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=529-535&author=M.+Aartsauthor=S.+Linardopoulosauthor=N.+C.+Turner&title=Tumour+selective+targeting+of+cell+cycle+kinases+for+cancer+treatment&doi=10.1016%2Fj.coph.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour selective targeting of cell cycle kinases for cancer treatment</span></div><div class="casAuthors">Aarts, Marieke; Linardopoulos, Spiros; Turner, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-535</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The deregulation of the cell cycle and checkpoint machinery in cancer presents a highly attractive therapeutic strategy.  We review here the strategies used to exploit the dysregulated cell cycle, both through targeting kinases required for cell cycle progression, and checkpoint kinases to inappropriately force cells through the cell cycle.  Appropriate control of the cell cycle is crit. for proliferating normal cells, and we discuss the importance of defining tumor specific vulnerabilities that could be targeted with cell cycle kinase inhibitors.  Recent studies have shown that ER-pos. breast cancers rely on CDK4 to promote proliferation.  TP53 mutant cancer cell lines are sensitive to WEE1 and CHK1 inhibitors in combination with chemotherapy, while PTEN-deficient aneuploid cancer cell lines are sensitive to TTK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLoVeyM7O1HrVg90H21EOLACvtfcHk0lgB2cOjwakWYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D&md5=21d34a68d937abd09dad8bc15fd56bce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DAarts%26aufirst%3DM.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26atitle%3DTumour%2520selective%2520targeting%2520of%2520cell%2520cycle%2520kinases%2520for%2520cancer%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2013%26volume%3D13%26spage%3D529%26epage%3D535%26doi%3D10.1016%2Fj.coph.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Naud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faisal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAndrew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matijssen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Orally Bioavailable 1<i>H</i>-Pyrrolo[3,2-<i>c</i>]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10045</span><span class="NLM_x">–</span> <span class="NLM_lpage">10065</span><span class="refDoi"> DOI: 10.1021/jm401395s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+M.+van+Montfortauthor=J.+Blagg&title=Structure-Based+Design+of+Orally+Bioavailable+1H-Pyrrolo%5B3%2C2-c%5Dpyridine+Inhibitors+of+Mitotic+Kinase+Monopolar+Spindle+1+%28MPS1%29&doi=10.1021%2Fjm401395s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span></div><div class="casAuthors">Naud, Sebastien; Westwood, Isaac M.; Faisal, Amir; Sheldrake, Peter; Bavetsias, Vassilios; Atrash, Butrus; Cheung, Kwai-Ming J.; Liu, Manjuan; Hayes, Angela; Schmitt, Jessica; Wood, Amy; Choi, Vanessa; Boxall, Kathy; Mak, Grace; Gurden, Mark; Valenti, Melanie; de Haven Brandon, Alexis; Henley, Alan; Baker, Ross; McAndrew, Craig; Matijssen, Berry; Burke, Rosemary; Hoelder, Swen; Eccles, Suzanne A.; Raynaud, Florence I.; Linardopoulos, Spiros; van Montfort, Rob L. M.; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10045-10065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.  MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy.  PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncol.  The authors report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo-[3,2-c]-pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to CCT251455.  This potent and selective chem. tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compd. to elucidate further the therapeutic potential of MPS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVRsRcyzCEBLVg90H21EOLACvtfcHk0lgB2cOjwakWYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO&md5=6564efe14dec83774e94c355be756845</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-Based%2520Design%2520of%2520Orally%2520Bioavailable%25201H-Pyrrolo%255B3%252C2-c%255Dpyridine%2520Inhibitors%2520of%2520Mitotic%2520Kinase%2520Monopolar%2520Spindle%25201%2520%2528MPS1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065%26doi%3D10.1021%2Fjm401395s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span><span class="refDoi"> DOI: 10.1021/jm501599u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501599u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1760-1775&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=K.+Nozuauthor=H.+Yoshidaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=Y.+Babaauthor=Y.+Nakamura&title=Discovery+of+Imidazo%5B1%2C2-b%5Dpyridazine+Derivatives%3A+Selective+and+Orally+Available+Mps1+%28TTK%29+Kinase+Inhibitors+Exhibiting+Remarkable+Antiproliferative+Activity&doi=10.1021%2Fjm501599u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span></div><div class="casAuthors">Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Hashizume, Hiroshi; Nozu, Kohei; Yoshida, Hiroshi; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Baba, Yoshiyasu; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1775</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is an attractive oncol. target due to its high expression level in cancer cells as well as the correlation of its expression levels with histol. grades of cancers.  An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign.  Although 10a exhibited good biochem. activity, its moderate cellular as well as antiproliferative activities needed to be improved.  The cocrystal structure of an analog of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat.  Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo.  This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8D9nRl5vWabVg90H21EOLACvtfcHk0liVLMKn9D9m7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D&md5=bee62a50247a363dc3e35fcdeac6a64f</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm501599u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501599u%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DNozu%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520Imidazo%255B1%252C2-b%255Dpyridazine%2520Derivatives%253A%2520Selective%2520and%2520Orally%2520Available%2520Mps1%2520%2528TTK%2529%2520Kinase%2520Inhibitors%2520Exhibiting%2520Remarkable%2520Antiproliferative%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1760%26epage%3D1775%26doi%3D10.1021%2Fjm501599u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris-Brandts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgadze, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on <i>N</i>-(3-(3-sulfamoylphenyl)-1<i>H</i>-indazol-5-yl)acetamides and carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4997</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.bmc.2014.06.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+B.+Patelauthor=L.+G.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+E.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+M.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=F.+Banauthor=V.+Nadeemauthor=T.+W.+Makauthor=G.+J.+Panauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29acetamides+and+carboxamides&doi=10.1016%2Fj.bmc.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%2BB.%26aulast%3DEdwards%26aufirst%3DL.%2BG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%2BJ.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997%26doi%3D10.1016%2Fj.bmc.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tardif, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassiano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimbora, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douce, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorweiler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papac, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlexander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. L.</span><span> </span><span class="NLM_article-title">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2275</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+Cellular+and+Antitumor+Effects+of+MPI-0479605%2C+a+Small-Molecule+Inhibitor+of+the+Mitotic+Kinase+Mps1&doi=10.1158%2F1535-7163.MCT-11-0453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0liVLMKn9D9m7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520Cellular%2520and%2520Antitumor%2520Effects%2520of%2520MPI-0479605%252C%2520a%2520Small-Molecule%2520Inhibitor%2520of%2520the%2520Mitotic%2520Kinase%2520Mps1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275%26doi%3D10.1158%2F1535-7163.MCT-11-0453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rymer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanochko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trajkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappin, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span> </span><span class="NLM_article-title">Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0138616</span><span class="refDoi"> DOI: 10.1371/journal.pone.0138616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1371%2Fjournal.pone.0138616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=26398286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0138616&author=R.+Martinezauthor=A.+Blasinaauthor=J.+F.+Hallinauthor=W.+Huauthor=I.+Rymerauthor=J.+Fanauthor=R.+L.+Hoffmanauthor=S.+Murphyauthor=M.+Marxauthor=G.+Yanochkoauthor=D.+Trajkovicauthor=D.+Dinhauthor=S.+Timofeevskiauthor=Z.+Zhuauthor=P.+Sunauthor=P.+B.+Lappinauthor=B.+W.+Murray&title=Mitotic+Checkpoint+Kinase+Mps1+Has+a+Role+in+Normal+Physiology+which+Impacts+Clinical+Utility&doi=10.1371%2Fjournal.pone.0138616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic checkpoint kinase Mps1 has a role in normal physiology which impacts clinical utility</span></div><div class="casAuthors">Martinez, Ricardo; Blasina, Alessandra; Hallin, Jill F.; Hu, Wenyue; Rymer, Isha; Fan, Jeffery; Hoffman, Robert L.; Murphy, Sean; Marx, Matthew; Yanochko, Gina; Trajkovic, Dusko; Dinh, Dac; Timofeevski, Sergei; Zhu, Zhou; Sun, Peiquing; Lappin, Patrick B.; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0138616/1-e0138616/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is well-tolerated.  A crit. cell cycle process that could be targeted is the mitotic checkpoint (spindle assembly checkpoint) which governs the metaphase-to-anaphase transition and insures proper chromosomal segregation.  The mitotic checkpoint kinase Mps1 was selected to explore whether enhancement in genomic instability is a viable therapeutic strategy.  The basal-a subset of triple-neg. breast cancer was chosen as a model system because it has a higher incidence of chromosomal instability and Mps1 expression is up-regulated.  Depletion of Mps1 reduces tumor cell viability relative to normal cells.  Highly selective, extremely potent Mps1 kinase inhibitors were created to investigate the roles of Mps1 catalytic activity in tumor cells and normal physiol. (PF-7006, PF-3837; Ki<0.5 nM; cellular IC50 2-6 nM).  Treatment of tumor cells in vitro with PF-7006 modulates expected Mps1-dependent biol. as demonstrated by mol. and phenotypic measures (reduced pHH3-Ser10 levels, shorter duration of mitosis, micro-nucleation, and apoptosis).  Tumor-bearing mice treated with PF-7006 exhibit tumor growth inhibition concomitant with pharmacodynamic modulation of a downstream biomarker (pHH3-Ser10).  Unfortunately, efficacy only occurs at drug exposures that cause dose-limiting body wt. loss, gastrointestinal toxicities, and neutropenia.  Mps1 inhibitor toxicities may be mitigated by inducing G1 cell cycle arrest in Rb1-competent cells with the cyclin-dependent kinase-4/6 inhibitor palbociclib.  Using an isogenic cellular model system, PF-7006 is shown to be selectively cytotoxic to Rb1-deficient cells relative to Rb1-competent cells (also a measure of kinase selectivity).  Human bone marrow cells pretreated with palbociclib have decreased PF-7006-dependent apoptosis relative to cells without palbociclib pretreatment.  Collectively, this study raises a concern that single agent therapies inhibiting Mps1 will not be well-tolerated clin. but may be when combined with a selective CDK4/6 drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc-9LR3Gfty7Vg90H21EOLACvtfcHk0liKq_RT9wanew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D&md5=68fc918b70df2cd020be0c4fec209c12</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138616%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%2BF.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DRymer%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DMurphy%26aufirst%3DS.%26aulast%3DMarx%26aufirst%3DM.%26aulast%3DYanochko%26aufirst%3DG.%26aulast%3DTrajkovic%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DLappin%26aufirst%3DP.%2BB.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DMitotic%2520Checkpoint%2520Kinase%2520Mps1%2520Has%2520a%2520Role%2520in%2520Normal%2520Physiology%2520which%2520Impacts%2520Clinical%2520Utility%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0138616%26doi%3D10.1371%2Fjournal.pone.0138616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wengner, A. M.; Siemeister, G.</span><span> </span><span class="NLM_article-title">Combination of a imidazopyridazine derivative and a mitotic agent for the treatment of cancer</span>. Patent WO2014198776A1, December 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combination+of+a+imidazopyridazine+derivative+and+a+mitotic+agent+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombination%2520of%2520a%2520imidazopyridazine%2520derivative%2520and%2520a%2520mitotic%2520agent%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wengner, A. M.; Siemeister, G.</span><span> </span><span class="NLM_article-title">Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor</span>. Patent WO2014198645, December 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combinations+for+the+treatment+of+cancer+comprising+a+mps-1+kinase+inhibitor+and+a+mitotic+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombinations%2520for%2520the%2520treatment%2520of%2520cancer%2520comprising%2520a%2520mps-1%2520kinase%2520inhibitor%2520and%2520a%2520mitotic%2520inhibitor%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Maia, A. R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Man, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omerzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterrenburg, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinsen, M. B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen-Seegers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J. A. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Doornmalen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitdehaag, J. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buijsman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaman, G. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span> </span><span class="NLM_article-title">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2180</span><span class="refDoi"> DOI: 10.1093/annonc/mdv293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1093%2Fannonc%2Fmdv293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=26153498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2180&author=A.+R.+R.+Maiaauthor=J.+de+Manauthor=U.+Boonauthor=A.+Janssenauthor=J.-Y.+Songauthor=M.+Omerzuauthor=J.+G.+Sterrenburgauthor=M.+B.+W.+Prinsenauthor=N.+Willemsen-Seegersauthor=J.+A.+D.+M.+de+Roosauthor=A.+M.+van+Doornmalenauthor=J.+C.+M.+Uitdehaagauthor=G.+J.+P.+L.+Kopsauthor=J.+Jonkersauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zamanauthor=R.+H.+Medema&title=Inhibition+of+the+spindle+assembly+checkpoint+kinase+TTK+enhances+the+efficacy+of+docetaxel+in+a+triple-negative+breast+cancer+model&doi=10.1093%2Fannonc%2Fmdv293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span></div><div class="casAuthors">Maia A R R; Janssen A; de Man J; Sterrenburg J G; Prinsen M B W; Willemsen-Seegers N; de Roos J A D M; van Doornmalen A M; Uitdehaag J C M; Buijsman R C; Zaman G J R; Boon U; Song J-Y; Omerzu M; Kops G J P L; Jonkers J; Medema R H</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2180-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Triple-negative breast cancers (TNBC) are considered the most aggressive type of breast cancer, for which no targeted therapy exists at the moment.  These tumors are characterized by having a high degree of chromosome instability and often overexpress the spindle assembly checkpoint kinase TTK.  To explore the potential of TTK inhibition as a targeted therapy in TNBC, we developed a highly potent and selective small molecule inhibitor of TTK, NTRC 0066-0.  RESULTS AND CONCLUSIONS:  The compound is characterized by long residence time on the target and inhibits the proliferation of a wide variety of human cancer cell lines with potency in the same range as marketed cytotoxic agents.  In cell lines and in mice, NTRC 0066-0 inhibits the phosphorylation of a TTK substrate and induces chromosome missegregation.  NTRC 0066-0 inhibits tumor growth in MDA-MB-231 xenografts as a single agent after oral application.  To address the effect of the inhibitor in breast cancer, we used a well-defined mouse model that spontaneously develops breast tumors that share key morphologic and molecular features with human TNBC.  Our studies show that combination of NTRC 0066-0 with a therapeutic dose of docetaxel resulted in doubling of mouse survival and extended tumor remission, without toxicity.  Furthermore, we observed that treatment efficacy is only achieved upon co-administration of the two compounds, which suggests a synergistic in vivo effect.  Therefore, we propose TTK inhibition as a novel therapeutic target for neoadjuvant therapy in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW4bdSIlyWFQ8IxFYvehhofW6udTcc2eZwi-Mko9EJ3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D&md5=579aa33d6fd0de70b6c68ae86d8316c0</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv293%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DA.%2BR.%2BR.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DBoon%26aufirst%3DU.%26aulast%3DJanssen%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.-Y.%26aulast%3DOmerzu%26aufirst%3DM.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3Dvan%2BDoornmalen%26aufirst%3DA.%2BM.%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DInhibition%2520of%2520the%2520spindle%2520assembly%2520checkpoint%2520kinase%2520TTK%2520enhances%2520the%2520efficacy%2520of%2520docetaxel%2520in%2520a%2520triple-negative%2520breast%2520cancer%2520model%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3D2180%26doi%3D10.1093%2Fannonc%2Fmdv293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4343</span><span class="NLM_x">–</span> <span class="NLM_lpage">4356</span><span class="refDoi"> DOI: 10.1021/jm4000215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4343-4356&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=Y.+Tachibanaauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=Y.+Hatoauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=M.+Higakiauthor=K.+Uedaauthor=H.+Yoshizawaauthor=Y.+Babaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Indazole-Based+Potent+and+Cell-Active+Mps1+Kinase+Inhibitors%3A+Rational+Design+from+Pan-Kinase+Inhibitor+Anthrapyrazolone+%28SP600125%29&doi=10.1021%2Fjm4000215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm4000215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000215%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DHato%26aufirst%3DY.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DIndazole-Based%2520Potent%2520and%2520Cell-Active%2520Mps1%2520Kinase%2520Inhibitors%253A%2520Rational%2520Design%2520from%2520Pan-Kinase%2520Inhibitor%2520Anthrapyrazolone%2520%2528SP600125%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4343%26epage%3D4356%26doi%3D10.1021%2Fjm4000215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hewitt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1083/jcb.201002133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1083%2Fjcb.201002133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=25-34&author=L.+Hewittauthor=A.+Tigheauthor=S.+Santaguidaauthor=A.+M.+Whiteauthor=C.+D.+Jonesauthor=A.+Musacchioauthor=S.+Greenauthor=S.+S.+Taylor&title=Sustained+Mps1+activity+is+required+in+mitosis+to+recruit+O-Mad2+to+the+Mad1-C-Mad2+core+complex&doi=10.1083%2Fjcb.201002133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201002133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201002133%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DL.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DSustained%2520Mps1%2520activity%2520is%2520required%2520in%2520mitosis%2520to%2520recruit%2520O-Mad2%2520to%2520the%2520Mad1-C-Mad2%2520core%2520complex%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D25%26epage%3D34%26doi%3D10.1083%2Fjcb.201002133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Langdon, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span><span class="refDoi"> DOI: 10.1021/ci400100c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400100c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFShtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=1100-1112&author=S.+R.+Langdonauthor=I.+M.+Westwoodauthor=R.+L.+M.+van+Montfortauthor=N.+Brownauthor=J.+Blagg&title=Scaffold-Focused+Virtual+Screening%3A+Prospective+Application+to+the+Discovery+of+TTK+Inhibitors&doi=10.1021%2Fci400100c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors</span></div><div class="casAuthors">Langdon, Sarah R.; Westwood, Isaac M.; van Montfort, Rob L. M.; Brown, Nathan; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1100-1112</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe and apply a scaffold-focused virtual screen based upon scaffold trees to the mitotic kinase TTK (MPS1).  Using level 1 of the scaffold tree, we perform both 2D and 3D similarity searches between a query scaffold and a level 1 scaffold library derived from a 2 million compd. library; 98 compds. from 27 unique top-ranked level 1 scaffolds are selected for biochem. screening.  We show that this scaffold-focused virtual screen prospectively identifies eight confirmed active compds. that are structurally differentiated from the query compd.  In comparison, 100 compds. were selected for biochem. screening using a virtual screen based upon whole mol. similarity resulting in 12 confirmed active compds. that are structurally similar to the query compd.  We elucidated the binding mode for four of the eight confirmed scaffold hops to TTK by detg. their protein-ligand crystal structures; each represents a ligand-efficient scaffold for inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKRrcvweEx7Vg90H21EOLACvtfcHk0li74cN9cOzByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFShtLw%253D&md5=622edfcd75e57a35d3d411b3190ed9cf</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Fci400100c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400100c%26sid%3Dliteratum%253Aachs%26aulast%3DLangdon%26aufirst%3DS.%2BR.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DScaffold-Focused%2520Virtual%2520Screening%253A%2520Prospective%2520Application%2520to%2520the%2520Discovery%2520of%2520TTK%2520Inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D1100%26epage%3D1112%26doi%3D10.1021%2Fci400100c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Chu, M. L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavas, L. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, L.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Catalytic Domain of the Mitotic Checkpoint Kinase Mps1 in Complex with SP600125</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">21495</span><span class="NLM_x">–</span> <span class="NLM_lpage">21500</span><span class="refDoi"> DOI: 10.1074/jbc.M803026200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1074%2Fjbc.M803026200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=18480048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21495-21500&author=M.+L.+H.+Chuauthor=L.+M.+G.+Chavasauthor=K.+T.+Douglasauthor=P.+A.+Eyersauthor=L.+Tabernero&title=Crystal+Structure+of+the+Catalytic+Domain+of+the+Mitotic+Checkpoint+Kinase+Mps1+in+Complex+with+SP600125&doi=10.1074%2Fjbc.M803026200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Catalytic Domain of the Mitotic Checkpoint Kinase Mps1 in Complex with SP600125</span></div><div class="casAuthors">Chu, Matthew L. H.; Chavas, Leonard M. G.; Douglas, Kenneth T.; Eyers, Patrick A.; Tabernero, Lydia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">21495-21500</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chromosomal instability can result from defective control of checkpoints and is assocd. with malignant cell growth.  Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase that has important roles in the prevention of aneuploidy during the cell cycle and might therefore be a potential target for new therapeutic agents in the treatment of cancer.  To gain insights into the mol. mechanism of Mps1 inhibition by small mols., we detd. the x-ray structure of Mps1, both alone and in complex with the ATP-competitive inhibitor SP600125.  Mps1 adopts a classic protein kinase fold, with the inhibitor sitting in the ATP-binding site where it is stabilized by hydrophobic interactions.  We identified a secondary pocket, not utilized by SP600125, which might be exploited for the rational design of specific Mps1 inhibitors.  These structures provide important insights into the interaction of this protein kinase with small mols. and suggest potential mechanisms for Mps1 regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVcfF84P3Cf7Vg90H21EOLACvtfcHk0liLiIlnM8uDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWrs7c%253D&md5=76da3ce88aacb04c6b216e05a3213f9c</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803026200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803026200%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DM.%2BL.%2BH.%26aulast%3DChavas%26aufirst%3DL.%2BM.%2BG.%26aulast%3DDouglas%26aufirst%3DK.%2BT.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DTabernero%26aufirst%3DL.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520the%2520Mitotic%2520Checkpoint%2520Kinase%2520Mps1%2520in%2520Complex%2520with%2520SP600125%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D21495%26epage%3D21500%26doi%3D10.1074%2Fjbc.M803026200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelluma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manak, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deveraux, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1038/nchembio.345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+P.+L.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+Mps1+cell+cycle+function&doi=10.1038%2Fnchembio.345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0liLiIlnM8uDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520Mps1%2520cell%2520cycle%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368%26doi%3D10.1038%2Fnchembio.345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alise, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span> </span><span class="NLM_article-title">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1083/jcb.201001036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1083%2Fjcb.201001036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20624901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=73-87&author=S.+Santaguidaauthor=A.+Tigheauthor=A.+M.+D%E2%80%99Aliseauthor=S.+S.+Taylorauthor=A.+Musacchio&title=Dissecting+the+role+of+MPS1+in+chromosome+biorientation+and+the+spindle+checkpoint+through+the+small+molecule+inhibitor+reversine&doi=10.1083%2Fjcb.201001036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span></div><div class="casAuthors">Santaguida, Stefano; Tighe, Anthony; D'Alise, Anna Morena; Taylor, Stephen S.; Musacchio, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-87</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The catalytic activity of the MPS1 kinase is crucial for the spindle assembly checkpoint and for chromosome biorientation on the mitotic spindle.  We report that the small mol. reversine is a potent mitotic inhibitor of MPS1.  Reversine inhibits the spindle assembly checkpoint in a dose-dependent manner.  Its addn. to mitotic HeLa cells causes the ejection of Mad1 and the ROD-ZWILCH-ZW10 complex, both of which are important for the spindle checkpoint, from unattached kinetochores.  By using reversine, we also demonstrate that MPS1 is required for the correction of improper chromosome-microtubule attachments.  We provide evidence that MPS1 acts downstream from the AURORA B kinase, another crucial component of the error correction pathway.  Our expts. describe a very useful tool to interfere with MPS1 activity in human cells.  They also shed light on the relationship between the error correction pathway and the spindle checkpoint and suggest that these processes are coregulated and are likely to share at least a subset of their catalytic machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPbUVMH1KC_7Vg90H21EOLACvtfcHk0liLiIlnM8uDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D&md5=fd022c4a8a7284eb5da7d67b04a6f8bb</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201001036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201001036%26sid%3Dliteratum%253Aachs%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Alise%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DDissecting%2520the%2520role%2520of%2520MPS1%2520in%2520chromosome%2520biorientation%2520and%2520the%2520spindle%2520checkpoint%2520through%2520the%2520small%2520molecule%2520inhibitor%2520reversine%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D73%26epage%3D87%26doi%3D10.1083%2Fjcb.201001036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2260</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.02.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.bmc.2015.02.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2247-2260&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=E.+Kojimaauthor=Y.+Mitsuokaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=H.+Yoshizawaauthor=H.+Muraiauthor=Y.+Nakamura&title=A+unique+hinge+binder+of+extremely+selective+aminopyridine-based+Mps1+%28TTK%29+kinase+inhibitors+with+cellular+activity&doi=10.1016%2Fj.bmc.2015.02.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.02.042%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DE.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DA%2520unique%2520hinge%2520binder%2520of%2520extremely%2520selective%2520aminopyridine-based%2520Mps1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520with%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2247%26epage%3D2260%26doi%3D10.1016%2Fj.bmc.2015.02.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disingrini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuvoloni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posteri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of new pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4507</span><span class="NLM_x">–</span> <span class="NLM_lpage">4511</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.bmcl.2011.05.122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4507-4511&author=M.+Caldarelliauthor=M.+Angioliniauthor=T.+Disingriniauthor=D.+Donatiauthor=M.+Guanciauthor=S.+Nuvoloniauthor=H.+Posteriauthor=F.+Quartieriauthor=M.+Silvagniauthor=R.+Colombo&title=Synthesis+and+SAR+of+new+pyrazolo%5B4%2C3-h%5Dquinazoline-3-carboxamide+derivatives+as+potent+and+selective+MPS1+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2011.05.122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.122%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DDisingrini%26aufirst%3DT.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGuanci%26aufirst%3DM.%26aulast%3DNuvoloni%26aufirst%3DS.%26aulast%3DPosteri%26aufirst%3DH.%26aulast%3DQuartieri%26aufirst%3DF.%26aulast%3DSilvagni%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520new%2520pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520MPS1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4507%26epage%3D4511%26doi%3D10.1016%2Fj.bmcl.2011.05.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennecozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depaolini, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucchi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span> </span><span class="NLM_article-title">Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">10255</span><span class="NLM_x">–</span> <span class="NLM_lpage">10264</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-2101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F0008-5472.CAN-10-2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=21159646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10255-10264&author=R.+Colomboauthor=M.+Caldarelliauthor=M.+Mennecozziauthor=M.+L.+Giorginiauthor=F.+Solaauthor=P.+Cappellaauthor=C.+Perreraauthor=S.+R.+Depaoliniauthor=L.+Rusconiauthor=U.+Cucchiauthor=N.+Avanziauthor=J.+A.+Bertrandauthor=R.+T.+Bossiauthor=E.+Pesentiauthor=A.+Galvaniauthor=A.+Isacchiauthor=F.+Colottaauthor=D.+Donatiauthor=J.+Moll&title=Targeting+the+Mitotic+Checkpoint+for+Cancer+Therapy+with+NMS-P715%2C+an+Inhibitor+of+MPS1+Kinase&doi=10.1158%2F0008-5472.CAN-10-2101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase</span></div><div class="casAuthors">Colombo, Riccardo; Caldarelli, Marina; Mennecozzi, Milena; Giorgini, Maria Laura; Sola, Francesco; Cappella, Paolo; Perrera, Claudia; Depaolini, Stefania Re; Rusconi, Luisa; Cucchi, Ulisse; Avanzi, Nilla; Bertrand, Jay Aaron; Bossi, Roberto Tiberio; Pesenti, Enrico; Galvani, Arturo; Isacchi, Antonella; Colotta, Francesco; Donati, Daniele; Moll, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10255-10264</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MPS1 kinase is a key regulator of the spindle assembly checkpoint (SAC), a mitotic mechanism specifically required for proper chromosomal alignment and segregation.  It has been found aberrantly overexpressed in a wide range of human tumors and is necessary for tumoral cell proliferation.  Here the authors report the identification and characterization of NMS-P715, a selective and orally bioavailable MPS1 small-mol. inhibitor, which selectively reduces cancer cell proliferation, leaving normal cells almost unaffected.  NMS-P715 accelerates mitosis and affects kinetochore components localization causing massive aneuploidy and cell death in a variety of tumoral cell lines and inhibits tumor growth in preclin. cancer models.  Inhibiting the SAC could represent a promising new approach to selectively target cancer cells.  Cancer Res; 70(24); 10255-64.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJeGyiQf0_uLVg90H21EOLACvtfcHk0ljEjop8Up3EQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK&md5=6478b34886d1d2f2a364d142bbd388fe</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2101%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DMennecozzi%26aufirst%3DM.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DPerrera%26aufirst%3DC.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520Mitotic%2520Checkpoint%2520for%2520Cancer%2520Therapy%2520with%2520NMS-P715%252C%2520an%2520Inhibitor%2520of%2520MPS1%2520Kinase%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10255%26epage%3D10264%26doi%3D10.1158%2F0008-5472.CAN-10-2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgadze, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of orally bioavailable tyrosine threonine kinase (TTK) inhibitors: 3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3366</span><span class="NLM_x">–</span> <span class="NLM_lpage">3392</span><span class="refDoi"> DOI: 10.1021/jm501740a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501740a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3366-3392&author=Y.+Liuauthor=Y.+Langauthor=N.+K.+Patelauthor=G.+Ngauthor=R.+Lauferauthor=S.-W.+Liauthor=L.+Edwardsauthor=B.+Forrestauthor=P.+B.+Sampsonauthor=M.+Feherauthor=F.+Banauthor=D.+E.+Awreyauthor=I.+Beletskayaauthor=G.+Maoauthor=R.+Hodgsonauthor=O.+Plotnikovaauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=B.+Madeiraauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=The+discovery+of+orally+bioavailable+tyrosine+threonine+kinase+%28TTK%29+inhibitors%3A+3-%284-%28heterocyclyl%29phenyl%29-1H-indazole-5-carboxamides+as+anticancer+agents&doi=10.1021%2Fjm501740a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501740a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520orally%2520bioavailable%2520tyrosine%2520threonine%2520kinase%2520%2528TTK%2529%2520inhibitors%253A%25203-%25284-%2528heterocyclyl%2529phenyl%2529-1H-indazole-5-carboxamides%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3366%26epage%3D3392%26doi%3D10.1021%2Fjm501740a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Diaminopyridine-Based Potent and Selective Mps1 Kinase Inhibitors Binding to an Unusual Flipped-Peptide Conformation</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1021/ml3000879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3000879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=560-564&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=K.+Higashinoauthor=Y.+Okanoauthor=G.+Tadanoauthor=Y.+Tachibanaauthor=Y.+Satoauthor=M.+Inoueauthor=T.+Wadaauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=S.+Tagashiraauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=T.+Yamamotoauthor=M.+Higakiauthor=T.+Endohauthor=K.+Uedaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Diaminopyridine-Based+Potent+and+Selective+Mps1+Kinase+Inhibitors+Binding+to+an+Unusual+Flipped-Peptide+Conformation&doi=10.1021%2Fml3000879"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fml3000879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000879%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DEndoh%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiaminopyridine-Based%2520Potent%2520and%2520Selective%2520Mps1%2520Kinase%2520Inhibitors%2520Binding%2520to%2520an%2520Unusual%2520Flipped-Peptide%2520Conformation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D560%26epage%3D564%26doi%3D10.1021%2Fml3000879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">The inherent acid lability of the Boc group prevented further development (further details will be published in due course).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eY5PuivHXBarbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Innocenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Fee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Expanding the scope of fused pyrimidines as kinase inhibitor scaffolds: synthesis and modification of pyrido[3,4-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1039/C4OB02238F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1039%2FC4OB02238F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=893-904&author=P.+Innocentiauthor=H.+Woodwardauthor=L.+O%E2%80%99Feeauthor=S.+Hoelder&title=Expanding+the+scope+of+fused+pyrimidines+as+kinase+inhibitor+scaffolds%3A+synthesis+and+modification+of+pyrido%5B3%2C4-d%5Dpyrimidines&doi=10.1039%2FC4OB02238F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC4OB02238F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB02238F%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DExpanding%2520the%2520scope%2520of%2520fused%2520pyrimidines%2520as%2520kinase%2520inhibitor%2520scaffolds%253A%2520synthesis%2520and%2520modification%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D893%26epage%3D904%26doi%3D10.1039%2FC4OB02238F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bavetsias, V.; Atrash, B.; Naud, S. G. A.; Sheldrake, P. W.; Blagg, J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolopyridinamine derivatives as Mps1 inhibitors</span>. Patent WO2012123745A1,<span class="NLM_x"> </span><span class="NLM_year">September 20, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=September+20%2C+2012&author=V.+Bavetsias&author=B.+Atrash&author=S.+G.+A.+Naud&author=P.+W.+Sheldrake&author=J.+Blagg&title=Preparation+of+pyrrolopyridinamine+derivatives+as+Mps1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBavetsias%26aufirst%3DV.%26atitle%3DPreparation%2520of%2520pyrrolopyridinamine%2520derivatives%2520as%2520Mps1%2520inhibitors%26date%3DSeptember%252020%252C%25202012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dave, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span> </span><span class="NLM_article-title">Pyridopyrimidines. Part I. Synthesis and biological activity of 2-thiopyrido[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)]ones</span> <span class="citation_source-journal">Indian J. Chem., Sect. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">21B</span><span class="NLM_x">, </span> <span class="NLM_fpage">750</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaL3sXnt1SnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21B&publication_year=1982&pages=750-752&author=C.+G.+Daveauthor=P.+R.+Shahauthor=V.+B.+Desaiauthor=S.+Srinivasan&title=Pyridopyrimidines.+Part+I.+Synthesis+and+biological+activity+of+2-thiopyrido%5B2%2C3-d%5Dpyrimidin-4%283H%29%5Dones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridopyrimidines.  Part I.  Synthesis and biological activity of 2-thiopyrido[2,3-d]pyrimidin-4(3H)]ones</span></div><div class="casAuthors">Dave, C. G.; Shah, P. R.; Desai, V. B.; Srinivasan, S.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">21B</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">750-2</span>CODEN:
                <span class="NLM_cas:coden">IJSBDB</span>;
        ISSN:<span class="NLM_cas:issn">0376-4699</span>.
    </div><div class="casAbstract">Thiopyridopyrimidinones I (R = Ph, Bu, PhCH2, MeC6H4, 3-ClC6H4, 4-MeOC6H4, cyclohexyl; R1 = H, Me; R2 = Me, Ph) were prepd. by condensation of aminopyridines II with isothiocyanates followed by cyclization of the resultant thioureas (III).  I and III were tested for antibacterial and antihistaminic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhw8UQ74uN0bVg90H21EOLACvtfcHk0liVmgm2rOJKSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXnt1SnsA%253D%253D&md5=3b605340ab7123ebabd6b55ae4786d91</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDave%26aufirst%3DC.%2BG.%26aulast%3DShah%26aufirst%3DP.%2BR.%26aulast%3DDesai%26aufirst%3DV.%2BB.%26aulast%3DSrinivasan%26aufirst%3DS.%26atitle%3DPyridopyrimidines.%2520Part%2520I.%2520Synthesis%2520and%2520biological%2520activity%2520of%25202-thiopyrido%255B2%252C3-d%255Dpyrimidin-4%25283H%2529%255Dones%26jtitle%3DIndian%2520J.%2520Chem.%252C%2520Sect.%2520B%26date%3D1982%26volume%3D21B%26spage%3D750%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhyeRl-h2RTYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">46</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2005%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pesson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabassier, S.</span><span> </span><span class="NLM_article-title">Nitriles and amide-oximes of 8-alkyl-5-oxo}5,8-dihydro[2,3-d]pyrido-6-pyrimidinecarboxylic acids</span> <span class="citation_source-journal">C. R. Seances Acad. Sci., Ser. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaE2MXht1Ggtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1974&pages=413-415&author=M.+Pessonauthor=S.+Chabassier&title=Nitriles+and+amide-oximes+of+8-alkyl-5-oxo%7D5%2C8-dihydro%5B2%2C3-d%5Dpyrido-6-pyrimidinecarboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nitriles and amide-oximes of 8-alkyl-5-oxo}5,8-dihydro[2,3-d]pyrido-6-pyrimidinecarboxylic acids</span></div><div class="casAuthors">Pesson, Marcel; Chabassier, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus des Seances de l'Academie des Sciences, Serie C:  Sciences Chimiques</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">413-15</span>CODEN:
                <span class="NLM_cas:coden">CHDCAQ</span>;
        ISSN:<span class="NLM_cas:issn">0567-6541</span>.
    </div><div class="casAbstract">Pyridopyrimidinecarboxamidoximes I [R = pyrrolidino, morpholino, piperidino, 4-methylpiperazino, SMe; R1 = C(:NOH)NH2] were prepd. by treating the pyrimidinecarboxy-lates II (R = Cl, SMe; R2 = Cl) with EtNHCH2CH2CN to give II (R = Cl, SMe; R2 = NEtCH2CH2CN), treating II (R = Cl, R2 = NEtCH2CH2CN) with secondary amines, cyclizing with KOCMe3 to III (R = pyrrolidino, morpholino, piperidino, 4-methylpiperazino), brominating-dehydrobrominating to I (R1 = CN) and treating with NH2OH.  Conversion of the CO2H group to C(:NOH)NH2 eliminated the antibacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLp1GhqJvMr7Vg90H21EOLACvtfcHk0lhyeRl-h2RTYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXht1Ggtro%253D&md5=202d92db0e14f4e63e68975e811a970f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPesson%26aufirst%3DM.%26aulast%3DChabassier%26aufirst%3DS.%26atitle%3DNitriles%2520and%2520amide-oximes%2520of%25208-alkyl-5-oxo%257D5%252C8-dihydro%255B2%252C3-d%255Dpyrido-6-pyrimidinecarboxylic%2520acids%26jtitle%3DC.%2520R.%2520Seances%2520Acad.%2520Sci.%252C%2520Ser.%2520C%26date%3D1974%26volume%3D279%26spage%3D413%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ajiro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimoto, T.</span><span> </span><span class="NLM_article-title">Specific site of histone H3 phosphorylation related to the maintenance of premature chromosome condensation. Evidence for catalytically induced interchange of the subunits</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">15379</span><span class="NLM_x">–</span> <span class="NLM_lpage">15381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=15379-15381&author=K.+Ajiroauthor=T.+Nishimoto&title=Specific+site+of+histone+H3+phosphorylation+related+to+the+maintenance+of+premature+chromosome+condensation.+Evidence+for+catalytically+induced+interchange+of+the+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAjiro%26aufirst%3DK.%26aulast%3DNishimoto%26aufirst%3DT.%26atitle%3DSpecific%2520site%2520of%2520histone%2520H3%2520phosphorylation%2520related%2520to%2520the%2520maintenance%2520of%2520premature%2520chromosome%2520condensation.%2520Evidence%2520for%2520catalytically%2520induced%2520interchange%2520of%2520the%2520subunits%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D15379%26epage%3D15381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Juan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traganos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauve, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darzynkiewicz, Z.</span><span> </span><span class="NLM_article-title">Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis</span> <span class="citation_source-journal">Cytometry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=9627219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVCls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=71-77&author=G.+Juanauthor=F.+Traganosauthor=W.+M.+Jamesauthor=J.+M.+Rayauthor=M.+Robergeauthor=D.+M.+Sauveauthor=H.+Andersonauthor=Z.+Darzynkiewicz&title=Histone+H3+phosphorylation+and+expression+of+cyclins+A+and+B1+measured+in+individual+cells+during+their+progression+through+G2+and+mitosis&doi=10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis</span></div><div class="casAuthors">Juan, Gloria; Traganos, Frank; James, William M.; Ray, Jill M.; Roberge, Michel; Sauve, Debra M.; Anderson, Hilary; Darzynkiewicz, Zbigniew</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">CYTODQ</span>;
        ISSN:<span class="NLM_cas:issn">0196-4763</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The phosphorylation of histone H3 (H3) on Ser-10 correlates with chromatin condensation at mitosis.  Here, a new monoclonal antibody (anti-H3-P) was developed that recognizes phosphorylated H3 (H3-P).  This antibody was used in multiparameter flow cytometric anal. to relate H3 phosphorylation in individual human leukemic cells to the cells' position in the cycle as well as their expression of cyclins A and B1.  Mitotic cells, from prophase to telophase, reacted with anti-H3-P; the binding of the antibody to chromatin of interphase cells was several times weaker.  Cell growth in the presence of staurosporine, an inhibitor of the kinase(s) that phosphorylate H3, abolished the cells' reactivity with the antibody.  The reactivity also was abolished by incubation of permeabilized mitotic cells with alk. phosphatase.  These data indicated that, within permeabilized cells, the antibody was indeed specific for H3-P and did not detect the unphosphorylated epitope.  All cells reacting with anti-H3-P, with the exception of prophase and early prometaphase, were cyclin A-neg.; the expression of cyclin B1 in these cells was 3-fold higher than in G2 cells.  The anal. of phosphorylation of H3 in individual cells when combined with multiparameter anal. of their cycle position and expression of other proteins offers new possibilities to study mol. mechanisms assocd. with the G2-to-M transition and chromatin condensation.  It also offers an assay to screen in vivo inhibitors of kinase(s) or phosphatase(s) involved in H3 phosphorylation or dephosphorylation, and it provides a valuable marker to identify mitotic cells by cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV2YQJ_iAILVg90H21EOLACvtfcHk0liPn-A-sMgMSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVCls7k%253D&md5=ab569687a961da48a4a163bf93b747f8</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0320%252819980601%252932%253A2%253C71%253A%253AAID-CYTO1%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DJuan%26aufirst%3DG.%26aulast%3DTraganos%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DW.%2BM.%26aulast%3DRay%26aufirst%3DJ.%2BM.%26aulast%3DRoberge%26aufirst%3DM.%26aulast%3DSauve%26aufirst%3DD.%2BM.%26aulast%3DAnderson%26aufirst%3DH.%26aulast%3DDarzynkiewicz%26aufirst%3DZ.%26atitle%3DHistone%2520H3%2520phosphorylation%2520and%2520expression%2520of%2520cyclins%2520A%2520and%2520B1%2520measured%2520in%2520individual%2520cells%2520during%2520their%2520progression%2520through%2520G2%2520and%2520mitosis%26jtitle%3DCytometry%26date%3D1998%26volume%3D32%26spage%3D71%26epage%3D77%26doi%3D10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Honold, K.; Paul, J.; Roeschlaub, C.; Schaefer, W.; Scheiblich, S.; Von, H.; Thomas; Whittle, A.</span><span> </span><span class="NLM_article-title">Preparation of 7H-pyrido[3,4-d]pyrimidin-8-ones as protein kinase inhibitors</span>. Patent WO2007088014A1, August 9,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+Honold&author=J.+Paul&author=C.+Roeschlaub&author=W.+Schaefer&author=S.+Scheiblich&author=H.+Von&author=+Thomas&author=A.+Whittle&title=Preparation+of+7H-pyrido%5B3%2C4-d%5Dpyrimidin-8-ones+as+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHonold%26aufirst%3DK.%26atitle%3DPreparation%2520of%25207H-pyrido%255B3%252C4-d%255Dpyrimidin-8-ones%2520as%2520protein%2520kinase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Software XDS for image rotation, recognition and crystal symmetry assignment</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Software+XDS+for+image+rotation%2C+recognition+and+crystal+symmetry+assignment&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liPn-A-sMgMSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DSoftware%2520XDS%2520for%2520image%2520rotation%252C%2520recognition%2520and%2520crystal%2520symmetry%2520assignment%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liPn-A-sMgMSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lgoG-Zj_JnN9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgoG-Zj_JnN9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgoG-Zj_JnN9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER, version 2.11.4; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhLMOyEqniTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Smart, O. S.; Womack, T. O.; Sharff, A.; Flensburg, C.; Keller, P.; Paciorek, W.; Vonrhein, C.; Bricogne, G.</span>Grade, version 1.2.1; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=O.+S.+Smart&author=T.+O.+Womack&author=A.+Sharff&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=C.+Vonrhein&author=G.+Bricogne&title=Grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DO.%2BS.%26jtitle%3DGrade%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bruno, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lommerse, J. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span> </span><span class="NLM_article-title">Isostar: a library of information about nonbonded interactions</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1023/A:1007934413448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1023%2FA%3A1007934413448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=9491345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaK1cXht1Olu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=525-537&author=I.+J.+Brunoauthor=J.+C.+Coleauthor=J.+P.+M.+Lommerseauthor=R.+S.+Rowlandauthor=R.+Taylorauthor=M.+L.+Verdonk&title=Isostar%3A+a+library+of+information+about+nonbonded+interactions&doi=10.1023%2FA%3A1007934413448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Isostar: a library of information about nonbonded interactions</span></div><div class="casAuthors">Bruno, Ian J.; Cole, Jason C.; Lommerse, Jos P. M.; Rowland, R. Scott; Taylor, Robin; Verdonk, Marcel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Crystallog. and theor. (ab initio) data on intermol. nonbonded interactions were gathered together in a computerized library ('IsoStar').  The library contains information about the nonbonded contacts formed by some 250 chem. groupings.  The data can be displayed visually and used to aid protein-ligand docking or the identification of bioisosteric replacements.  Data from the library show that there is great variability in the geometrical preferences of different types of hydrogen bonds, although in general there is a tendency for H-bonds to form along lone-pair directions.  The H-bond acceptor abilities of oxygen and sulfur atoms are highly dependent on intramol. environments.  The nonbonded contacts formed by many hydrophobic groups show surprisingly strong directional preferences.  Many unusual nonbonded interactions are to be found in the library and are of potential value for designing novel biol. active mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcIzn6KO_NVbVg90H21EOLACvtfcHk0lhLMOyEqniTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht1Olu7s%253D&md5=ec168252a1dc7bddc341235db0f5ccfb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007934413448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007934413448%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DLommerse%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26atitle%3DIsostar%253A%2520a%2520library%2520of%2520information%2520about%2520nonbonded%2520interactions%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D525%26epage%3D537%26doi%3D10.1023%2FA%3A1007934413448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaver-Fay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snoeyink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">W375</span><span class="NLM_x">–</span> <span class="NLM_lpage">W383</span><span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-W383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eZ4cX_-KHldv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3DW383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farningham, D. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span> </span><span class="NLM_article-title">Guidelines for the welfare and use of animals in cancer research</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1577</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+H.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2ea90wLHd5NU0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%2BH.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c','cit4d'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e','cit10f','cit10g'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':[],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Volker K. Schulze, Ulrich Klar, Dirk Kosemund, Antje M. Wengner, Gerhard Siemeister, Detlef Stöckigt, Roland Neuhaus, Philip Lienau, Benjamin Bader, Stefan Prechtl, Simon J. Holton, Hans Briem, Tobias Marquardt, Hartmut Schirok, Rolf Jautelat, Rolf Bohlmann, Duy Nguyen, Amaury E. Fernández-Montalván, Ulf Bömer, Uwe Eberspaecher, Michael Brüning, Olaf Döhr, Marian Raschke, Bertolt Kreft, Dominik Mumberg, Karl Ziegelbauer, Michael Brands, Franz von Nussbaum, <span class="NLM_string-name hlFld-ContribAuthor">Marcus Koppitz</span>. </span><span class="cited-content_cbyCitation_article-title">Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8025-8042. <a href="https://doi.org/10.1021/acs.jmedchem.9b02035" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTreating%252BCancer%252Bby%252BSpindle%252BAssembly%252BCheckpoint%252BAbrogation%25253A%252BDiscovery%252Bof%252BTwo%252BClinical%252BCandidates%25252C%252BBAY%252B1161909%252Band%252BBAY%252B1217389%25252C%252BTargeting%252BMPS1%252BKinase%26aulast%3DSchulze%26aufirst%3DVolker%2BK.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D09122019%26date%3D27042020%26volume%3D63%26issue%3D15%26spage%3D8025%26epage%3D8042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer R. Riggs, Jan Elsner, Dan Cashion, Dale Robinson, Lida Tehrani, Mark Nagy, Kimberly E. Fultz, Rama Krishna Narla, Xiaohui Peng, Tam Tran, Ashutosh Kulkarni, Sogole Bahmanyar, Kevin Condroski, Barbra Pagarigan, Gustavo Fenalti, Laurie LeBrun, Katerina Leftheris, Dan Zhu, <span class="NLM_string-name hlFld-ContribAuthor">John F. Boylan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4401-4410. <a href="https://doi.org/10.1021/acs.jmedchem.8b01869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01869%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BOptimization%252BLeading%252Bto%252Ban%252BOrally%252BActive%252BTTK%252BProtein%252BKinase%252BInhibitor%252Bwith%252BRobust%252BSingle%252BAgent%252BEfficacy%26aulast%3DRiggs%26aufirst%3DJennifer%2BR.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D28112018%26date%3D30042019%26date%3D18042019%26volume%3D62%26issue%3D9%26spage%3D4401%26epage%3D4410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hannah
L. Woodward, Paolo Innocenti, Kwai-Ming J. Cheung, Angela Hayes, Jennie Roberts, Alan T. Henley, Amir Faisal, Grace Wing-Yan Mak, Gary Box, Isaac M. Westwood, Nora Cronin, Michael Carter, Melanie Valenti, Alexis De Haven Brandon, Lisa O’Fee, Harry Saville, Jessica Schmitt, Rosemary Burke, Fabio Broccatelli, Rob L. M. van Montfort, Florence I. Raynaud, Suzanne A. Eccles, Spiros Linardopoulos, Julian Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Swen Hoelder</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8226-8240. <a href="https://doi.org/10.1021/acs.jmedchem.8b00690" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00690%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntroduction%252Bof%252Ba%252BMethyl%252BGroup%252BCurbs%252BMetabolism%252Bof%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BMonopolar%252BSpindle%252B1%252B%252528MPS1%252529%252BInhibitors%252Band%252BEnables%252Bthe%252BDiscovery%252Bof%252Bthe%252BPhase%252B1%252BClinical%252BCandidate%252BN2-%2525282-Ethoxy-4-%2525284-methyl-4H-1%25252C2%25252C4-triazol-3-yl%252529phenyl%252529-6-methyl-N8-neopentylpyrido%25255B3%25252C4-d%25255Dpyrimidine-2%25252C8-diamine%252B%252528BOS172722%252529%26aulast%3DWoodward%26aufirst%3DHannah%2BL.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01052018%26date%3D10092018%26volume%3D61%26issue%3D18%26spage%3D8226%26epage%3D8240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Riggs</span>, <span class="hlFld-ContribAuthor ">Mark  Nagy</span>, <span class="hlFld-ContribAuthor ">Jan  Elsner</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Dan  Cashion</span>, <span class="hlFld-ContribAuthor ">Dale  Robinson</span>, <span class="hlFld-ContribAuthor ">Roy  Harris</span>, <span class="hlFld-ContribAuthor ">Dehua  Huang</span>, <span class="hlFld-ContribAuthor ">Lida  Tehrani</span>, <span class="hlFld-ContribAuthor ">Gordafaried  Deyanat-Yazdi</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Narla</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Peng</span>, <span class="hlFld-ContribAuthor ">Tam  Tran</span>, <span class="hlFld-ContribAuthor ">Leo  Barnes</span>, <span class="hlFld-ContribAuthor ">Terra  Miller</span>, <span class="hlFld-ContribAuthor ">Jason  Katz</span>, <span class="hlFld-ContribAuthor ">Yang  Tang</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Mehran F.  Moghaddam</span>, <span class="hlFld-ContribAuthor ">Sogole  Bahmanyar</span>, <span class="hlFld-ContribAuthor ">Barbra  Pagarigan</span>, <span class="hlFld-ContribAuthor ">Silvia  Delker</span>, <span class="hlFld-ContribAuthor ">Laurie  LeBrun</span>, <span class="hlFld-ContribAuthor ">Philip P.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Andrew  Calabrese</span>, <span class="hlFld-ContribAuthor ">Stacie S.  Canan</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>, <span class="hlFld-ContribAuthor ">Dan  Zhu</span>, and <span class="hlFld-ContribAuthor ">John F.  Boylan</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8989-9002. <a href="https://doi.org/10.1021/acs.jmedchem.7b01223" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01223%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252Ba%252BDual%252BTTK%252BProtein%252BKinase%25252FCDC2-Like%252BKinase%252B%252528CLK2%252529%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BTriple%252BNegative%252BBreast%252BCancer%252BInitiated%252Bfrom%252Ba%252BPhenotypic%252BScreen%26aulast%3DRiggs%26aufirst%3DJennifer%2BR.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18082017%26date%3D27102017%26date%3D09112017%26date%3D09102017%26volume%3D60%26issue%3D21%26spage%3D8989%26epage%3D9002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Planken</span>, <span class="hlFld-ContribAuthor ">Douglas C.  Behenna</span>, <span class="hlFld-ContribAuthor ">Sajiv K.  Nair</span>, <span class="hlFld-ContribAuthor ">Theodore O.  Johnson</span>, <span class="hlFld-ContribAuthor ">Asako  Nagata</span>, <span class="hlFld-ContribAuthor ">Chau  Almaden</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">T. Eric  Ballard</span>, <span class="hlFld-ContribAuthor ">Louise  Bernier</span>, <span class="hlFld-ContribAuthor ">Hengmiao  Cheng</span>, <span class="hlFld-ContribAuthor ">Sujin  Cho-Schultz</span>, <span class="hlFld-ContribAuthor ">Deepak  Dalvie</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Dac M.  Dinh</span>, <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Rose Ann  Ferre</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Michelle  Hemkens</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Jean  Matthews</span>, <span class="hlFld-ContribAuthor ">Brion W.  Murray</span>, <span class="hlFld-ContribAuthor ">Sherry  Niessen</span>, <span class="hlFld-ContribAuthor ">Suvi T. M.  Orr</span>, <span class="hlFld-ContribAuthor ">Mason  Pairish</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Manli  Shi</span>, <span class="hlFld-ContribAuthor ">James  Solowiej</span>, <span class="hlFld-ContribAuthor ">Khanh  Tran</span>, <span class="hlFld-ContribAuthor ">Elaine  Tseng</span>, <span class="hlFld-ContribAuthor ">Paolo  Vicini</span>, <span class="hlFld-ContribAuthor ">Yuli  Wang</span>, <span class="hlFld-ContribAuthor ">Scott L.  Weinrich</span>, <span class="hlFld-ContribAuthor ">Ru  Zhou</span>, <span class="hlFld-ContribAuthor ">Michael  Zientek</span>, <span class="hlFld-ContribAuthor ">Longqing  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqin  Luo</span>, <span class="hlFld-ContribAuthor ">Shuibo  Xin</span>, <span class="hlFld-ContribAuthor ">Chengyi  Zhang</span>, and <span class="hlFld-ContribAuthor ">Jennifer  Lafontaine</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 3002-3019. <a href="https://doi.org/10.1021/acs.jmedchem.6b01894" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01894%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%252528%2525283R%25252C4R%252529-4-Fluoro-1-%2525286-%252528%2525283-methoxy-1-methyl-1H-pyrazol-4-yl%252529amino%252529-9-methyl-9H-purin-2-yl%252529pyrrolidine-3-yl%252529acrylamide%252B%252528PF-06747775%252529%252Bthrough%252BStructure-Based%252BDrug%252BDesign%25253A%252BA%252BHigh%252BAffinity%252BIrreversible%252BInhibitor%252BTargeting%252BOncogenic%252BEGFR%252BMutants%252Bwith%252BSelectivity%252Bover%252BWild-Type%252BEGFR%26aulast%3DPlanken%26aufirst%3DSimon%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11012017%26date%3D29032017%26date%3D13042017%26date%3D13032017%26volume%3D60%26issue%3D7%26spage%3D3002%26epage%3D3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentin  Wydra</span>, <span class="hlFld-ContribAuthor ">Stefan  Gerstenecker</span>, <span class="hlFld-ContribAuthor ">Dieter  Schollmeyer</span>, <span class="hlFld-ContribAuthor ">Stanislav  Andreev</span>, <span class="hlFld-ContribAuthor ">Teodor  Dimitrov</span>, <span class="hlFld-ContribAuthor ">Ricardo Augusto  Massarico Serafim</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">N-(6-Chloro-3-nitropyridin-2-yl)-5-(1-methyl-1H-pyrazol-4-yl)isoquinolin-3-amine. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (1)
                                     , M1181. <a href="https://doi.org/10.3390/M1181" title="DOI URL">https://doi.org/10.3390/M1181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1181%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3DN-%2525286-Chloro-3-nitropyridin-2-yl%252529-5-%2525281-methyl-1H-pyrazol-4-yl%252529isoquinolin-3-amine%26aulast%3DWydra%26aufirst%3DValentin%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D1%26spage%3DM1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashish P.  Shah</span>, <span class="hlFld-ContribAuthor ">Chhagan N.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual Screening of Novel Hybrid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an In Silico Approach. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Therapy Reviews</span><span> <strong>2020,</strong> <em>16 </em>
                                    (1)
                                     , 70-77. <a href="https://doi.org/10.2174/1573394715666190618114748" title="DOI URL">https://doi.org/10.2174/1573394715666190618114748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573394715666190618114748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573394715666190618114748%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Therapy%2520Reviews%26atitle%3DVirtual%252BScreening%252Bof%252BNovel%252BHybrid%252BNon-Steroidal%252BAnti-Inflammatory%252BDrugs%252B%252528NSAIDs%252529%25253A%252BExploring%252BMultiple%252BTargeted%252BCancer%252BTherapy%252Bby%252Ban%252BIn%252BSilico%252BApproach%26aulast%3DShah%26aufirst%3DAshish%2BP.%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Monier</span>, <span class="hlFld-ContribAuthor ">Doaa  Abdel-Latif</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Başak D.  Mert</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of 6-6 Bicyclic Systems: Chemistry of Pyrido[3,4- d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 812-854. <a href="https://doi.org/10.2174/1570179416666190704113647" title="DOI URL">https://doi.org/10.2174/1570179416666190704113647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190704113647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190704113647%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252B6-6%252BBicyclic%252BSystems%25253A%252BChemistry%252Bof%252BPyrido%25255B3%25252C4-%252Bd%25255Dpyrimidines%26aulast%3DMonier%26aufirst%3DMohamed%26date%3D2019%26volume%3D16%26issue%3D6%26spage%3D812%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Zibo  Chen</span>, <span class="hlFld-ContribAuthor ">Masanori  Kawakami</span>, <span class="hlFld-ContribAuthor ">Yulong  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Roszik</span>, <span class="hlFld-ContribAuthor ">Lisa Maria  Mustachio</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Kurie</span>, <span class="hlFld-ContribAuthor ">Pamela  Villalobos</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Carmen  Behrens</span>, <span class="hlFld-ContribAuthor ">Barbara  Mino</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Solis</span>, <span class="hlFld-ContribAuthor ">Jennifer  Silvester</span>, <span class="hlFld-ContribAuthor ">Kelsie L.  Thu</span>, <span class="hlFld-ContribAuthor ">David W  Cescon</span>, <span class="hlFld-ContribAuthor ">Jaime  Rodriguez-Canales</span>, <span class="hlFld-ContribAuthor ">Ignacio I.  Wistuba</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Ethan  Dmitrovsky</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (10)
                                     , 1775-1786. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0864" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0864%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTyrosine%252BThreonine%252BKinase%252BInhibition%252BEliminates%252BLung%252BCancers%252Bby%252BAugmenting%252BApoptosis%252Band%252BPolyploidy%26aulast%3DZheng%26aufirst%3DLin%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D10%26spage%3D1775%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.  Anderhub</span>, <span class="hlFld-ContribAuthor ">Grace Wing-Yan  Mak</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gurden</span>, <span class="hlFld-ContribAuthor ">Amir  Faisal</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Drosopoulos</span>, <span class="hlFld-ContribAuthor ">Katie  Walsh</span>, <span class="hlFld-ContribAuthor ">Hannah L.  Woodward</span>, <span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Sébastien  Naud</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Efthymia  Theofani</span>, <span class="hlFld-ContribAuthor ">Simone  Filosto</span>, <span class="hlFld-ContribAuthor ">Harry  Saville</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (10)
                                     , 1696-1707. <a href="https://doi.org/10.1158/1535-7163.MCT-18-1203" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-1203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-1203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-1203%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DHigh%252BProliferation%252BRate%252Band%252Ba%252BCompromised%252BSpindle%252BAssembly%252BCheckpoint%252BConfers%252BSensitivity%252Bto%252Bthe%252BMPS1%252BInhibitor%252BBOS172722%252Bin%252BTriple-Negative%252BBreast%252BCancers%26aulast%3DAnderhub%26aufirst%3DSimon%2BJ.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D10%26spage%3D1696%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shutao  Wang</span>, <span class="hlFld-ContribAuthor ">Muxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Junli  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaguo  Li</span>, <span class="hlFld-ContribAuthor ">Chenchen  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 247-268. <a href="https://doi.org/10.1016/j.ejmech.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdesign%252Band%252Banticancer%252Bactivities%252Bof%252Bsmall-molecule%252Bmonopolar%252Bspindle%252B1%252Binhibitors%25253A%252BA%252BMedicinal%252Bchemistry%252Bperspective%26aulast%3DWang%26aufirst%3DShutao%26date%3D2019%26volume%3D175%26spage%3D247%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy A.  Loughlin</span>, <span class="hlFld-ContribAuthor ">Asmaa  Boufridi</span>. </span><span class="cited-content_cbyCitation_article-title">6-6 Bicyclic Systems: Three Heteroatoms 1:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14794-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14794-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14794-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14794-8%26sid%3Dliteratum%253Aachs%26atitle%3D6-6%252BBicyclic%252BSystems%25253A%252BThree%252BHeteroatoms%252B1%25253A2%26aulast%3DLoughlin%26aufirst%3DWendy%2BA.%26date%3D2019%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Young  Kim</span>, <span class="hlFld-ContribAuthor ">Josep  Saurí</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Cohen</span>, <span class="hlFld-ContribAuthor ">Gary E.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Observation of untoward
              3
              J
              cc
              correlations in 1,1-ADEQUATE spectra of pyrimidine analogs: Avoiding potential interpretation pitfalls. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2018,</strong> <em>56 </em>
                                    (8)
                                     , 775-781. <a href="https://doi.org/10.1002/mrc.4736" title="DOI URL">https://doi.org/10.1002/mrc.4736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.4736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.4736%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3DObservation%252Bof%252Buntoward%252B3%252BJ%252Bcc%252Bcorrelations%252Bin%252B1%25252C1-ADEQUATE%252Bspectra%252Bof%252Bpyrimidine%252Banalogs%25253A%252BAvoiding%252Bpotential%252Binterpretation%252Bpitfalls%26aulast%3DKim%26aufirst%3DHai-Young%26date%3D2018%26date%3D2018%26volume%3D56%26issue%3D8%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daren  Fearon</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>, <span class="hlFld-ContribAuthor ">Vassilios  Bavetsias</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 3021-3029. <a href="https://doi.org/10.1016/j.bmc.2018.04.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bprofiling%252Bof%252Ba%252B3-aminopyridin-2-one-based%252Bkinase%252Btargeted%252Bfragment%252Blibrary%25253A%252BIdentification%252Bof%252B3-amino-5-%252528pyridin-4-yl%252529pyridin-2%2525281H%252529-one%252Bscaffold%252Bfor%252Bmonopolar%252Bspindle%252B1%252B%252528MPS1%252529%252Band%252BAurora%252Bkinases%252Binhibition%26aulast%3DFearon%26aufirst%3DDaren%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D3021%26epage%3D3029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Rita R.  Maia</span>, <span class="hlFld-ContribAuthor ">Simon  Linder</span>, <span class="hlFld-ContribAuthor ">Ji-Ying  Song</span>, <span class="hlFld-ContribAuthor ">Chantal  Vaarting</span>, <span class="hlFld-ContribAuthor ">Ute  Boon</span>, <span class="hlFld-ContribAuthor ">Colin E. J.  Pritchard</span>, <span class="hlFld-ContribAuthor ">Arno  Velds</span>, <span class="hlFld-ContribAuthor ">Ivo J.  Huijbers</span>, <span class="hlFld-ContribAuthor ">Olaf  van Tellingen</span>, <span class="hlFld-ContribAuthor ">Jos  Jonkers</span>, <span class="hlFld-ContribAuthor ">René H.  Medema</span>. </span><span class="cited-content_cbyCitation_article-title">Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2018,</strong> <em>118 </em>
                                    (12)
                                     , 1586-1595. <a href="https://doi.org/10.1038/s41416-018-0081-2" title="DOI URL">https://doi.org/10.1038/s41416-018-0081-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-018-0081-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-018-0081-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DMps1%252Binhibitors%252Bsynergise%252Bwith%252Blow%252Bdoses%252Bof%252Btaxanes%252Bin%252Bpromoting%252Btumour%252Bcell%252Bdeath%252Bby%252Benhancement%252Bof%252Berrors%252Bin%252Bcell%252Bdivision%26aulast%3DMaia%26aufirst%3DAna%2BRita%2BR.%26date%3D2018%26date%3D2018%26volume%3D118%26issue%3D12%26spage%3D1586%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Cui-cui  Jiang</span>, <span class="hlFld-ContribAuthor ">Jin-gui  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (6)
                                     , 1488. <a href="https://doi.org/10.3390/molecules23061488" title="DOI URL">https://doi.org/10.3390/molecules23061488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23061488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23061488%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInsights%252Binto%252BResistance%252BMechanisms%252Bof%252BInhibitors%252Bto%252BMps1%252BC604Y%252BMutation%252Bvia%252Ba%252BComprehensive%252BMolecular%252BModeling%252BStudy%26aulast%3DChen%26aufirst%3DYuan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D6%26spage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshitaka  Hiruma</span>, <span class="hlFld-ContribAuthor ">Andre  Koch</span>, <span class="hlFld-ContribAuthor ">Nazila  Hazraty</span>, <span class="hlFld-ContribAuthor ">Foteini  Tsakou</span>, <span class="hlFld-ContribAuthor ">René H.  Medema</span>, <span class="hlFld-ContribAuthor ">Robbie P.  Joosten</span>, <span class="hlFld-ContribAuthor ">Anastassis  Perrakis</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2017,</strong> <em>292 </em>
                                    (35)
                                     , 14496-14504. <a href="https://doi.org/10.1074/jbc.M117.783555" title="DOI URL">https://doi.org/10.1074/jbc.M117.783555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M117.783555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M117.783555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DUnderstanding%252Binhibitor%252Bresistance%252Bin%252BMps1%252Bkinase%252Bthrough%252Bnovel%252Bbiophysical%252Bassays%252Band%252Bstructures%26aulast%3DHiruma%26aufirst%3DYoshitaka%26date%3D2017%26volume%3D292%26issue%3D35%26spage%3D14496%26epage%3D14504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir  Faisal</span>, <span class="hlFld-ContribAuthor ">Grace W Y  Mak</span>, <span class="hlFld-ContribAuthor ">Mark D  Gurden</span>, <span class="hlFld-ContribAuthor ">Cristina P R  Xavier</span>, <span class="hlFld-ContribAuthor ">Simon J  Anderhub</span>, <span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Isaac M  Westwood</span>, <span class="hlFld-ContribAuthor ">Sébastien  Naud</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Melanie R  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis K  De Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Lisa  O'Fee</span>, <span class="hlFld-ContribAuthor ">Jessica  Schmitt</span>, <span class="hlFld-ContribAuthor ">Hannah L  Woodward</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L M  vanMontfort</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Florence I  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A  Eccles</span>, <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2017,</strong> <em>116 </em>
                                    (9)
                                     , 1166-1176. <a href="https://doi.org/10.1038/bjc.2017.75" title="DOI URL">https://doi.org/10.1038/bjc.2017.75</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2017.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2017.75%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DCharacterisation%252Bof%252BCCT271850%25252C%252Ba%252Bselective%25252C%252Boral%252Band%252Bpotent%252BMPS1%252Binhibitor%25252C%252Bused%252Bto%252Bdirectly%252Bmeasure%252Bin%252Bvivo%252BMPS1%252Binhibition%252Bvs%252Btherapeutic%252Befficacy%26aulast%3DFaisal%26aufirst%3DAmir%26date%3D2017%26date%3D2017%26volume%3D116%26issue%3D9%26spage%3D1166%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Graham C.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Richard  Brokx</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Mark R.  Bray</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>. </span><span class="cited-content_cbyCitation_article-title">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2017,</strong> <em>114 </em>
                                    (12)
                                     , 3127-3132. <a href="https://doi.org/10.1073/pnas.1700234114" title="DOI URL">https://doi.org/10.1073/pnas.1700234114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DFunctional%252Bcharacterization%252Bof%252BCFI-402257%25252C%252Ba%252Bpotent%252Band%252Bselective%252BMps1%25252FTTK%252Bkinase%252Binhibitor%25252C%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DMason%26aufirst%3DJacqueline%2BM.%26date%3D2017%26date%3D2017%26volume%3D114%26issue%3D12%26spage%3D3127%26epage%3D3132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0019.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published MPS1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Isoquinoline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Furan-2-ylboronic acid or 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, DME/water, μW, 105 °C; (b) 4-methoxyaniline <b>12</b> or 2,4-dimethoxyaniline <b>13</b>, <sup><i>t</i></sup>BuXPhos, Pd<sub>2</sub>dba<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, <sup><i>t</i></sup>BuOH/water, μW, 80–100 °C. Reaction yields are in parentheses.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrido[3,4-<i>d</i>]pyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, THF/water, 65 °C (<b>17</b>); (b) cyclopropyl boronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(OAc)<sub>2</sub>, PCy<sub>3</sub>, toluene/water, 95 °C (<b>18</b>); (c) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) <i>N</i>-(4-methoxyphenyl)formamide <b>21</b> or <i>N</i>-(2,4-dimethoxyphenyl)formamide <b>22</b>, DMSO, Cs<sub>2</sub>CO<sub>3</sub>, 100 °C (<b>24a</b>,<b>b</b>); (e) 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>23</b>, TFA, 1,2,3-trifluoroethanol, μW, 130 °C (<b>24c</b>,<b>d</b>); (f) ArNHCHO (<b>26a</b>–<b>e</b>), NaH, THF, rt; (g) 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole or phenyl boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane/water, 100 °C. Reaction yields are in parentheses.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Functionalization of Pyrido[3,4-<i>d</i>]pyrimidine Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Amine, NMP, 80–135 °C; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)aniline <b>23</b>, TFA, 1,2,3-trifluoroethanol, μW, 130 °C. Reaction yields are in parentheses.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Derivatives Containing 8-Position N, O, and S Substituents<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Amine, NMP, 80–135 °C (<b>34a</b>–<b>e</b>, <b>g</b>, <b>h</b>); (b) cyclohexyl thiol, K<sub>2</sub>CO<sub>3</sub>, DMF, rt (<b>34f</b>); (c) Ag<sub>2</sub>CO<sub>3</sub>, bromomethyl cyclopropane, CHCl<sub>3</sub>, rt to 60 °C; (d) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) <i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide <b>26a</b>, NaH, THF, rt. Reaction yields are in parentheses.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0020.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Superimposed crystal structure of MPS1 (pale green) bound to <b>1</b> (carbon atoms colored pink), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, onto the structure of MPS1 (not shown) bound to <b>39</b> (carbon atoms colored yellow), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHY">5EHY</a>, showing the complementary binding of the modestly potent hit <b>39</b> and MPS1 inhibitor <b>1</b> to the hinge region of MPS1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0021.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hybridization strategy for the development of a novel chemical series of inhibitors of MPS1, from previously reported inhibitor <b>1</b> and screening hit <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0022.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Superimposed crystal structure of MPS1 (pale green) bound to <b>1</b> (carbon atoms colored pink), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, onto the structure of MPS1 (not shown) bound to <b>15b</b> (carbon atoms colored cyan), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6">5EI6</a>. (B) Superimposed crystal structure of MPS1 (pale green) bound to <b>1</b> (carbon atoms colored pink), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, onto the structure of MPS1 (not shown) bound to <b>24b</b> (carbons atoms colored green), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2">5EI2</a>. (C) Superimposed crystal structure of MPS1 (pale green) bound to <b>15b</b> (carbon atoms colored cyan), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6">5EI6</a>, onto the structure of MPS1 (not shown) bound to <b>24b</b> (carbon atoms colored green), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2">5EI2</a>, showing the extent of the conformational difference between the isoquinoline and pyrido[3,4-<i>d</i>]pyrimidine scaffolds. (D) Side-by-side view of compound <b>15b</b> (carbon atoms colored cyan) and <b>24b</b> (carbon atoms colored green) showing the difference in angle of the <i>N</i>-methylpyrazole group. 2Fo – Fc density contoured at 1σ is overlaid and displayed in the same color as the respective compound carbon atom color. A water molecule interacting with compound <b>24b</b> is also displayed as a red sphere. <b>15b</b> exhibits a dihedral angle of 98°, and <b>24b</b> exhibits a dihedral angle of −20°.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Crystal structure of MPS1 (pale green) bound to <b>24c</b> (carbon atoms colored orange), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, showing residues (Ile531, Val539, Met671, and Pro673) present in the hydrophobic pocket occupied by 8-position pyrazole. (B) Superimposed crystal structure of MPS1 (pale green) bound to <b>24c</b> (carbon atoms colored orange), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, onto the structure of MPS1 (not shown) bound to <b>1</b> (carbon atoms colored pink), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, showing that this is the same pocket occupied by the carbamate group of <b>1</b> (carbon atoms colored pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Superimposed crystal structure of MPS1 (pale green) bound to <b>24c</b> (carbon atoms colored orange), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, onto the structure of MPS1 (not shown) bound to <b>34e</b> (carbon atoms colored blue), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0">5EH0</a>, showing the hydrophobic pocket formed by Ile531, Val539, Met671, and Pro673. The bulkier neopentyl substituent of <b>34e</b> addresses the pocket to a greater extent than the pyrazole substituent of <b>24c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/medium/jm-2015-01811b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A,B) Representative immunoblots of phospho-histone H3 showing dose-dependent PD modulation in HCT116 human tumor xenografts, following 100 mg/kg b.i.d. dosing of <b>34h</b> for 3 consecutive days. Total histone H3, cleaved poly ADP ribose polymerase (PARP, a measure of apoptosis) and glyceraldehyde 3-phosphate dehydrogenase (GADPH, for protein loading) are also shown. (C) Phospho-histone H3 versus total histone H3 ratio for control and treated samples at 2 and 6 h after last dose. Asterisks show statistically significant differences from control groups as determined by one-way ANOVA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.5b01811/20160422/images/large/jm-2015-01811b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01811&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1038/nrc2049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F&doi=10.1038%2Fnrc2049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0ljI8anZduF3zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117%26doi%3D10.1038%2Fnrc2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwell, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span> </span><span class="NLM_article-title">Past and future of the mitotic spindle as an oncology target</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/S1471-4892(01)00064-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2FS1471-4892%2801%2900064-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=11710735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=370-377&author=K.+W.+Woodauthor=W.+D.+Cornwellauthor=J.+R.+Jackson&title=Past+and+future+of+the+mitotic+spindle+as+an+oncology+target&doi=10.1016%2FS1471-4892%2801%2900064-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Past and future of the mitotic spindle as an oncology target</span></div><div class="casAuthors">Wood, Kenneth W.; Cornwell, William D.; Jackson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Tubulin poisons were first discovered decades ago, but the recent clin. and com. success of Taxol has led to a renaissance in the search for novel mitotic spindle poisons to treat cancer.  Many tubulin poisons have been identified, but few have demonstrated clin. utility.  Recent studies have begun to identify the factors that differentiate the efficacy of these agents.  In addn., promising alternative approaches to targeting the mitotic spindle have been identified from detailed studies of mitotic regulation and mechanics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLTbni6UbogrVg90H21EOLACvtfcHk0ljI8anZduF3zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D&md5=1e7120d622f29b6d89d5127eaa72f61b</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2801%2900064-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252801%252900064-9%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DCornwell%26aufirst%3DW.%2BD.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26atitle%3DPast%2520and%2520future%2520of%2520the%2520mitotic%2520spindle%2520as%2520an%2520oncology%2520target%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2001%26volume%3D1%26spage%3D370%26epage%3D377%26doi%3D10.1016%2FS1471-4892%2801%2900064-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span> </span><span class="NLM_article-title">Mitosis-targeted anti-cancer therapies: where they stand</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e411</span><span class="refDoi"> DOI: 10.1038/cddis.2012.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fcddis.2012.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=23076219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e411&author=K.+S.+Chanauthor=C.+G.+Kohauthor=H.+Y.+Li&title=Mitosis-targeted+anti-cancer+therapies%3A+where+they+stand&doi=10.1038%2Fcddis.2012.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Mitosis-targeted anti-cancer therapies: where they stand</span></div><div class="casAuthors">Chan, K.-S.; Koh, C.-G.; Li, H.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">e411, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The strategy of clin. targeting cancerous cells at their most vulnerable state during mitosis has instigated numerous studies into the mitotic cell death (MCD) pathway.  As the hallmark of cancer revolves around cell-cycle deregulation, it is not surprising that antimitotic therapies are effective against the abnormal proliferation of transformed cells.  Moreover, these antimitotic drugs are also highly selective and sensitive.  Despite the robust rate of discovery and the development of mitosis-selective inhibitors, the unpredictable complexities of the human body's response to these drugs still herald the biggest challenge towards clin. success.  Undoubtedly, the need to bridge the gap between promising preclin. trials and effective translational bedside treatment prompts further investigations towards mapping out the mechanistic pathways of MCD, understanding how these drugs work as medicine in the body and more comprehensive target validations.  In this review, current antimitotic agents are summarized with particular emphasis on the evaluation of their clin. efficacy as well as their limitations.  In addn., we discuss the basis behind the lack of activity of these inhibitors in human trials and the potential and future directions of mitotic anticancer strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJjbhSTCZ8rVg90H21EOLACvtfcHk0lj4jccY0-TuPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSjtQ%253D%253D&md5=cfab128f78a4437ae746aeb777f72320</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.148%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BS.%26aulast%3DKoh%26aufirst%3DC.%2BG.%26aulast%3DLi%26aufirst%3DH.%2BY.%26atitle%3DMitosis-targeted%2520anti-cancer%2520therapies%253A%2520where%2520they%2520stand%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De411%26doi%3D10.1038%2Fcddis.2012.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardwick, K. G.</span><span> </span><span class="NLM_article-title">The spindle checkpoint</span> <span class="citation_source-journal">Trends Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1016/S0168-9525(97)01340-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2FS0168-9525%2897%2901340-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=9448456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1998&pages=1-4&author=K.+G.+Hardwick&title=The+spindle+checkpoint&doi=10.1016%2FS0168-9525%2897%2901340-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle checkpoint</span></div><div class="casAuthors">Hardwick, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">TRGEE2</span>;
        ISSN:<span class="NLM_cas:issn">0168-9525</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 33 refs., on the spindle checkpoint, localization of checkpoint components, global signaling, and a role for the checkpoint proteins in the timing of a normal mitosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCK07I41QTXrVg90H21EOLACvtfcHk0lj4jccY0-TuPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D&md5=b7c46a342b829847a9c7ebacbbe03915</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0168-9525%2897%2901340-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-9525%252897%252901340-1%26sid%3Dliteratum%253Aachs%26aulast%3DHardwick%26aufirst%3DK.%2BG.%26atitle%3DThe%2520spindle%2520checkpoint%26jtitle%3DTrends%2520Genet.%26date%3D1998%26volume%3D14%26spage%3D1%26epage%3D4%26doi%3D10.1016%2FS0168-9525%2897%2901340-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amendola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodricks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, D.</span><span> </span><span class="NLM_article-title">Expression of TTK, a novel human protein kinase, is associated with cell proliferation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">16000</span><span class="NLM_x">–</span> <span class="NLM_lpage">16006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=16000-16006&author=G.+B.+Millsauthor=R.+Schmandtauthor=M.+McGillauthor=A.+Amendolaauthor=M.+Hillauthor=K.+Jacobsauthor=C.+Mayauthor=A.+M.+Rodricksauthor=S.+Campbellauthor=D.+Hogg&title=Expression+of+TTK%2C+a+novel+human+protein+kinase%2C+is+associated+with+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DMcGill%26aufirst%3DM.%26aulast%3DAmendola%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRodricks%26aufirst%3DA.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DExpression%2520of%2520TTK%252C%2520a%2520novel%2520human%2520protein%2520kinase%252C%2520is%2520associated%2520with%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D16000%26epage%3D16006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lauze, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoelcker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luca, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span> </span><span class="NLM_article-title">Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=1655-1663&author=E.+Lauzeauthor=B.+Stoelckerauthor=F.+C.+Lucaauthor=E.+Weissauthor=A.+R.+Schutzauthor=M.+Winey&title=Yeast+spindle+pole+body+duplication+gene+MPS1+encodes+an+essential+dual+specificity+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauze%26aufirst%3DE.%26aulast%3DStoelcker%26aufirst%3DB.%26aulast%3DLuca%26aufirst%3DF.%2BC.%26aulast%3DWeiss%26aufirst%3DE.%26aulast%3DSchutz%26aufirst%3DA.%2BR.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DYeast%2520spindle%2520pole%2520body%2520duplication%2520gene%2520MPS1%2520encodes%2520an%2520essential%2520dual%2520specificity%2520protein%2520kinase%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D1655%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, E. D.</span><span> </span><span class="NLM_article-title">The spindle-assembly checkpoint in space and time</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1038/nrm2163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnrm2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=17426725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=379-393&author=A.+Musacchioauthor=E.+D.+Salmon&title=The+spindle-assembly+checkpoint+in+space+and+time&doi=10.1038%2Fnrm2163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle-assembly checkpoint in space and time</span></div><div class="casAuthors">Musacchio, Andrea; Salmon, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-393</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, the spindle-assembly checkpoint (SAC) is a ubiquitous safety device that ensures the fidelity of chromosome segregation in mitosis.  The SAC prevents chromosome missegregation and aneuploidy, and its dysfunction is implicated in tumorigenesis.  Recent mol. analyses have begun to shed light on the complex interaction of the checkpoint proteins with kinetochores - structures that mediate the binding of spindle microtubules to chromosomes in mitosis.  These studies are finally starting to reveal the mechanisms of checkpoint activation and silencing during mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBFNiU9YS2zbVg90H21EOLACvtfcHk0lj4jccY0-TuPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D&md5=b790220dccee5f0ad57f41aef0a3be32</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1038%2Fnrm2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2163%26sid%3Dliteratum%253Aachs%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DE.%2BD.%26atitle%3DThe%2520spindle-assembly%2520checkpoint%2520in%2520space%2520and%2520time%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D379%26epage%3D393%26doi%3D10.1038%2Fnrm2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Daniel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">5384</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span><span class="refDoi"> DOI: 10.1073/pnas.1007645108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1073%2Fpnas.1007645108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5384-5389&author=J.+Danielauthor=J.+Coulterauthor=J.-H.+Wooauthor=K.+Wilsbachauthor=E.+Gabrielson&title=High+levels+of+the+Mps1+checkpoint+protein+are+protective+of+aneuploidy+in+breast+cancer+cells&doi=10.1073%2Fpnas.1007645108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1007645108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1007645108%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DHigh%2520levels%2520of%2520the%2520Mps1%2520checkpoint%2520protein%2520are%2520protective%2520of%2520aneuploidy%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5384%26epage%3D5389%26doi%3D10.1073%2Fpnas.1007645108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes-Pereira, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Cabral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafiq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natrajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiu, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterskog, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Functional Viability Profiles of Breast Cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-11-0107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F2159-8290.CD-11-0107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=260-273&author=R.+Broughauthor=J.+R.+Frankumauthor=D.+Simsauthor=A.+MacKayauthor=A.+M.+Mendes-Pereiraauthor=I.+Bajramiauthor=S.+Costa-Cabralauthor=R.+Rafiqauthor=A.+S.+Ahmadauthor=M.+A.+Ceroneauthor=R.+Natrajanauthor=R.+Sharpeauthor=K.-K.+Shiuauthor=D.+Wetterskogauthor=K.+J.+Dedesauthor=M.+B.+Lambrosauthor=T.+Rawjeeauthor=S.+Linardopoulosauthor=J.+S.+Reis-Filhoauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=A.+Ashworth&title=Functional+Viability+Profiles+of+Breast+Cancer&doi=10.1158%2F2159-8290.CD-11-0107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-11-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-11-0107%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%2BR.%26aulast%3DSims%26aufirst%3DD.%26aulast%3DMacKay%26aufirst%3DA.%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DCerone%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DShiu%26aufirst%3DK.-K.%26aulast%3DWetterskog%26aufirst%3DD.%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DRawjee%26aufirst%3DT.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFunctional%2520Viability%2520Profiles%2520of%2520Breast%2520Cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D260%26epage%3D273%26doi%3D10.1158%2F2159-8290.CD-11-0107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gordon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span> </span><span class="NLM_article-title">Causes and consequences of aneuploidy in cancer</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1038/nrg3123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnrg3123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=22269907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=189-203&author=D.+J.+Gordonauthor=B.+Resioauthor=D.+Pellman&title=Causes+and+consequences+of+aneuploidy+in+cancer&doi=10.1038%2Fnrg3123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Causes and consequences of aneuploidy in cancer</span></div><div class="casAuthors">Gordon, David J.; Resio, Benjamin; Pellman, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-203</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer.  Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood.  Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations.  We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4uwB4F0Xu7Vg90H21EOLACvtfcHk0lgAvBqmFQU-ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D&md5=9c730e7390d7aafd54301777e2270721</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrg3123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3123%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BJ.%26aulast%3DResio%26aufirst%3DB.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DCauses%2520and%2520consequences%2520of%2520aneuploidy%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D189%26epage%3D203%26doi%3D10.1038%2Fnrg3123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yuan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersto, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tully, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F1078-0432.CCR-05-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=16428479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=405-410&author=B.+Yuanauthor=Y.+Xuauthor=J.-H.+Wooauthor=Y.+Wangauthor=Y.+K.+Baeauthor=D.-S.+Yoonauthor=R.+P.+Werstoauthor=E.+Tullyauthor=K.+Wilsbachauthor=E.+Gabrielson&title=Increased+Expression+of+Mitotic+Checkpoint+Genes+in+Breast+Cancer+Cells+with+Chromosomal+Instability&doi=10.1158%2F1078-0432.CCR-05-0903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span></div><div class="casAuthors">Yuan, Bibo; Xu, Yi; Woo, Ju-Hyung; Wang, Yunyue; Bae, Young Kyung; Yoon, Dae-Sung; Wersto, Robert P.; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints.  Because the mol. basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.  Exptl. Design: We analyzed sequences and expression levels (RNA and protein) of eight major spindle checkpoint genes (MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, and TTK) in a panel of 12 breast cancer cell lines, most with established genetic instability and defective spindle damage checkpoint response.  MRNA levels of these genes were also measured in primary tumor samples, and immunohistochem. staining was used to evaluate BUB1B protein levels in a panel of 270 addnl. cases of breast cancer.  Results: No functionally significant sequence variations were found for any of the eight genes in the breast cancer cell lines with chromosomal instability.  More surprisingly, the mRNA and protein levels for these checkpoint genes are significantly higher in the genetically unstable breast cancer cell lines and in high-grade primary breast cancer tissues than in the stable (and checkpoint proficient) MCF-10A and normal mammary epithelial cells, or in normal breast tissues.  In fact, overexpression of the BUB1B protein is a marker that recognizes nearly 80% of breast cancers in paraffin-embedded tissues.  Conclusions: Defective mitotic spindle checkpoints in breast cancer are most likely not caused by low expression or mutations of these eight checkpoint genes.  High levels of these particular transcripts could represent a cellular compensation for defects in other mol. components of the mitotic spindle damage checkpoint, and increased expression of these genes might be markers of breast cancers with chromosomal instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcNtMRC1xcrVg90H21EOLACvtfcHk0lgAvBqmFQU-ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D&md5=06a8afcd6636218ae3a7bf38fe9939b4</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0903%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DYoon%26aufirst%3DD.-S.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DTully%26aufirst%3DE.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DIncreased%2520Expression%2520of%2520Mitotic%2520Checkpoint%2520Genes%2520in%2520Breast%2520Cancer%2520Cells%2520with%2520Chromosomal%2520Instability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D405%26epage%3D410%26doi%3D10.1158%2F1078-0432.CCR-05-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mizukami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, H.</span><span> </span><span class="NLM_article-title">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1454</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.00844.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1111%2Fj.1349-7006.2008.00844.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=18452554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1448-1454&author=Y.+Mizukamiauthor=K.+Konoauthor=Y.+Daigoauthor=A.+Takanoauthor=T.+Tsunodaauthor=Y.+Kawaguchiauthor=Y.+Nakamuraauthor=H.+Fujii&title=Detection+of+novel+cancer-testis+antigen-specific+T-cell+responses+in+TIL%2C+regional+lymph+nodes%2C+and+PBL+in+patients+with+esophageal+squamous+cell+carcinoma&doi=10.1111%2Fj.1349-7006.2008.00844.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span></div><div class="casAuthors">Mizukami, Yoshiki; Kono, Koji; Daigo, Yataro; Takano, Atsushi; Tsunoda, Takuya; Kawaguchi, Yoshihiko; Nakamura, Yusuke; Fujii, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1448-1454</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">The authors recently identified three HLA-A2402-restricted epitope peptides derived from cancer-testis antigens (CTA), TTK protein kinase (TTK), lymphocyte antigen 6 complex locus K (LY6K), and insulin-like growth factor (IGF)-II mRNA binding protein 3 (IMP-3) for the development of immunotherapies against esophageal squamous cell carcinoma (ESCC).  To evaluate their immunotherapeutic potential in ESCC patients, the authors estd. by ELISPOT assay the TTK-, LY6K-, or IMP-3-specific T-cell immune responses in tumor-infiltrating lymphocytes (TIL), regional lymph node lymphocytes (RLNL), and peripheral blood lymphocytes (PBL) expanded from 20HLA-A2402 (+) ESCC patients, and correlated their immune activity with the expression levels of TTK, LY6K, and IMP-3, and MHC class I in the tumors.  Induction of TTK-antigen specific T-cell response in TIL to the peptide-pulsed target cells was detected in 14 out of 20 (70%) cases, while LY6K or IMP-3 specific T-cell activity was obsd. in 11 of 20 (55%) or in eight of 20 (40%) cases, resp.  Furthermore, T-cell activity in RLNL and PBL was detectable in the similar proportion of the 20 ESCC patients.  Interestingly, CTA-specific T-cell immune response was found in 13 of 14 (93%) TIL obtained from ESCC tumors with strong MHC class I expression, while it could be obsd. only in two of six (33%) TIL from ESCC tumors with weak MHC class I expression.  These results strongly suggest the pre-existence of specific T-cell responses to HLA-A24-restricted epitope peptides from TTK, LY6K, and IMP-3 in ESCC patients.  Monitoring antigen-specific T-cell responses, as well as the expression levels of MHC class I and epitope CTA in tumors, should be a selection index for application of cancer vaccine therapies to the patients who are likely to show good immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8reosidZGbVg90H21EOLACvtfcHk0ljGgEt3plZsmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D&md5=dcb4be9405b2f37475bcd8785b27722a</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00844.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00844.x%26sid%3Dliteratum%253Aachs%26aulast%3DMizukami%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DH.%26atitle%3DDetection%2520of%2520novel%2520cancer-testis%2520antigen-specific%2520T-cell%2520responses%2520in%2520TIL%252C%2520regional%2520lymph%2520nodes%252C%2520and%2520PBL%2520in%2520patients%2520with%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D1448%26epage%3D1454%26doi%3D10.1111%2Fj.1349-7006.2008.00844.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Salvatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nappi, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miccoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirafici, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">10148</span><span class="NLM_x">–</span> <span class="NLM_lpage">10158</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F0008-5472.CAN-07-1887" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10148-10158&author=G.+Salvatoreauthor=T.+C.+Nappiauthor=P.+Salernoauthor=Y.+Jiangauthor=C.+Garbiauthor=C.+Ugoliniauthor=P.+Miccoliauthor=F.+Basoloauthor=M.+D.+Castelloneauthor=A.+M.+Ciraficiauthor=R.+M.+Melilloauthor=A.+Fuscoauthor=M.+L.+Bittnerauthor=M.+Santoro&title=A+Cell+Proliferation+and+Chromosomal+Instability+Signature+in+Anaplastic+Thyroid+Carcinoma&doi=10.1158%2F0008-5472.CAN-07-1887"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-1887%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DG.%26aulast%3DNappi%26aufirst%3DT.%2BC.%26aulast%3DSalerno%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGarbi%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DC.%26aulast%3DMiccoli%26aufirst%3DP.%26aulast%3DBasolo%26aufirst%3DF.%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DCirafici%26aufirst%3DA.%2BM.%26aulast%3DMelillo%26aufirst%3DR.%2BM.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BL.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DA%2520Cell%2520Proliferation%2520and%2520Chromosomal%2520Instability%2520Signature%2520in%2520Anaplastic%2520Thyroid%2520Carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10148%26epage%3D10158%26doi%3D10.1158%2F0008-5472.CAN-07-1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Thykjaer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruhoffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demtroder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orntoft, T. F.</span><span> </span><span class="NLM_article-title">Identification of gene expression patterns in superficial and invasive human bladder cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2492-2499&author=T.+Thykjaerauthor=C.+Workmanauthor=M.+Kruhofferauthor=K.+Demtroderauthor=H.+Wolfauthor=L.+D.+Andersenauthor=C.+M.+Frederiksenauthor=S.+Knudsenauthor=T.+F.+Orntoft&title=Identification+of+gene+expression+patterns+in+superficial+and+invasive+human+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThykjaer%26aufirst%3DT.%26aulast%3DWorkman%26aufirst%3DC.%26aulast%3DKruhoffer%26aufirst%3DM.%26aulast%3DDemtroder%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DH.%26aulast%3DAndersen%26aufirst%3DL.%2BD.%26aulast%3DFrederiksen%26aufirst%3DC.%2BM.%26aulast%3DKnudsen%26aufirst%3DS.%26aulast%3DOrntoft%26aufirst%3DT.%2BF.%26atitle%3DIdentification%2520of%2520gene%2520expression%2520patterns%2520in%2520superficial%2520and%2520invasive%2520human%2520bladder%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2492%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tannous, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Stoop, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandrowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiddingh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sol, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerweij, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedekind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niers, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barazas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, R. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Witt Hamer, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandertop, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Würdinger, T.</span><span> </span><span class="NLM_article-title">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span> <span class="citation_source-journal">J. Nat. Canc. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1331</span><span class="refDoi"> DOI: 10.1093/jnci/djt168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1093%2Fjnci%2Fdjt168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=23940287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=1322-1331&author=B.+A.+Tannousauthor=M.+Keramiauthor=P.+M.+Van+der+Stoopauthor=N.+Kwiatkowskiauthor=J.+Wangauthor=W.+Zhouauthor=A.+F.+Kesslerauthor=G.+Lewandrowskiauthor=L.+Hiddinghauthor=N.+Solauthor=T.+Lagerweijauthor=L.+Wedekindauthor=J.+M.+Niersauthor=M.+Barazasauthor=R.+J.+A.+Nilssonauthor=D.+Geertsauthor=P.+C.+De+Witt+Hamerauthor=C.+Hagemannauthor=W.+P.+Vandertopauthor=O.+Van+Tellingenauthor=D.+P.+Noskeauthor=N.+S.+Grayauthor=T.+W%C3%BCrdinger&title=Effects+of+the+Selective+MPS1+Inhibitor+MPS1-IN-3+on+Glioblastoma+Sensitivity+to+Antimitotic+Drugs&doi=10.1093%2Fjnci%2Fdjt168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span></div><div class="casAuthors">Tannous, Bakhos A.; Kerami, Mariam; Van der Stoop, Petra M.; Kwiatkowski, Nicholas; Wang, Jinhua; Zhou, Wenjun; Kessler, Almuth F.; Lewandrowski, Grant; Hiddingh, Lotte; Sol, Nik; Lagerweij, Tonny; Wedekind, Laurine; Niers, Johanna M.; Barazas, Marco; Nilsson, R. Jonas A.; Geerts, Dirk; De Witt Hamer, Philip C.; Hagemann, Carsten; Vandertop, W. Peter; Van Tellingen, Olaf; Noske, David P.; Gray, Nathanael S.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1322-1331</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastomas exhibit a high level of chemotherapeutic resistance, including to the antimitotic agents vincristine and taxol.  During the mitotic agent-induced arrest, glioblastoma cells are able to perform damage-control and self-repair to continue proliferation.  Monopolar spindle 1 (MPS1/TTK) is a checkpoint kinase and a gatekeeper of the mitotic arrest.  Methods We used glioblastoma cells to det. the expression of MPS1 and to det. the effects of MPS1 inhibition on mitotic errors and cell viability in combination with vincristine and taxol.  The effect of MPS1 inhibition was assessed in different orthotopic glioblastoma mouse models (n = 3-7 mice/group).  MPS1 expression levels were examd. in relation to patient survival.  Results Using publicly available gene expression data, we detd. that MPS1 overexpression corresponds pos. with tumor grade and neg. with patient survival (two-sided t test, P < .001).  Patients with high MPS1 expression (n = 203) had a median and mean survival of 487 and 913 days (95% confidence intervals [CI] = 751 to 1075), resp., and a 2-yr survival rate of 35%, whereas patients with intermediate MPS1 expression (n = 140) had a median and mean survival of 858 and 1183 days (95% CI = 1177 to 1189), resp., and a 2-yr survival rate of 56%.  We demonstrate that MPS1 inhibition by RNAi results in sensitization to antimitotic agents.  We developed a selective small-mol. inhibitor of MPS1, MPS1-IN-3, which caused mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induced mitotic checkpoint override, increased aneuploidy, and augmented cell death.  MPS1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models (two-sided log-rank test, P < .01), resulting in prolonged survival without toxicity.  Conclusions Our results collectively demonstrate that MPS1, a putative therapeutic target in glioblastoma, can be selectively inhibited by MPS1-IN-3 sensitizing glioblastoma cells to antimitotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUG67Lkc5qcbVg90H21EOLACvtfcHk0lh0bzeV53SWdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK&md5=b7e51ef38e02d9fbf0ce0191af530b3a</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjt168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjt168%26sid%3Dliteratum%253Aachs%26aulast%3DTannous%26aufirst%3DB.%2BA.%26aulast%3DKerami%26aufirst%3DM.%26aulast%3DVan%2Bder%2BStoop%26aufirst%3DP.%2BM.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DLewandrowski%26aufirst%3DG.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DSol%26aufirst%3DN.%26aulast%3DLagerweij%26aufirst%3DT.%26aulast%3DWedekind%26aufirst%3DL.%26aulast%3DNiers%26aufirst%3DJ.%2BM.%26aulast%3DBarazas%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DVandertop%26aufirst%3DW.%2BP.%26aulast%3DVan%2BTellingen%26aufirst%3DO.%26aulast%3DNoske%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DW%25C3%25BCrdinger%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520Selective%2520MPS1%2520Inhibitor%2520MPS1-IN-3%2520on%2520Glioblastoma%2520Sensitivity%2520to%2520Antimitotic%2520Drugs%26jtitle%3DJ.%2520Nat.%2520Canc.%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D1322%26epage%3D1331%26doi%3D10.1093%2Fjnci%2Fdjt168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Slee, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasaway, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victorino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korc, M.</span><span> </span><span class="NLM_article-title">Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F1535-7163.MCT-13-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=24282275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=307-315&author=R.+B.+Sleeauthor=B.+R.+Grimesauthor=R.+Bansalauthor=J.+Goreauthor=C.+Blackburnauthor=L.+Brownauthor=R.+Gasawayauthor=J.+Jeongauthor=J.+Victorinoauthor=K.+L.+Marchauthor=R.+Colomboauthor=B.+S.+Herbertauthor=M.+Korc&title=Selective+inhibition+of+pancreatic+ductal+adenocarcinoma+cell+growth+by+the+mitotic+MPS1+kinase+inhibitor+NMS-P715&doi=10.1158%2F1535-7163.MCT-13-0324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715</span></div><div class="casAuthors">Slee, Roger B.; Grimes, Brenda R.; Bansal, Ruchi; Gore, Jesse; Blackburn, Corinne; Brown, Lyndsey; Gasaway, Rachel; Jeong, Jaesik; Victorino, Jose; March, Keith L.; Colombo, Riccardo; Herbert, Brittney-Shea; Korc, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-315</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most solid tumors, including pancreatic ductal adenocarcinoma (PDAC), exhibit structural and numerical chromosome instability (CIN).  Although often implicated as a driver of tumor progression and drug resistance, CIN also reduces cell fitness and poses a vulnerability that can be exploited therapeutically.  The spindle assembly checkpoint (SAC) ensures correct chromosome-microtubule attachment, thereby minimizing chromosome segregation errors.  Many tumors exhibit upregulation of SAC components such as MPS1, which may help contain CIN within survivable limits.  Prior studies showed that MPS1 inhibition with the small mol. NMS-P715 limits tumor growth in xenograft models.  In cancer cell lines, NMS-P715 causes cell death assocd. with impaired SAC function and increased chromosome missegregation.  Although normal cells appeared more resistant, effects on stem cells, which are the dose-limiting toxicity of most chemotherapeutics, were not examd.  Elevated expression of 70 genes (CIN70), including MPS1, provides a surrogate measure of CIN and predicts poor patient survival in multiple tumor types.  Our new findings show that the degree of CIN70 upregulation varies considerably among PDAC tumors, with higher CIN70 gene expression predictive of poor outcome.  We identified a 25 gene subset (PDAC CIN25) whose overexpression was most strongly correlated with poor survival and included MPS1.  In vitro, growth of human and murine PDAC cells is inhibited by NMS-P715 treatment, whereas adipose-derived human mesenchymal stem cells are relatively resistant and maintain chromosome stability upon exposure to NMS-P715.  These studies suggest that NMS-P715 could have a favorable therapeutic index and warrant further investigation of MPS1 inhibition as a new PDAC treatment strategy.  Mol Cancer Ther; 13(2); 307-15. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooKyK5kaMEOLVg90H21EOLACvtfcHk0ljyWWewDnEIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLc%253D&md5=5a7352667013f1fd2bfc11b233fbe548</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0324%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DR.%2BB.%26aulast%3DGrimes%26aufirst%3DB.%2BR.%26aulast%3DBansal%26aufirst%3DR.%26aulast%3DGore%26aufirst%3DJ.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DGasaway%26aufirst%3DR.%26aulast%3DJeong%26aufirst%3DJ.%26aulast%3DVictorino%26aufirst%3DJ.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DHerbert%26aufirst%3DB.%2BS.%26aulast%3DKorc%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%2520cell%2520growth%2520by%2520the%2520mitotic%2520MPS1%2520kinase%2520inhibitor%2520NMS-P715%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D307%26epage%3D315%26doi%3D10.1158%2F1535-7163.MCT-13-0324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Aarts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span> </span><span class="NLM_article-title">Tumour selective targeting of cell cycle kinases for cancer treatment</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/j.coph.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.coph.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=23597425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=529-535&author=M.+Aartsauthor=S.+Linardopoulosauthor=N.+C.+Turner&title=Tumour+selective+targeting+of+cell+cycle+kinases+for+cancer+treatment&doi=10.1016%2Fj.coph.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour selective targeting of cell cycle kinases for cancer treatment</span></div><div class="casAuthors">Aarts, Marieke; Linardopoulos, Spiros; Turner, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-535</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The deregulation of the cell cycle and checkpoint machinery in cancer presents a highly attractive therapeutic strategy.  We review here the strategies used to exploit the dysregulated cell cycle, both through targeting kinases required for cell cycle progression, and checkpoint kinases to inappropriately force cells through the cell cycle.  Appropriate control of the cell cycle is crit. for proliferating normal cells, and we discuss the importance of defining tumor specific vulnerabilities that could be targeted with cell cycle kinase inhibitors.  Recent studies have shown that ER-pos. breast cancers rely on CDK4 to promote proliferation.  TP53 mutant cancer cell lines are sensitive to WEE1 and CHK1 inhibitors in combination with chemotherapy, while PTEN-deficient aneuploid cancer cell lines are sensitive to TTK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLoVeyM7O1HrVg90H21EOLACvtfcHk0ljyWWewDnEIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D&md5=21d34a68d937abd09dad8bc15fd56bce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DAarts%26aufirst%3DM.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26atitle%3DTumour%2520selective%2520targeting%2520of%2520cell%2520cycle%2520kinases%2520for%2520cancer%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2013%26volume%3D13%26spage%3D529%26epage%3D535%26doi%3D10.1016%2Fj.coph.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Naud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faisal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAndrew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matijssen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Orally Bioavailable 1<i>H</i>-Pyrrolo[3,2-<i>c</i>]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10045</span><span class="NLM_x">–</span> <span class="NLM_lpage">10065</span><span class="refDoi"> DOI: 10.1021/jm401395s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+M.+van+Montfortauthor=J.+Blagg&title=Structure-Based+Design+of+Orally+Bioavailable+1H-Pyrrolo%5B3%2C2-c%5Dpyridine+Inhibitors+of+Mitotic+Kinase+Monopolar+Spindle+1+%28MPS1%29&doi=10.1021%2Fjm401395s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span></div><div class="casAuthors">Naud, Sebastien; Westwood, Isaac M.; Faisal, Amir; Sheldrake, Peter; Bavetsias, Vassilios; Atrash, Butrus; Cheung, Kwai-Ming J.; Liu, Manjuan; Hayes, Angela; Schmitt, Jessica; Wood, Amy; Choi, Vanessa; Boxall, Kathy; Mak, Grace; Gurden, Mark; Valenti, Melanie; de Haven Brandon, Alexis; Henley, Alan; Baker, Ross; McAndrew, Craig; Matijssen, Berry; Burke, Rosemary; Hoelder, Swen; Eccles, Suzanne A.; Raynaud, Florence I.; Linardopoulos, Spiros; van Montfort, Rob L. M.; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10045-10065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.  MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy.  PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncol.  The authors report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo-[3,2-c]-pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to CCT251455.  This potent and selective chem. tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compd. to elucidate further the therapeutic potential of MPS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVRsRcyzCEBLVg90H21EOLACvtfcHk0ljyWWewDnEIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO&md5=6564efe14dec83774e94c355be756845</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-Based%2520Design%2520of%2520Orally%2520Bioavailable%25201H-Pyrrolo%255B3%252C2-c%255Dpyridine%2520Inhibitors%2520of%2520Mitotic%2520Kinase%2520Monopolar%2520Spindle%25201%2520%2528MPS1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065%26doi%3D10.1021%2Fjm401395s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span><span class="refDoi"> DOI: 10.1021/jm501599u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501599u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1760-1775&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=K.+Nozuauthor=H.+Yoshidaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=Y.+Babaauthor=Y.+Nakamura&title=Discovery+of+Imidazo%5B1%2C2-b%5Dpyridazine+Derivatives%3A+Selective+and+Orally+Available+Mps1+%28TTK%29+Kinase+Inhibitors+Exhibiting+Remarkable+Antiproliferative+Activity&doi=10.1021%2Fjm501599u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span></div><div class="casAuthors">Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Hashizume, Hiroshi; Nozu, Kohei; Yoshida, Hiroshi; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Baba, Yoshiyasu; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1775</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is an attractive oncol. target due to its high expression level in cancer cells as well as the correlation of its expression levels with histol. grades of cancers.  An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign.  Although 10a exhibited good biochem. activity, its moderate cellular as well as antiproliferative activities needed to be improved.  The cocrystal structure of an analog of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat.  Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo.  This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8D9nRl5vWabVg90H21EOLACvtfcHk0lilQYi4XY5ifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D&md5=bee62a50247a363dc3e35fcdeac6a64f</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm501599u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501599u%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DNozu%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520Imidazo%255B1%252C2-b%255Dpyridazine%2520Derivatives%253A%2520Selective%2520and%2520Orally%2520Available%2520Mps1%2520%2528TTK%2529%2520Kinase%2520Inhibitors%2520Exhibiting%2520Remarkable%2520Antiproliferative%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1760%26epage%3D1775%26doi%3D10.1021%2Fjm501599u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris-Brandts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgadze, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on <i>N</i>-(3-(3-sulfamoylphenyl)-1<i>H</i>-indazol-5-yl)acetamides and carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4997</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.bmc.2014.06.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+B.+Patelauthor=L.+G.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+E.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+M.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=F.+Banauthor=V.+Nadeemauthor=T.+W.+Makauthor=G.+J.+Panauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29acetamides+and+carboxamides&doi=10.1016%2Fj.bmc.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%2BB.%26aulast%3DEdwards%26aufirst%3DL.%2BG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%2BJ.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997%26doi%3D10.1016%2Fj.bmc.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tardif, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassiano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimbora, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douce, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorweiler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papac, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlexander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. L.</span><span> </span><span class="NLM_article-title">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2275</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+Cellular+and+Antitumor+Effects+of+MPI-0479605%2C+a+Small-Molecule+Inhibitor+of+the+Mitotic+Kinase+Mps1&doi=10.1158%2F1535-7163.MCT-11-0453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0li2RGT8UzvXeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520Cellular%2520and%2520Antitumor%2520Effects%2520of%2520MPI-0479605%252C%2520a%2520Small-Molecule%2520Inhibitor%2520of%2520the%2520Mitotic%2520Kinase%2520Mps1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275%26doi%3D10.1158%2F1535-7163.MCT-11-0453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rymer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanochko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trajkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappin, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span> </span><span class="NLM_article-title">Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0138616</span><span class="refDoi"> DOI: 10.1371/journal.pone.0138616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1371%2Fjournal.pone.0138616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=26398286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0138616&author=R.+Martinezauthor=A.+Blasinaauthor=J.+F.+Hallinauthor=W.+Huauthor=I.+Rymerauthor=J.+Fanauthor=R.+L.+Hoffmanauthor=S.+Murphyauthor=M.+Marxauthor=G.+Yanochkoauthor=D.+Trajkovicauthor=D.+Dinhauthor=S.+Timofeevskiauthor=Z.+Zhuauthor=P.+Sunauthor=P.+B.+Lappinauthor=B.+W.+Murray&title=Mitotic+Checkpoint+Kinase+Mps1+Has+a+Role+in+Normal+Physiology+which+Impacts+Clinical+Utility&doi=10.1371%2Fjournal.pone.0138616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic checkpoint kinase Mps1 has a role in normal physiology which impacts clinical utility</span></div><div class="casAuthors">Martinez, Ricardo; Blasina, Alessandra; Hallin, Jill F.; Hu, Wenyue; Rymer, Isha; Fan, Jeffery; Hoffman, Robert L.; Murphy, Sean; Marx, Matthew; Yanochko, Gina; Trajkovic, Dusko; Dinh, Dac; Timofeevski, Sergei; Zhu, Zhou; Sun, Peiquing; Lappin, Patrick B.; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0138616/1-e0138616/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is well-tolerated.  A crit. cell cycle process that could be targeted is the mitotic checkpoint (spindle assembly checkpoint) which governs the metaphase-to-anaphase transition and insures proper chromosomal segregation.  The mitotic checkpoint kinase Mps1 was selected to explore whether enhancement in genomic instability is a viable therapeutic strategy.  The basal-a subset of triple-neg. breast cancer was chosen as a model system because it has a higher incidence of chromosomal instability and Mps1 expression is up-regulated.  Depletion of Mps1 reduces tumor cell viability relative to normal cells.  Highly selective, extremely potent Mps1 kinase inhibitors were created to investigate the roles of Mps1 catalytic activity in tumor cells and normal physiol. (PF-7006, PF-3837; Ki<0.5 nM; cellular IC50 2-6 nM).  Treatment of tumor cells in vitro with PF-7006 modulates expected Mps1-dependent biol. as demonstrated by mol. and phenotypic measures (reduced pHH3-Ser10 levels, shorter duration of mitosis, micro-nucleation, and apoptosis).  Tumor-bearing mice treated with PF-7006 exhibit tumor growth inhibition concomitant with pharmacodynamic modulation of a downstream biomarker (pHH3-Ser10).  Unfortunately, efficacy only occurs at drug exposures that cause dose-limiting body wt. loss, gastrointestinal toxicities, and neutropenia.  Mps1 inhibitor toxicities may be mitigated by inducing G1 cell cycle arrest in Rb1-competent cells with the cyclin-dependent kinase-4/6 inhibitor palbociclib.  Using an isogenic cellular model system, PF-7006 is shown to be selectively cytotoxic to Rb1-deficient cells relative to Rb1-competent cells (also a measure of kinase selectivity).  Human bone marrow cells pretreated with palbociclib have decreased PF-7006-dependent apoptosis relative to cells without palbociclib pretreatment.  Collectively, this study raises a concern that single agent therapies inhibiting Mps1 will not be well-tolerated clin. but may be when combined with a selective CDK4/6 drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc-9LR3Gfty7Vg90H21EOLACvtfcHk0li2RGT8UzvXeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D&md5=68fc918b70df2cd020be0c4fec209c12</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138616%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%2BF.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DRymer%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DMurphy%26aufirst%3DS.%26aulast%3DMarx%26aufirst%3DM.%26aulast%3DYanochko%26aufirst%3DG.%26aulast%3DTrajkovic%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DLappin%26aufirst%3DP.%2BB.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DMitotic%2520Checkpoint%2520Kinase%2520Mps1%2520Has%2520a%2520Role%2520in%2520Normal%2520Physiology%2520which%2520Impacts%2520Clinical%2520Utility%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0138616%26doi%3D10.1371%2Fjournal.pone.0138616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wengner, A. M.; Siemeister, G.</span><span> </span><span class="NLM_article-title">Combination of a imidazopyridazine derivative and a mitotic agent for the treatment of cancer</span>. Patent WO2014198776A1, December 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combination+of+a+imidazopyridazine+derivative+and+a+mitotic+agent+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombination%2520of%2520a%2520imidazopyridazine%2520derivative%2520and%2520a%2520mitotic%2520agent%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wengner, A. M.; Siemeister, G.</span><span> </span><span class="NLM_article-title">Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor</span>. Patent WO2014198645, December 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combinations+for+the+treatment+of+cancer+comprising+a+mps-1+kinase+inhibitor+and+a+mitotic+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombinations%2520for%2520the%2520treatment%2520of%2520cancer%2520comprising%2520a%2520mps-1%2520kinase%2520inhibitor%2520and%2520a%2520mitotic%2520inhibitor%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Maia, A. R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Man, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boon, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omerzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterrenburg, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinsen, M. B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen-Seegers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Roos, J. A. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Doornmalen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitdehaag, J. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buijsman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaman, G. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span> </span><span class="NLM_article-title">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2180</span><span class="refDoi"> DOI: 10.1093/annonc/mdv293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1093%2Fannonc%2Fmdv293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=26153498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2180&author=A.+R.+R.+Maiaauthor=J.+de+Manauthor=U.+Boonauthor=A.+Janssenauthor=J.-Y.+Songauthor=M.+Omerzuauthor=J.+G.+Sterrenburgauthor=M.+B.+W.+Prinsenauthor=N.+Willemsen-Seegersauthor=J.+A.+D.+M.+de+Roosauthor=A.+M.+van+Doornmalenauthor=J.+C.+M.+Uitdehaagauthor=G.+J.+P.+L.+Kopsauthor=J.+Jonkersauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zamanauthor=R.+H.+Medema&title=Inhibition+of+the+spindle+assembly+checkpoint+kinase+TTK+enhances+the+efficacy+of+docetaxel+in+a+triple-negative+breast+cancer+model&doi=10.1093%2Fannonc%2Fmdv293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span></div><div class="casAuthors">Maia A R R; Janssen A; de Man J; Sterrenburg J G; Prinsen M B W; Willemsen-Seegers N; de Roos J A D M; van Doornmalen A M; Uitdehaag J C M; Buijsman R C; Zaman G J R; Boon U; Song J-Y; Omerzu M; Kops G J P L; Jonkers J; Medema R H</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2180-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Triple-negative breast cancers (TNBC) are considered the most aggressive type of breast cancer, for which no targeted therapy exists at the moment.  These tumors are characterized by having a high degree of chromosome instability and often overexpress the spindle assembly checkpoint kinase TTK.  To explore the potential of TTK inhibition as a targeted therapy in TNBC, we developed a highly potent and selective small molecule inhibitor of TTK, NTRC 0066-0.  RESULTS AND CONCLUSIONS:  The compound is characterized by long residence time on the target and inhibits the proliferation of a wide variety of human cancer cell lines with potency in the same range as marketed cytotoxic agents.  In cell lines and in mice, NTRC 0066-0 inhibits the phosphorylation of a TTK substrate and induces chromosome missegregation.  NTRC 0066-0 inhibits tumor growth in MDA-MB-231 xenografts as a single agent after oral application.  To address the effect of the inhibitor in breast cancer, we used a well-defined mouse model that spontaneously develops breast tumors that share key morphologic and molecular features with human TNBC.  Our studies show that combination of NTRC 0066-0 with a therapeutic dose of docetaxel resulted in doubling of mouse survival and extended tumor remission, without toxicity.  Furthermore, we observed that treatment efficacy is only achieved upon co-administration of the two compounds, which suggests a synergistic in vivo effect.  Therefore, we propose TTK inhibition as a novel therapeutic target for neoadjuvant therapy in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW4bdSIlyWFQ8IxFYvehhofW6udTcc2eaBnUFe7wOZM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D&md5=579aa33d6fd0de70b6c68ae86d8316c0</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv293%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DA.%2BR.%2BR.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DBoon%26aufirst%3DU.%26aulast%3DJanssen%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.-Y.%26aulast%3DOmerzu%26aufirst%3DM.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3Dvan%2BDoornmalen%26aufirst%3DA.%2BM.%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DInhibition%2520of%2520the%2520spindle%2520assembly%2520checkpoint%2520kinase%2520TTK%2520enhances%2520the%2520efficacy%2520of%2520docetaxel%2520in%2520a%2520triple-negative%2520breast%2520cancer%2520model%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3D2180%26doi%3D10.1093%2Fannonc%2Fmdv293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4343</span><span class="NLM_x">–</span> <span class="NLM_lpage">4356</span><span class="refDoi"> DOI: 10.1021/jm4000215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4343-4356&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=Y.+Tachibanaauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=Y.+Hatoauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=M.+Higakiauthor=K.+Uedaauthor=H.+Yoshizawaauthor=Y.+Babaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Indazole-Based+Potent+and+Cell-Active+Mps1+Kinase+Inhibitors%3A+Rational+Design+from+Pan-Kinase+Inhibitor+Anthrapyrazolone+%28SP600125%29&doi=10.1021%2Fjm4000215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm4000215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000215%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DHato%26aufirst%3DY.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DIndazole-Based%2520Potent%2520and%2520Cell-Active%2520Mps1%2520Kinase%2520Inhibitors%253A%2520Rational%2520Design%2520from%2520Pan-Kinase%2520Inhibitor%2520Anthrapyrazolone%2520%2528SP600125%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4343%26epage%3D4356%26doi%3D10.1021%2Fjm4000215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hewitt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1083/jcb.201002133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1083%2Fjcb.201002133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=25-34&author=L.+Hewittauthor=A.+Tigheauthor=S.+Santaguidaauthor=A.+M.+Whiteauthor=C.+D.+Jonesauthor=A.+Musacchioauthor=S.+Greenauthor=S.+S.+Taylor&title=Sustained+Mps1+activity+is+required+in+mitosis+to+recruit+O-Mad2+to+the+Mad1-C-Mad2+core+complex&doi=10.1083%2Fjcb.201002133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201002133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201002133%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DL.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DSustained%2520Mps1%2520activity%2520is%2520required%2520in%2520mitosis%2520to%2520recruit%2520O-Mad2%2520to%2520the%2520Mad1-C-Mad2%2520core%2520complex%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D25%26epage%3D34%26doi%3D10.1083%2Fjcb.201002133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Langdon, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span><span class="refDoi"> DOI: 10.1021/ci400100c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400100c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFShtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=1100-1112&author=S.+R.+Langdonauthor=I.+M.+Westwoodauthor=R.+L.+M.+van+Montfortauthor=N.+Brownauthor=J.+Blagg&title=Scaffold-Focused+Virtual+Screening%3A+Prospective+Application+to+the+Discovery+of+TTK+Inhibitors&doi=10.1021%2Fci400100c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors</span></div><div class="casAuthors">Langdon, Sarah R.; Westwood, Isaac M.; van Montfort, Rob L. M.; Brown, Nathan; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1100-1112</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe and apply a scaffold-focused virtual screen based upon scaffold trees to the mitotic kinase TTK (MPS1).  Using level 1 of the scaffold tree, we perform both 2D and 3D similarity searches between a query scaffold and a level 1 scaffold library derived from a 2 million compd. library; 98 compds. from 27 unique top-ranked level 1 scaffolds are selected for biochem. screening.  We show that this scaffold-focused virtual screen prospectively identifies eight confirmed active compds. that are structurally differentiated from the query compd.  In comparison, 100 compds. were selected for biochem. screening using a virtual screen based upon whole mol. similarity resulting in 12 confirmed active compds. that are structurally similar to the query compd.  We elucidated the binding mode for four of the eight confirmed scaffold hops to TTK by detg. their protein-ligand crystal structures; each represents a ligand-efficient scaffold for inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKRrcvweEx7Vg90H21EOLACvtfcHk0lj9uk56yLaL3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFShtLw%253D&md5=622edfcd75e57a35d3d411b3190ed9cf</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Fci400100c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400100c%26sid%3Dliteratum%253Aachs%26aulast%3DLangdon%26aufirst%3DS.%2BR.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DScaffold-Focused%2520Virtual%2520Screening%253A%2520Prospective%2520Application%2520to%2520the%2520Discovery%2520of%2520TTK%2520Inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D1100%26epage%3D1112%26doi%3D10.1021%2Fci400100c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Chu, M. L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavas, L. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, L.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Catalytic Domain of the Mitotic Checkpoint Kinase Mps1 in Complex with SP600125</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">21495</span><span class="NLM_x">–</span> <span class="NLM_lpage">21500</span><span class="refDoi"> DOI: 10.1074/jbc.M803026200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1074%2Fjbc.M803026200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=18480048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21495-21500&author=M.+L.+H.+Chuauthor=L.+M.+G.+Chavasauthor=K.+T.+Douglasauthor=P.+A.+Eyersauthor=L.+Tabernero&title=Crystal+Structure+of+the+Catalytic+Domain+of+the+Mitotic+Checkpoint+Kinase+Mps1+in+Complex+with+SP600125&doi=10.1074%2Fjbc.M803026200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Catalytic Domain of the Mitotic Checkpoint Kinase Mps1 in Complex with SP600125</span></div><div class="casAuthors">Chu, Matthew L. H.; Chavas, Leonard M. G.; Douglas, Kenneth T.; Eyers, Patrick A.; Tabernero, Lydia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">21495-21500</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chromosomal instability can result from defective control of checkpoints and is assocd. with malignant cell growth.  Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase that has important roles in the prevention of aneuploidy during the cell cycle and might therefore be a potential target for new therapeutic agents in the treatment of cancer.  To gain insights into the mol. mechanism of Mps1 inhibition by small mols., we detd. the x-ray structure of Mps1, both alone and in complex with the ATP-competitive inhibitor SP600125.  Mps1 adopts a classic protein kinase fold, with the inhibitor sitting in the ATP-binding site where it is stabilized by hydrophobic interactions.  We identified a secondary pocket, not utilized by SP600125, which might be exploited for the rational design of specific Mps1 inhibitors.  These structures provide important insights into the interaction of this protein kinase with small mols. and suggest potential mechanisms for Mps1 regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVcfF84P3Cf7Vg90H21EOLACvtfcHk0lgdxT9kY-QP-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWrs7c%253D&md5=76da3ce88aacb04c6b216e05a3213f9c</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803026200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803026200%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DM.%2BL.%2BH.%26aulast%3DChavas%26aufirst%3DL.%2BM.%2BG.%26aulast%3DDouglas%26aufirst%3DK.%2BT.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DTabernero%26aufirst%3DL.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520the%2520Mitotic%2520Checkpoint%2520Kinase%2520Mps1%2520in%2520Complex%2520with%2520SP600125%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D21495%26epage%3D21500%26doi%3D10.1074%2Fjbc.M803026200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelluma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manak, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deveraux, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1038/nchembio.345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+P.+L.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+Mps1+cell+cycle+function&doi=10.1038%2Fnchembio.345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0lgdxT9kY-QP-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520Mps1%2520cell%2520cycle%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368%26doi%3D10.1038%2Fnchembio.345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alise, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span> </span><span class="NLM_article-title">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1083/jcb.201001036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1083%2Fjcb.201001036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20624901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=73-87&author=S.+Santaguidaauthor=A.+Tigheauthor=A.+M.+D%E2%80%99Aliseauthor=S.+S.+Taylorauthor=A.+Musacchio&title=Dissecting+the+role+of+MPS1+in+chromosome+biorientation+and+the+spindle+checkpoint+through+the+small+molecule+inhibitor+reversine&doi=10.1083%2Fjcb.201001036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span></div><div class="casAuthors">Santaguida, Stefano; Tighe, Anthony; D'Alise, Anna Morena; Taylor, Stephen S.; Musacchio, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-87</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The catalytic activity of the MPS1 kinase is crucial for the spindle assembly checkpoint and for chromosome biorientation on the mitotic spindle.  We report that the small mol. reversine is a potent mitotic inhibitor of MPS1.  Reversine inhibits the spindle assembly checkpoint in a dose-dependent manner.  Its addn. to mitotic HeLa cells causes the ejection of Mad1 and the ROD-ZWILCH-ZW10 complex, both of which are important for the spindle checkpoint, from unattached kinetochores.  By using reversine, we also demonstrate that MPS1 is required for the correction of improper chromosome-microtubule attachments.  We provide evidence that MPS1 acts downstream from the AURORA B kinase, another crucial component of the error correction pathway.  Our expts. describe a very useful tool to interfere with MPS1 activity in human cells.  They also shed light on the relationship between the error correction pathway and the spindle checkpoint and suggest that these processes are coregulated and are likely to share at least a subset of their catalytic machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPbUVMH1KC_7Vg90H21EOLACvtfcHk0lgdxT9kY-QP-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D&md5=fd022c4a8a7284eb5da7d67b04a6f8bb</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201001036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201001036%26sid%3Dliteratum%253Aachs%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Alise%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DDissecting%2520the%2520role%2520of%2520MPS1%2520in%2520chromosome%2520biorientation%2520and%2520the%2520spindle%2520checkpoint%2520through%2520the%2520small%2520molecule%2520inhibitor%2520reversine%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D73%26epage%3D87%26doi%3D10.1083%2Fjcb.201001036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2260</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.02.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.bmc.2015.02.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2247-2260&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=E.+Kojimaauthor=Y.+Mitsuokaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=H.+Yoshizawaauthor=H.+Muraiauthor=Y.+Nakamura&title=A+unique+hinge+binder+of+extremely+selective+aminopyridine-based+Mps1+%28TTK%29+kinase+inhibitors+with+cellular+activity&doi=10.1016%2Fj.bmc.2015.02.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.02.042%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DE.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DA%2520unique%2520hinge%2520binder%2520of%2520extremely%2520selective%2520aminopyridine-based%2520Mps1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520with%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2247%26epage%3D2260%26doi%3D10.1016%2Fj.bmc.2015.02.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disingrini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuvoloni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posteri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of new pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4507</span><span class="NLM_x">–</span> <span class="NLM_lpage">4511</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2Fj.bmcl.2011.05.122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4507-4511&author=M.+Caldarelliauthor=M.+Angioliniauthor=T.+Disingriniauthor=D.+Donatiauthor=M.+Guanciauthor=S.+Nuvoloniauthor=H.+Posteriauthor=F.+Quartieriauthor=M.+Silvagniauthor=R.+Colombo&title=Synthesis+and+SAR+of+new+pyrazolo%5B4%2C3-h%5Dquinazoline-3-carboxamide+derivatives+as+potent+and+selective+MPS1+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2011.05.122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.122%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DDisingrini%26aufirst%3DT.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGuanci%26aufirst%3DM.%26aulast%3DNuvoloni%26aufirst%3DS.%26aulast%3DPosteri%26aufirst%3DH.%26aulast%3DQuartieri%26aufirst%3DF.%26aulast%3DSilvagni%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520new%2520pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520MPS1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4507%26epage%3D4511%26doi%3D10.1016%2Fj.bmcl.2011.05.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennecozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depaolini, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucchi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span> </span><span class="NLM_article-title">Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">10255</span><span class="NLM_x">–</span> <span class="NLM_lpage">10264</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-2101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1158%2F0008-5472.CAN-10-2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=21159646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10255-10264&author=R.+Colomboauthor=M.+Caldarelliauthor=M.+Mennecozziauthor=M.+L.+Giorginiauthor=F.+Solaauthor=P.+Cappellaauthor=C.+Perreraauthor=S.+R.+Depaoliniauthor=L.+Rusconiauthor=U.+Cucchiauthor=N.+Avanziauthor=J.+A.+Bertrandauthor=R.+T.+Bossiauthor=E.+Pesentiauthor=A.+Galvaniauthor=A.+Isacchiauthor=F.+Colottaauthor=D.+Donatiauthor=J.+Moll&title=Targeting+the+Mitotic+Checkpoint+for+Cancer+Therapy+with+NMS-P715%2C+an+Inhibitor+of+MPS1+Kinase&doi=10.1158%2F0008-5472.CAN-10-2101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase</span></div><div class="casAuthors">Colombo, Riccardo; Caldarelli, Marina; Mennecozzi, Milena; Giorgini, Maria Laura; Sola, Francesco; Cappella, Paolo; Perrera, Claudia; Depaolini, Stefania Re; Rusconi, Luisa; Cucchi, Ulisse; Avanzi, Nilla; Bertrand, Jay Aaron; Bossi, Roberto Tiberio; Pesenti, Enrico; Galvani, Arturo; Isacchi, Antonella; Colotta, Francesco; Donati, Daniele; Moll, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10255-10264</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MPS1 kinase is a key regulator of the spindle assembly checkpoint (SAC), a mitotic mechanism specifically required for proper chromosomal alignment and segregation.  It has been found aberrantly overexpressed in a wide range of human tumors and is necessary for tumoral cell proliferation.  Here the authors report the identification and characterization of NMS-P715, a selective and orally bioavailable MPS1 small-mol. inhibitor, which selectively reduces cancer cell proliferation, leaving normal cells almost unaffected.  NMS-P715 accelerates mitosis and affects kinetochore components localization causing massive aneuploidy and cell death in a variety of tumoral cell lines and inhibits tumor growth in preclin. cancer models.  Inhibiting the SAC could represent a promising new approach to selectively target cancer cells.  Cancer Res; 70(24); 10255-64.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJeGyiQf0_uLVg90H21EOLACvtfcHk0lhi-g3m6N5AmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK&md5=6478b34886d1d2f2a364d142bbd388fe</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2101%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DMennecozzi%26aufirst%3DM.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DPerrera%26aufirst%3DC.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520Mitotic%2520Checkpoint%2520for%2520Cancer%2520Therapy%2520with%2520NMS-P715%252C%2520an%2520Inhibitor%2520of%2520MPS1%2520Kinase%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10255%26epage%3D10264%26doi%3D10.1158%2F0008-5472.CAN-10-2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgadze, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of orally bioavailable tyrosine threonine kinase (TTK) inhibitors: 3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3366</span><span class="NLM_x">–</span> <span class="NLM_lpage">3392</span><span class="refDoi"> DOI: 10.1021/jm501740a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501740a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3366-3392&author=Y.+Liuauthor=Y.+Langauthor=N.+K.+Patelauthor=G.+Ngauthor=R.+Lauferauthor=S.-W.+Liauthor=L.+Edwardsauthor=B.+Forrestauthor=P.+B.+Sampsonauthor=M.+Feherauthor=F.+Banauthor=D.+E.+Awreyauthor=I.+Beletskayaauthor=G.+Maoauthor=R.+Hodgsonauthor=O.+Plotnikovaauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=J.+M.+Masonauthor=X.+Weiauthor=D.+C.-C.+Linauthor=Y.+Cheauthor=R.+Kiarashauthor=B.+Madeiraauthor=G.+C.+Fletcherauthor=T.+W.+Makauthor=M.+R.+Brayauthor=H.+W.+Pauls&title=The+discovery+of+orally+bioavailable+tyrosine+threonine+kinase+%28TTK%29+inhibitors%3A+3-%284-%28heterocyclyl%29phenyl%29-1H-indazole-5-carboxamides+as+anticancer+agents&doi=10.1021%2Fjm501740a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501740a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520orally%2520bioavailable%2520tyrosine%2520threonine%2520kinase%2520%2528TTK%2529%2520inhibitors%253A%25203-%25284-%2528heterocyclyl%2529phenyl%2529-1H-indazole-5-carboxamides%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3366%26epage%3D3392%26doi%3D10.1021%2Fjm501740a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kusakabe, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Diaminopyridine-Based Potent and Selective Mps1 Kinase Inhibitors Binding to an Unusual Flipped-Peptide Conformation</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1021/ml3000879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3000879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=560-564&author=K.-i.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=K.+Higashinoauthor=Y.+Okanoauthor=G.+Tadanoauthor=Y.+Tachibanaauthor=Y.+Satoauthor=M.+Inoueauthor=T.+Wadaauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=S.+Tagashiraauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=T.+Yamamotoauthor=M.+Higakiauthor=T.+Endohauthor=K.+Uedaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Diaminopyridine-Based+Potent+and+Selective+Mps1+Kinase+Inhibitors+Binding+to+an+Unusual+Flipped-Peptide+Conformation&doi=10.1021%2Fml3000879"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fml3000879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000879%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-i.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DEndoh%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiaminopyridine-Based%2520Potent%2520and%2520Selective%2520Mps1%2520Kinase%2520Inhibitors%2520Binding%2520to%2520an%2520Unusual%2520Flipped-Peptide%2520Conformation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D560%26epage%3D564%26doi%3D10.1021%2Fml3000879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">The inherent acid lability of the Boc group prevented further development (further details will be published in due course).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebkYnT8a6icGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Innocenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Fee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Expanding the scope of fused pyrimidines as kinase inhibitor scaffolds: synthesis and modification of pyrido[3,4-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1039/C4OB02238F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1039%2FC4OB02238F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=893-904&author=P.+Innocentiauthor=H.+Woodwardauthor=L.+O%E2%80%99Feeauthor=S.+Hoelder&title=Expanding+the+scope+of+fused+pyrimidines+as+kinase+inhibitor+scaffolds%3A+synthesis+and+modification+of+pyrido%5B3%2C4-d%5Dpyrimidines&doi=10.1039%2FC4OB02238F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC4OB02238F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB02238F%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DExpanding%2520the%2520scope%2520of%2520fused%2520pyrimidines%2520as%2520kinase%2520inhibitor%2520scaffolds%253A%2520synthesis%2520and%2520modification%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D893%26epage%3D904%26doi%3D10.1039%2FC4OB02238F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bavetsias, V.; Atrash, B.; Naud, S. G. A.; Sheldrake, P. W.; Blagg, J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolopyridinamine derivatives as Mps1 inhibitors</span>. Patent WO2012123745A1,<span class="NLM_x"> </span><span class="NLM_year">September 20, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=September+20%2C+2012&author=V.+Bavetsias&author=B.+Atrash&author=S.+G.+A.+Naud&author=P.+W.+Sheldrake&author=J.+Blagg&title=Preparation+of+pyrrolopyridinamine+derivatives+as+Mps1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBavetsias%26aufirst%3DV.%26atitle%3DPreparation%2520of%2520pyrrolopyridinamine%2520derivatives%2520as%2520Mps1%2520inhibitors%26date%3DSeptember%252020%252C%25202012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dave, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span> </span><span class="NLM_article-title">Pyridopyrimidines. Part I. Synthesis and biological activity of 2-thiopyrido[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)]ones</span> <span class="citation_source-journal">Indian J. Chem., Sect. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">21B</span><span class="NLM_x">, </span> <span class="NLM_fpage">750</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaL3sXnt1SnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21B&publication_year=1982&pages=750-752&author=C.+G.+Daveauthor=P.+R.+Shahauthor=V.+B.+Desaiauthor=S.+Srinivasan&title=Pyridopyrimidines.+Part+I.+Synthesis+and+biological+activity+of+2-thiopyrido%5B2%2C3-d%5Dpyrimidin-4%283H%29%5Dones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyridopyrimidines.  Part I.  Synthesis and biological activity of 2-thiopyrido[2,3-d]pyrimidin-4(3H)]ones</span></div><div class="casAuthors">Dave, C. G.; Shah, P. R.; Desai, V. B.; Srinivasan, S.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">21B</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">750-2</span>CODEN:
                <span class="NLM_cas:coden">IJSBDB</span>;
        ISSN:<span class="NLM_cas:issn">0376-4699</span>.
    </div><div class="casAbstract">Thiopyridopyrimidinones I (R = Ph, Bu, PhCH2, MeC6H4, 3-ClC6H4, 4-MeOC6H4, cyclohexyl; R1 = H, Me; R2 = Me, Ph) were prepd. by condensation of aminopyridines II with isothiocyanates followed by cyclization of the resultant thioureas (III).  I and III were tested for antibacterial and antihistaminic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhw8UQ74uN0bVg90H21EOLACvtfcHk0lh9k0Hplf1n0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXnt1SnsA%253D%253D&md5=3b605340ab7123ebabd6b55ae4786d91</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDave%26aufirst%3DC.%2BG.%26aulast%3DShah%26aufirst%3DP.%2BR.%26aulast%3DDesai%26aufirst%3DV.%2BB.%26aulast%3DSrinivasan%26aufirst%3DS.%26atitle%3DPyridopyrimidines.%2520Part%2520I.%2520Synthesis%2520and%2520biological%2520activity%2520of%25202-thiopyrido%255B2%252C3-d%255Dpyrimidin-4%25283H%2529%255Dones%26jtitle%3DIndian%2520J.%2520Chem.%252C%2520Sect.%2520B%26date%3D1982%26volume%3D21B%26spage%3D750%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lh9k0Hplf1n0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">46</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2005%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pesson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabassier, S.</span><span> </span><span class="NLM_article-title">Nitriles and amide-oximes of 8-alkyl-5-oxo}5,8-dihydro[2,3-d]pyrido-6-pyrimidinecarboxylic acids</span> <span class="citation_source-journal">C. R. Seances Acad. Sci., Ser. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaE2MXht1Ggtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1974&pages=413-415&author=M.+Pessonauthor=S.+Chabassier&title=Nitriles+and+amide-oximes+of+8-alkyl-5-oxo%7D5%2C8-dihydro%5B2%2C3-d%5Dpyrido-6-pyrimidinecarboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nitriles and amide-oximes of 8-alkyl-5-oxo}5,8-dihydro[2,3-d]pyrido-6-pyrimidinecarboxylic acids</span></div><div class="casAuthors">Pesson, Marcel; Chabassier, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus des Seances de l'Academie des Sciences, Serie C:  Sciences Chimiques</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">413-15</span>CODEN:
                <span class="NLM_cas:coden">CHDCAQ</span>;
        ISSN:<span class="NLM_cas:issn">0567-6541</span>.
    </div><div class="casAbstract">Pyridopyrimidinecarboxamidoximes I [R = pyrrolidino, morpholino, piperidino, 4-methylpiperazino, SMe; R1 = C(:NOH)NH2] were prepd. by treating the pyrimidinecarboxy-lates II (R = Cl, SMe; R2 = Cl) with EtNHCH2CH2CN to give II (R = Cl, SMe; R2 = NEtCH2CH2CN), treating II (R = Cl, R2 = NEtCH2CH2CN) with secondary amines, cyclizing with KOCMe3 to III (R = pyrrolidino, morpholino, piperidino, 4-methylpiperazino), brominating-dehydrobrominating to I (R1 = CN) and treating with NH2OH.  Conversion of the CO2H group to C(:NOH)NH2 eliminated the antibacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLp1GhqJvMr7Vg90H21EOLACvtfcHk0lh9k0Hplf1n0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXht1Ggtro%253D&md5=202d92db0e14f4e63e68975e811a970f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPesson%26aufirst%3DM.%26aulast%3DChabassier%26aufirst%3DS.%26atitle%3DNitriles%2520and%2520amide-oximes%2520of%25208-alkyl-5-oxo%257D5%252C8-dihydro%255B2%252C3-d%255Dpyrido-6-pyrimidinecarboxylic%2520acids%26jtitle%3DC.%2520R.%2520Seances%2520Acad.%2520Sci.%252C%2520Ser.%2520C%26date%3D1974%26volume%3D279%26spage%3D413%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ajiro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimoto, T.</span><span> </span><span class="NLM_article-title">Specific site of histone H3 phosphorylation related to the maintenance of premature chromosome condensation. Evidence for catalytically induced interchange of the subunits</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">15379</span><span class="NLM_x">–</span> <span class="NLM_lpage">15381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1985&pages=15379-15381&author=K.+Ajiroauthor=T.+Nishimoto&title=Specific+site+of+histone+H3+phosphorylation+related+to+the+maintenance+of+premature+chromosome+condensation.+Evidence+for+catalytically+induced+interchange+of+the+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAjiro%26aufirst%3DK.%26aulast%3DNishimoto%26aufirst%3DT.%26atitle%3DSpecific%2520site%2520of%2520histone%2520H3%2520phosphorylation%2520related%2520to%2520the%2520maintenance%2520of%2520premature%2520chromosome%2520condensation.%2520Evidence%2520for%2520catalytically%2520induced%2520interchange%2520of%2520the%2520subunits%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1985%26volume%3D260%26spage%3D15379%26epage%3D15381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Juan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traganos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauve, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darzynkiewicz, Z.</span><span> </span><span class="NLM_article-title">Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis</span> <span class="citation_source-journal">Cytometry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=9627219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVCls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=71-77&author=G.+Juanauthor=F.+Traganosauthor=W.+M.+Jamesauthor=J.+M.+Rayauthor=M.+Robergeauthor=D.+M.+Sauveauthor=H.+Andersonauthor=Z.+Darzynkiewicz&title=Histone+H3+phosphorylation+and+expression+of+cyclins+A+and+B1+measured+in+individual+cells+during+their+progression+through+G2+and+mitosis&doi=10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis</span></div><div class="casAuthors">Juan, Gloria; Traganos, Frank; James, William M.; Ray, Jill M.; Roberge, Michel; Sauve, Debra M.; Anderson, Hilary; Darzynkiewicz, Zbigniew</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">CYTODQ</span>;
        ISSN:<span class="NLM_cas:issn">0196-4763</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The phosphorylation of histone H3 (H3) on Ser-10 correlates with chromatin condensation at mitosis.  Here, a new monoclonal antibody (anti-H3-P) was developed that recognizes phosphorylated H3 (H3-P).  This antibody was used in multiparameter flow cytometric anal. to relate H3 phosphorylation in individual human leukemic cells to the cells' position in the cycle as well as their expression of cyclins A and B1.  Mitotic cells, from prophase to telophase, reacted with anti-H3-P; the binding of the antibody to chromatin of interphase cells was several times weaker.  Cell growth in the presence of staurosporine, an inhibitor of the kinase(s) that phosphorylate H3, abolished the cells' reactivity with the antibody.  The reactivity also was abolished by incubation of permeabilized mitotic cells with alk. phosphatase.  These data indicated that, within permeabilized cells, the antibody was indeed specific for H3-P and did not detect the unphosphorylated epitope.  All cells reacting with anti-H3-P, with the exception of prophase and early prometaphase, were cyclin A-neg.; the expression of cyclin B1 in these cells was 3-fold higher than in G2 cells.  The anal. of phosphorylation of H3 in individual cells when combined with multiparameter anal. of their cycle position and expression of other proteins offers new possibilities to study mol. mechanisms assocd. with the G2-to-M transition and chromatin condensation.  It also offers an assay to screen in vivo inhibitors of kinase(s) or phosphatase(s) involved in H3 phosphorylation or dephosphorylation, and it provides a valuable marker to identify mitotic cells by cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxV2YQJ_iAILVg90H21EOLACvtfcHk0lgSEDT8tdI1iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVCls7k%253D&md5=ab569687a961da48a4a163bf93b747f8</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0320%252819980601%252932%253A2%253C71%253A%253AAID-CYTO1%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DJuan%26aufirst%3DG.%26aulast%3DTraganos%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DW.%2BM.%26aulast%3DRay%26aufirst%3DJ.%2BM.%26aulast%3DRoberge%26aufirst%3DM.%26aulast%3DSauve%26aufirst%3DD.%2BM.%26aulast%3DAnderson%26aufirst%3DH.%26aulast%3DDarzynkiewicz%26aufirst%3DZ.%26atitle%3DHistone%2520H3%2520phosphorylation%2520and%2520expression%2520of%2520cyclins%2520A%2520and%2520B1%2520measured%2520in%2520individual%2520cells%2520during%2520their%2520progression%2520through%2520G2%2520and%2520mitosis%26jtitle%3DCytometry%26date%3D1998%26volume%3D32%26spage%3D71%26epage%3D77%26doi%3D10.1002%2F%28SICI%291097-0320%2819980601%2932%3A2%3C71%3A%3AAID-CYTO1%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Honold, K.; Paul, J.; Roeschlaub, C.; Schaefer, W.; Scheiblich, S.; Von, H.; Thomas; Whittle, A.</span><span> </span><span class="NLM_article-title">Preparation of 7H-pyrido[3,4-d]pyrimidin-8-ones as protein kinase inhibitors</span>. Patent WO2007088014A1, August 9,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+Honold&author=J.+Paul&author=C.+Roeschlaub&author=W.+Schaefer&author=S.+Scheiblich&author=H.+Von&author=+Thomas&author=A.+Whittle&title=Preparation+of+7H-pyrido%5B3%2C4-d%5Dpyrimidin-8-ones+as+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHonold%26aufirst%3DK.%26atitle%3DPreparation%2520of%25207H-pyrido%255B3%252C4-d%255Dpyrimidin-8-ones%2520as%2520protein%2520kinase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Software XDS for image rotation, recognition and crystal symmetry assignment</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Software+XDS+for+image+rotation%2C+recognition+and+crystal+symmetry+assignment&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgSEDT8tdI1iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DSoftware%2520XDS%2520for%2520image%2520rotation%252C%2520recognition%2520and%2520crystal%2520symmetry%2520assignment%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhKj3Tf1YuJFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lhKj3Tf1YuJFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhKj3Tf1YuJFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhKj3Tf1YuJFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER, version 2.11.4; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0liOKfTnWZsiiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Smart, O. S.; Womack, T. O.; Sharff, A.; Flensburg, C.; Keller, P.; Paciorek, W.; Vonrhein, C.; Bricogne, G.</span>Grade, version 1.2.1; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=O.+S.+Smart&author=T.+O.+Womack&author=A.+Sharff&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=C.+Vonrhein&author=G.+Bricogne&title=Grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DO.%2BS.%26jtitle%3DGrade%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bruno, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lommerse, J. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span> </span><span class="NLM_article-title">Isostar: a library of information about nonbonded interactions</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1023/A:1007934413448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1023%2FA%3A1007934413448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=9491345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A528%3ADyaK1cXht1Olu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=525-537&author=I.+J.+Brunoauthor=J.+C.+Coleauthor=J.+P.+M.+Lommerseauthor=R.+S.+Rowlandauthor=R.+Taylorauthor=M.+L.+Verdonk&title=Isostar%3A+a+library+of+information+about+nonbonded+interactions&doi=10.1023%2FA%3A1007934413448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Isostar: a library of information about nonbonded interactions</span></div><div class="casAuthors">Bruno, Ian J.; Cole, Jason C.; Lommerse, Jos P. M.; Rowland, R. Scott; Taylor, Robin; Verdonk, Marcel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Crystallog. and theor. (ab initio) data on intermol. nonbonded interactions were gathered together in a computerized library ('IsoStar').  The library contains information about the nonbonded contacts formed by some 250 chem. groupings.  The data can be displayed visually and used to aid protein-ligand docking or the identification of bioisosteric replacements.  Data from the library show that there is great variability in the geometrical preferences of different types of hydrogen bonds, although in general there is a tendency for H-bonds to form along lone-pair directions.  The H-bond acceptor abilities of oxygen and sulfur atoms are highly dependent on intramol. environments.  The nonbonded contacts formed by many hydrophobic groups show surprisingly strong directional preferences.  Many unusual nonbonded interactions are to be found in the library and are of potential value for designing novel biol. active mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcIzn6KO_NVbVg90H21EOLACvtfcHk0liOKfTnWZsiiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht1Olu7s%253D&md5=ec168252a1dc7bddc341235db0f5ccfb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007934413448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007934413448%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DLommerse%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26atitle%3DIsostar%253A%2520a%2520library%2520of%2520information%2520about%2520nonbonded%2520interactions%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D525%26epage%3D537%26doi%3D10.1023%2FA%3A1007934413448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaver-Fay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snoeyink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">W375</span><span class="NLM_x">–</span> <span class="NLM_lpage">W383</span><span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-W383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eY7aqLm7M5dt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3DW383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farningham, D. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span> </span><span class="NLM_article-title">Guidelines for the welfare and use of animals in cancer research</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1577</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+H.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2eY7aqLm7M5dt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%2BH.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J','PDB','4C4J'); return false;">PDB: 4C4J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHY','PDB','5EHY'); return false;">PDB: 5EHY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6','PDB','5EI6'); return false;">PDB: 5EI6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2','PDB','5EI2'); return false;">PDB: 5EI2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8','PDB','5EI8'); return false;">PDB: 5EI8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0','PDB','5EH0'); return false;">PDB: 5EH0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01811">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13651"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01811">10.1021/acs.jmedchem.5b01811</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental procedures and analytical data for final compounds <b>24b</b>, <b>24c</b>, <b>28c</b>, <b>28d</b>, <b>28e</b>, <b>33b</b>, <b>34b</b>–<b>e</b>, <b>34g</b>, <b>34h</b>, intermediates and formamides. Aurora A and B inhibition data available for all compounds. CYP and hERG activity as well as kinase selectivity profiling of <b>34h</b>. Crystallographic analysis of compounds <b>15b</b>, <b>24b</b>, <b>24c</b>, <b>34e</b>, <b>39</b> bound to MPS1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_001.csv">jm5b01811_si_001.csv (3.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01811/suppl_file/jm5b01811_si_002.pdf">jm5b01811_si_002.pdf (281.34 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for compounds <b>1</b>, <b>15b</b>, <b>24b</b>, <b>24c</b>, <b>34e</b> and <b>39</b> can be accessed using PBD codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI6">5EI6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI2">5EI2</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EI8">5EI8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0">5EH0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHY">5EHY</a>, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-8%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01811%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01811" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a2ec798943ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
